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This work represents part of an investigation testing the hypothesis that 
polymorphisms in circadian genes are associated with variation in circadian 
phenotype. Clock was selected as a suitable gene to investigate since previous studies 
showed that a splice site mutation in mice altered circadian period (tau) and sleep. In 
humans, a polymorphism had been linked with diurnal preference.
By screening genetic databases (Genbank), three potential coding polymorphisms 
were identified. Two of these (a single nucleotide polymorphism causing substitution 
of glutamate for a lysine codon (exon 13) and insertion of a glutamine codon (exon 
20)) were assessed in:
1) Blind subjects (free running rhythms, previously characterised tau values)
2) Clinically diagnosed delayed sleep phase syndrome patients
3) Control subjects
The polymorphisms were not observed in these populations. The third polymorphism 
identified was a single nucleotide polymorphism that altered the amino acid residue 
present in exon 14.
To assess if novel Clock polymorphisms were associated with variation in tau, regions 
of Clock were amplified from subject DNA (population 1 above) and sequenced. No 
polymorphisms were identified suggesting that the variation in tau observed was not 
linked to polymorphisms in the regions of Clock investigated.
Since the Clock gene polymorphism at the 3111 locus in the 3’ untranslated region 
was reported to be associated with diurnal preference, it was assessed to investigate 
whether it was associated with tau and/ or delayed sleep phase syndrome. 
Simultaneously, a functional assay was developed to investigate a possible role for 
this polymorphism in mRNA stability/ translatability. However, no association was 
observed between this polymorphism and either tau or delayed sleep phase syndrome. 
In addition, no differences were observed in the functional assay between the two 
alleles. Finally, this polymorphism was assessed in subjects with extreme diurnal 
preferences (characterised as part of this thesis). No association was observed 
suggesting that the conclusions made in the previous investigation were invalid.
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1. INTRODUCTION
1.1 Regulation of gene expression in mammals
The regulation of eukaryotic gene expression is an extremely complex multistage 
process that can be influenced by both intracellular and extracellular factors at each 
stage. The DNA sequence of the whole gene and its surroundings on the chromosome 
are important to this process since, in addition to encoding the amino acid sequence of 
the protein, it also contains information which directs transcription and translation 
through the binding of specific motifs in either DNA or RNA, and processes such as 
splicing, polyadenylation, mRNA protection and degradation, and localisation signals. 
Some of these signals may be cell and/or tissue specific and so expression of 
particular genes in particular tissues can be controlled.
The non-coding regions include the regions upstream and downstream of a gene in 
which the 5’ (upstream) and 3’ (downstream) untranslated regions (5’ UTR and 3’ 
UTR) are situated. In addition to containing the 5’ UTR, the region upstream of the 
gene contains the promoter region from which transcription is initiated by RNA 
polymerase II, and a number of site specific sequences to which transcriptional 
regulators can bind and then act in either an inhibiting or enhancing manner, for 
example by causing the DNA structure to change so that another component of the 
transcriptional machinery can bind.
Once transcribed the heteronuclear RNA (hnRNA) is processed to produce mRNA. 
Capping usually takes place involving the addition of a methylated guanosine to the 
5’ end of the transcribed RNA molecule. Addition of a cap is thought to help resist
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exonuclease attack at the 5’ end of the molecule, and also assist in splicing and the 
transportation of mRNA from the nucleus to the cytoplasm. In addition, a poly A tail 
is usually added to the 3’ end of the molecule after cleavage has occurred at a 
designated site. For this to happen, certain sequence motifs again need to be present. 
The poly A tail is thought to stabilise the mRNA structure and assist with 
transportation and also translation. Splicing occurs in the nucleus with the removal of 
intronic material resulting in a mature mRNA molecule. The exact function of these 
intronic regions is unclear. However, they may contain regulatory information 
required during transcription. In addition, they contain the conserved sequence motifs 
required for splicing. In certain cases RNA editing may also occur, with enzymes 
substituting or modifying certain nucleotides; for example adenosine can be 
deaminated to inosine which is read as guanine by translational machinery (Shaub and 
Keller, 2002). The 5’ and 3’ UTRs are present in messenger RNA after splicing has 
occurred but are not translated and are thought to contain the sequence information 
that determines mRNA stability and localisation, and controls translation.
The mature mRNA molecule is transported to the cytoplasm ready for translation. 
This is initiated from an AUG (methionine) codon embedded in a specific sequence 
motif. Amino acids are linked together in the correct order by tRNA molecules that 
translate the information contained in the mRNA via the ribosomal machinery. The 
mRNA sequence is read in groups of three nucleotides. There are a possible 64 
different triplet codon combinations, three of which signal termination of translation. 
The remaining combinations code for 20 amino acids and thus some amino acids are 
represented by more than one triplet codon. In addition, the codon UGA that usually 
signals termination may be recognised as a site for the insertion of selenocysteine (a
2
cysteine residue with selenium attached) if specific cis- and trans- acting elements are 
present, leading to the production of a selenoprotein (Driscoll and Copeland, 2003). 
Within a particular species there is usually one preferred codon per amino acid with 
the tRNA containing the appropriate anticodon being more abundant. When an amino 
acid is encoded by a less frequent codon, there may be a slight pause in translation 
until the correct tRNA anticodon is encountered. However, in the majority of cases, a 
tRNA with at least the first two bases of the codon matching those in the anticodon is 
sufficient. Sequences situated within the 5’ and 3’ untranslated region are responsible 
for stabilisation/degradation of the mRNA and also for recruiting the ribosomal 
machinery during translation.
Once a protein has been produced, it can undergo further modification. Enzymes can 
modify a number of amino acids - phosphorylation, méthylation, hydroxylation, 
acétylation, carboxylation and glycosylation of specific residues can occur. For 
example threonine, tyrosine and serine residues can be phosphorylated if they are 
surrounded by a particular amino acid sequence that is recognised by the appropriate 
enzyme. Cleavage of polypeptide chains can also occur either removing localisation 
signals or alternatively splitting a large chain into smaller mature components. Certain 
motifs may also be present in the protein that cause it to fold in a particular manner or 
bind to other proteins or entities that assist in its function such as co-factors. In 
addition, there may be amino acid motifs present that are recognised by chaperone 
proteins causing the protein to be transported to a particular sub-cellular site or label it 
for export. The processes involved in gene expression are summarised in Figure 1.1.
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1.1.1 Mutations
Mutations occurring in the coding regions of genes could potentially alter the amino 
acid sequence of the resulting protein, the rate at which it is translated (Hartl and 
Clark, 1989) or introduce/destroy a splice site. Mutations occurring in other regions of 
genes could alter the sequence information that is used to initiate, direct and terminate 
transcription, translation and processes such as splicing and mRNA stability thus 
potentially affecting the rate and amount of mRNA and/or protein produced. The 
kinds of mutations that can occur are summarised in Table 1.1.
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Table 1.1: Types of mutations observed in genes
Polymorphism Description
Base substitution/Single 
nucleotide polymorphism 
(SNP):
One nucleotide is replaced by another
Transition C to T or T to C (pyrimidine to pyrimidine); A to G or G to A 
(purine to purine) substitutions
Transversion A or G to C or T (purine to pyrimidine); C or T to A or G 
(pyrimidine to purine)
Classification of 
substitutions in coding 
regions:
Silent/Synonymous The substituted base does not alter the amino acid sequence of 
the protein. However, due to preferred codon usage, translation 
rate may be altered (Hartl and Clark, 1989) or a splice site may be 
destroyed/created.
Mis-sense/Non-
synonymous
The substitution alters the amino acid inserted:
i) Conservative- the amino acid is similar in properties 
to the one replaced
ii) Non-conservative- the amino acid is different in 
properties to the one replaced
Non-sense
The substitution causes a stop codon to be introduced in the 
place of an amino acid
Insertions/Deletions:
Base insertion/deletion The insertion/deletion of one nucleotide- if in the coding region 
this results in a frameshift- a shift in the translational reading 
frame usually leading to a different sequence of amino acids 
downstream from the mutation
Codon insertion/deletion The insertion/deletion of three nucleotides leading to the insertion/ 
deletion of one amino acid- the remaining amino acid sequence is 
unaffected. This may lead to a change in protein structure causing 
altered or loss of function depending on exactly where the amino 
acid is inserted/deleted
Larger insertion/deletion The insertion/deletion of a larger region of DNA. This can be 
caused by unequal crossing over at DNA recombination, through 
tandem repeat duplication caused by slipped strand mis-pairing 
during DNA replication or through transposable elements
Dynamic The expansion/ contraction of highly unstable trinucleotide 
repeats. Repeat lengths below a certain level are stable in mitosis 
and meiosis, but above this level they become increasingly 
unstable. The mutation changes as it passes from parent to child 
with the possibility of both expansion and contraction
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1.2 Circadian rhythms
Biological rhythms that take approximately 24 hours to complete one cycle are known 
as circadian rhythms. They respond to changes in the predictable light-dark cycle, and 
include for example melatonin production, core body temperature and the sleep-wake 
cycle in humans. Other non-photic environmental stimuli such as activity and meal 
timing are also known to act as synchronisers (Arendt, 1998a). Circadian rhythms 
persist in constant conditions and are endogenously generated by a circadian oscillator 
located in the suprachiasmatic nuclei (SCN) (Weaver, 1998). In such circumstances, 
the organism is said to be ‘free-running’ and the intrinsic endogenous period (t) is 
expressed. In humans this is usually slightly longer than 24 hours (Arendt, 1998a, 
Czeisler et al., 1999). Circadian rhythms allow an organism to predict the oncoming 
environmental changes and prepare for them in advance (Turek, 1998). However, if 
the externally imposed time cues are altered in some way, for example variation in the 
light-dark cycle due to seasonal changes or time zone differences, then the circadian 
system needs to be able to respond and reset itself, otherwise organisms could not 
adapt to the new cycle pattern and would be at a selective disadvantage (Foster and 
Provencio, 1999). The circadian system is thus driven endogenously but is capable of 
responding to external stimuli that can synchronise it in response to environmental 
time cues.
1.3 Circadian rhythms in hiimans
Many biochemical, behavioural and physiological activities are influenced by the 
circadian system. These include the endocrine, immune, digestive, cardiovascular and 
urinaiy systems and processes such as drug metabolism (Arendt, 1995). Hence
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lifestyle, susceptibility to and treatment of all diseases are influenced by the circadian 
system.
One population group in particular that would benefit from a greater understanding of 
the circadian system is shift workers. It is estimated that approximately 20 % of the 
population of developed countries work shifts. Since humans are diurnal (adapted to 
be active during the day), night shift work causes individuals to become 
desynchronised from environmental and social cues. Adaptation to the new shift work 
schedule can be slow and perpetual desynchronisation can occur in cases of 
continuous shift rotation. It has been reported that shift workers suffer from sleep 
disruption and fatigue, gastrointestinal diseases and have an increased risk of 
cardiovascular disease. Abnormal responses to nighttime meals have been observed in 
shift work situations with evidence for insulin resistance and lipid intolerance: risk 
factors for cardiovascular disease (Hampton et al., 1996). Some shift schedules favour 
adaptation more than others (Barnes et al., 1998). Individual variation in response is 
frequently observed (Gibbs et al., 2002). This may be due in part to the intra­
individual variation observed in time of day preferences in the human population.
As well as shift workers, the lifestyles of other individuals are also influenced by 
insufficient adaptation to environmental and social cues such as in the case of jet lag 
(Arendt, 1997) and blindness (Lockley et al., 1997). In addition, a number of 
circadian rhythm sleep disorders have been identified such as advanced sleep phase 
syndrome (ASPS) and delayed sleep phase syndrome (DSPS). In each of these 
disorders individuals are typically entrained with an approximate 24-hour rhythm. 
However, the phase of their circadian rhythms and sleep patterns is extremely early in
the case of ASPS or late in the case of DSPS, making it difficult to adapt to usual 
daily routines.
1.3.1 Measurement of circadian phenotype
Circadian phenotype can be measured in a number of different ways. To determine 
the length of a subject’s endogenous period (%), it is usual to measure an output 
marker of the circadian clock in constant conditions, i.e. a ‘time-free’ environment. 
Usual output markers that exhibit robust endogenous circadian rhythm patterns 
include melatonin, cortisol, core body temperature and the activity-rest cycle (Arendt,
1995). The most frequently used marker is melatonin. The production of melatonin 
from the pineal gland is the best-characterised circadian output pathway and assays 
have been developed to measure melatonin in plasma (Fraser et al., 1983) and saliva 
(English et al., 1993). The saliva method has the advantage of non-invasive sample 
collection, whereas the plasma method allows collection of samples from a cannula 
without having to wake subjects during the night. In addition, an assay has been 
developed to measure the main metabolite of melatonin, 6-sulphatoxymelatonin 
(amT6s) in urine (Aldhous et al., 1988). This approach is also non-invasive and is 
appropriate for use in the field with an overnight collection period so that subjects do 
not have to wake up for sample collection.
Recently, a study showed that z (determined using core body temperature as a marker) 
was correlated with wake time, diurnal preference determined using the validated 
Horne-Ostberg (HO) questionnaire (Home and Ostberg, 1976) and entrained phase 
(determined using core body temperature) in young adults (Duffy et al., 2001). 
Subjects with shorter i  values had increased morning preferences and earlier phases
and wake times than those with longer x values. Another study by Duffy and 
colleagues in older individuals reported a trend between wake time and x (P=0.07) 
and between HO score and x (P=0.11) in the same direction as observed in the young 
individuals (Duffy et al., 2002). However, in contrast, no association was observed 
between phase (assessed using core body temperature measurements) and x. The 
authors reported that the x values between the young and old subject groups were not 
significantly different, in contrast to previous reports which suggested that the earlier 
wake times observed in older subjects were due to a shortening of x (Czeisler et al., 
1986). Hence, an estimation of x can be obtained using the HO questionnaire 
especially in young adults. However, it is not as precise as measuring actual x in 
controlled conditions and is perhaps not as accurate in older individuals as it is in 
younger individuals.
Assessment of circadian phenotype is important, in particular for the analysis of 
disorders in which the circadian system has a role such as DSPS (Nagtegaal et al., 
1998). In addition, analysis of endogenous circadian phenotype could assist in 
understanding inter-individual variations in adapting to situations where 
environmental time cues are altered such as shift work schedules and jet lag. The 
determination of the circadian phenotype of an individual may also improve treatment 
by indicating the most effective times for medication. For example, it has been shown 
that survival rate and treatment can be improved if drugs for ovarian cancer are given 
at specific circadian times (Kobayashi et al., 2002).
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1.3.1.1 Horne-Ostberg questionnaire
The Horne-Ostberg questionnaire (Home and Ostberg, 1976) was adapted from an 
original Swedish language questionnaire and is used as a tool for assessing diurnal 
preference. Initially, 22 questions were tested for inclusion in the final assessment 
tool. However, three of these did not satisfy validation criteria. Thus, the final 
questionnaire consists of 19 questions that are either multiple choice or a time line is 
provided for an individual’s answer (Appendix 1). A scoring scheme that ranges from 
16-86 was devised based on the responses of 150 subjects aged between 18 and 32 
years. It is divided into five categories:
Definite morning type: 70-86
Moderate morning type: 59-69
Neither type: 42-58
Moderate evening type: 31-41
Definite evening type: 16-30
The questionnaire was validated against daily oral temperature measurements of 48 of 
the initial 150 volunteers (selected randomly). During a 3-week period, these subjects 
were asked to measure their temperature approximately every half an hour daily 
whilst they were awake in their usual environment i.e. entrained, habitual conditions. 
This study group consisted of 18 definite/moderate morning types, 20 definite/ 
moderate evening types and 10 intermediate types. Analysis of the oral temperature 
data showed that the peaks of the oral temperature curves for the morning, 
intermediate and evening groups occurred at 19:32, 20:25 and 20:40 h: mins 
respectively with the morning and evening peak times being significantly different 
from each other.
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Since its introduction the HO questionnaire has been used extensively in the field. HO 
score has been shown to increase with age i.e. individuals tend towards increased 
momingness as they get older (Carrier et al., 1997). In addition, it has been reported 
that females have increased morning tendencies compared to males (Chelminski et al., 
1997). The questionnaire has been translated into other languages (e.g. Kerkhof, 
1984) and adapted into other versions including a shortened one (Adan and Almirall, 
1991) and a version for school children for whom some of the original questions 
would not be relevant (Carskadon et al., 1993).
A number of other questionnaires have been developed to assess diurnal preference. 
However, in a study comparing three of the commonly used questionnaires by 
psychometric analysis, the HO questionnaire was deemed to be the most accurate 
(Smith et al., 1989). Extensive validation has been conducted for the HO 
questionnaire since its introduction in 1976 making it the questionnaire of choice for 
research of this kind. As previously stated (section 1.3.1), Duffy and co-workers 
(2001, 2002) investigated the association between HO score and x in young and old 
individuals. A correlation between these two factors was observed in young subjects 
and a trend in the same direction was observed in older subjects but this was not 
significant (P=0.11). Hence, the questionnaire can give a good indication of x but is 
naturally not as accurate or precise as actual measurement of x. However, these 
measurements are time consuming and laborious.
1.3.1.2 Measurement of x in free-running blind subjects
Although factors such as meal timing and exercise have been shown to influence the 
circadian system, the light-dark cycle appears to be the most important environmental
12
time cue and without it individuals can become abnormally entrained or even free run 
and become desynchronised from their environment. A study assessing the melatonin 
rhythms of blind individuals reported that of the 30 subjects who were classified as 
having no visual light perception, only seven showed normal 24-hour entrainment in 
their habitual environment (Lockley et al., 1997). Five possessed abnormally 
entrained melatonin rhythms. In these cases, the rhythm exhibited 24-hour periodicity 
but was either phase advanced or phase delayed compared to normally entrained 
subjects. The remaining subjects (n=17) exhibited free-running melatonin rhythms 
and so did not appear to be entrained in their usual environment. Therefore, their t 
values could be assessed in the field in their habitual environments.
1.3.1.3 Characterisation of DSPS
The properties of sleep are thought to be determined by the integration of 
environmental and social factors with two endogenous systems implicated in sleep 
control: the homeostatic system (thought to record previous sleep history), and the 
circadian system (Dijk and Lockley, 2002).
DSPS is typically characterised by a larger phase delay of the sleep-wake cycle than 
observed in the normal population (Weitzman et al., 1981). Individuals diagnosed 
with DSPS suffer from sleep onset insomnia and do not usually fall asleep until 02:00 
-  06:00. These patients also find it extremely difficult to rise at conventional times the 
next day, preferring to sleep until late morning/early afternoon (Ancoli-Israel et al., 
2001). DSPS is usually classed as a circadian rhythm disorder. However, the 
underlying factors that contribute to its cause are unclear. A recent study conducted 
by Shibui and colleagues (2001) investigated sleep-wake and melatonin rhythms in
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DSPS subjects. The phases of both sleep and melatonin were found to be significantly 
delayed compared to normal subjects. In addition, the length of the sleep episode and 
the timing between wake up time and the melatonin onset, mid point and offset time 
were longer than observed in normal subjects. Timing between sleep onset and 
melatonin timing was not found to be different. The authors concluded that both a 
delay of the circadian system and a functional disturbance of the sleep-wake system 
could be responsible for DSPS in these subjects.
1.4 The circadian machinery in mammals
Although the vast majority of experiments conducted in order to elucidate the 
pathways and components of the mammalian system have been conducted in rodents. 
This information is inferred to be relevant in humans (Turek, 1998).
The circadian system consists of three major components:
i) Input pathways
ii) Central oscillator
iii) Output pathways
1.4.1 Input pathways
As previously stated, light appears to be the most important environmental time cue 
and so information concerning changes in the light-dark cycle must be collected and 
interpreted by the body. Information concerning input from other environmental time 
cues also needs to be processed and then possibly integrated with information from 
the photic input pathway either before or when it reaches the central pacemaker.
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1.4.1.1 Photic input
In mammals, it is accepted that photic input occurs via ocular photoreception since 
ocular enucleation of mice causes them to free-run (Foster, 1998). Additionally, in 
humans, individuals with no eyes display a greater occurrence of free-running 
circadian rhythms compared to those with one eye, and in turn those with one eye 
display more circadian abnormalities than those with two intact eyes (Lockley et al.,
1997). In mice in which the visual photoreceptors (rods and cones) are lacking, 
unattenuated circadian responses to light are still observed (Freedman et al., 1999, 
Lucas et al., 1999). In addition, it appears that these responses are still maintained in 
mice lacking Cryptochromes 1 and 2. Cryptochrome fulfils a role as a circadian 
photoreceptor in Drosophila (Cashmore et al., 1999). One report suggested that 
entrainment was possible in humans through exposure of the popliteal region behind 
the knee to bright light (Campbell and Murphy, 1998) followed by humoral 
phototransduction (Oren, 1996). However, this suggestion has been comprehensively 
disproven (Lockley et al., 1998, Wright and Czeisler, 2002). A recent report suggests 
that melanopsin, a novel photoreceptor, is mainly responsible for circadian light 
perception (Hattar et al., 2003, Panda et al., 2003). The study conducted by Hattar and 
colleagues (2003) shows that in mice in which the melanopsin gene has been ablated, 
the ganglion cells that would normally be photoreceptive to light via melanopsin fail 
to respond and circadian features of behaviour are impaired. Mice lacking melanopsin 
and containing disabled rods and cones do not entrain at all to light suggesting that 
these three photoreceptors are responsible for circadian photoreception.
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1.4.1.2 Non-photic input
Other investigations have concentrated on the influence of non-photic input on 
pacemaker activity. It is thought that input via this route is integrated with information 
from the eyes in the intergeniculate leaflet of the lateral geniculate nucleus in the 
thalamus. Alternatively, it could be conveyed directly to the central pacemaker from 
the Raphe nucleus (van Esseveldt et al., 2000). Additionally, it has been suggested 
that limited information could be received by neurones in the shell of the SCN from 
the cortex, basal forebrain and hypothalamus (Moga and Moore, 1997).
1.4.1.3 Pathways to the central core oscillator
From the eyes the major pathway through which information reaches the central 
oscillator in the anterior hypothalamus is via the retinohypothalamic tract (RHT) 
(Weaver, 1998). The neurotransmitters responsible are thought to be excitatory amino 
acids which act on N-methyl-D-aspartic acid (NMDA) receptor-channel complexes 
on post-synaptic terminals (cells in the central oscillator). Signals from this route are 
thought to act on cells in the core of the SCN (Moore and Lenn, 1972). Stimulation of 
these receptor-channels causes an influx of calcium ions that are capable of binding to 
calmodulin. In turn the Ca2+/calmodulin (CaM) complex is responsible for activation 
of CaM-dependent protein kinase II that can phosphorylate cAMP response element 
binding protein (CREB). Once activated, CREB is capable of binding to cAMP 
response elements (CRE) located in the promoter regions of certain genes such as c- 
fos and jun-B (immediate early genes and transcription factors) (Komhauser et al.,
1996). The target genes of these transcription factors have not yet been established but 
c-fos may be of particular importance in synchronisation of circadian rhythms since
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its levels fluctuate in a circadian manner (Geusz et al., 1997). It is also possible that 
activated CREB binds to CRE element in the promoter region of Period 1- one of the 
genes thought to be responsible for the generation of circadian rhythms in the central 
oscillator (Kuhlman et al, 2000).
Input from the intergeniculate leaflet and the Raphe nuclei also acts at the core of the 
SCN via neuropeptide Y (Swanson et al., 1974) and 5-hydroxytryptamine (Bosler and 
Beaudet, 1985), respectively.
1.4.2 Central oscillator
The SCN was identified as the major pacemaker in mammals following experiments 
in rats where the SCN was removed and circadian rhythms were found to be abolished 
(Moore and Eichler, 1972). This view is supported by a wealth of information gained 
about the SCN (Weaver, 1998) and includes the discovery of links to the retina via the 
RHT and also the expression of immediate early genes previously described (Chapter 
1.4.1.3). In addition, it has been shown that rhythms of glucose metabolism (Newman 
and Hospod, 1986), neural firing rates (Green and Gillette, 1982), neuropeptide 
production/secretion occur in the SCN both in vivo and in vitro (Isobe and Nishino,
1998), and that rhythmicity is restored in SCN-lesioned animals by transplantation of 
SCN tissue (Lehman et al., 1987). The circadian rhythm generated in this case is 
determined by the genotype of the tissue donor.
Circadian rhythms throughout the body are thought to be co-ordinated by internally 
generated periodic neuronal firing of the SCN. It is thought that rhythmic alterations 
in membrane potential and/ or channel activity linked to sodium are responsible for
17
generating electrical activity (de Jeu et al., 1998). Each SCN neurone has a precise 
firing period that may differ (sometimes by as much as hours) from that of other 
neurones present (Liu et al., 1997). Concerted circadian output therefore appears to be 
created by determining the average firing rhythm of all SCN neurones. Within 
individual SCN cells, it is believed that the endogenous rhythm generated is 
characterised by a series of interactions between gene products and their genes. These 
transcriptional and translational processes are required for progression through the 
circadian cycle (Florez et al., 1995) and in addition regulate clock controlled genes 
that in turn drive outputs such as electrical firing (Reppert and Weaver, 2001). 
Examples of clock-controlled genes include vasopressin propressophysin (Jin et al.,
1999) and albumin E-element binding protein (Ripperger et al., 2000).
1.4.3 Output pathways and peripheral oscillators
Two main output pathways have been identified to date through which the SCN 
coordinates rhythmicity throughout the body. Transforming growth factor alpha is 
produced rhythmically in the SCN, excreted and acts locally at sites within the 
hypothalamus (Kramer et al., 2001). It is thought that via this pathway locomotor 
activity is regulated-mediated by EOF receptors in the subparaventricular zone of the 
hypothalamus. Mice with an altered EOF receptor that does not function properly 
display excessive daytime locomotor activity. In addition, this activity is not 
suppressed in response to light (Kramer et al., 2001).
The second output pathway from the SCN is via humoral signals (such as 
glucocorticoids) to peripheral sites, for example the liver (Balsalobre et al., 2000). 
These hormones are produced at sites outside of the SCN after they receive signals
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from this master oscillator. The main output pathways from the SCN via neuronal 
projections are to the subparaventricular zone of the hypothalamus (from the core of 
the SCN), the dorsomedial nucleus of the hypothalamus and the paraventricular 
nucleus of the thalamus (from the shell) (van Esselvedt et al., 2000). In addition, there 
are minor projections to the medial preoptic nucleus, the anteroventral nucleus, the 
lateral septim, the stria terminalis, the paratenial nucleus, the lateral geniculate 
nucleus, the periaquaductal gray and the raphe nuclei. The pathways to the raphe 
nuclei and the lateral genicualte nucleus (regions involved in the processing and 
sending of input information to the SCN) may serve as feedback loops (van Esselveldt 
et al., 2000).
The main neurotransmitters involved are thought to be vasopressin, AVP and GABA. 
GABA is involved in the regulation of melatonin synthesis (pineal gland) by 
inhibiting the production of a positive regulator produced by the paraventricular 
nucleus (Kalsbeek et al., 1999).
Although the SCN is recognised as the central oscillator relaying information 
concerning environmental light-dark cycles to the rest of the body, the clock genes 
required to generate circadian rhythms are also transcribed and translated at these 
peripheral sites. However, there are a number of differences. By comparing the phase 
of production of the genes that are rhythmically expressed, it can be seen that 
production in the peripheral sites is delayed by up to nine hours compared to 
production in the SCN (Wilsbacher and Takahashi, 1998). However, the delay is not 
the same at all sites, suggesting that messages from the SCN are interpreted 
differently at each site through specific genes and their products (Reppert and
19
Weaver, 2001). The fact that rhythms in the genes responsible for circadian rhythm 
generation are delayed in peripheral sites compared to the SCN suggests that this is 
the site of the central oscillator. For example, it has been shown that transcription 
regulated by a dimer of two clock gene products (CLOCK and BMAL1) is inhibited 
in vascular cells by a hormone-dependent interaction with the nuclear receptors 
RARct and RXRot (McNamara et al., 2001). Another difference between the central 
and peripheral oscillators is that the expression of Small appears to be controlled 
differently in the SCN compared to the peripheral sites (Oishi et al., 2000). In 
addition, it has been shown that the SCN is more capable of sustaining its rhythm in 
the absence of time cues compared to the peripheral oscillators (Yamazaki et al., 
2000). However, certain peripheral oscillators will respond to entrainment from non- 
photic stimuli such as food in the liver, lung and skeletal muscle (Yamazaki et al.,
2000).
Of the output pathways arising from the SCN, the projection to the pineal gland 
(sympathetic innervation via the superior cervical ganglia) is well characterised 
(Klein, 1985). Other output pathways exhibiting circadian variation include 
vasopressin production in the SCN and cerebrospinal fluid, somatostatin in the SCN, 
albumin D-element binding protein and cholesterol 7-hydroxylase in the liver and 
inducible cAMP early repressor (ICER) in the pineal gland (Sehgal, 1995). ICER is 
thought to form part of an autoregulatory loop feeding back to the SCN. In addition, it 
has been shown that ICER regulates the amplitude and rhythmicity of serotonin N- 
acetyl transferase (NAT). This is the rate-limiting enzyme involved in the synthesis of 
melatonin (Arendt, 1995), and during the dark phase this enzyme can be increased 30- 
70 fold. In addition, melatonin production can be acutely suppressed following
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exposure to light, and by varying light-dark cycles its rhythm can be synchronised by 
the SCN via output pathways (Arendt, 1995). It is via this hormone that light-dark 
information is relayed to the rest of the body (Arendt, 1998b).
1.5 Mammalian clock genes
The first indication that variation in circadian period in mammals could be accounted 
for by genetic variation was reported in 1988 (Ralph and Menaker, 1988). A hamster 
was identified that had a shorter free-running rhythm in locomotor activity. Wild type 
hamsters display a rhythm of 24 h whereas hamsters heterozygous for this mutation 
had a rhythm of 22 h and homozygotes 20 h. The mutation was named tau and until 
only recently the nature of this mutation was unknown. However, work conducted by 
Lowrey and colleagues (2000) showed that the variation in phenotype observed was 
due to a mutation in casein kinase I epsilon (CKle)- an enzyme responsible for 
phosphorylating PERIOD (another core clock component) The mutant form of the 
enzyme is severely impaired in its ability to phosphorylate PER. Resulting in a 
shortened circadian period (Lowrey et al., 2000).
The first mammalian circadian gene to be identified was Clock (since this is the gene 
under investigation in this thesis its discovery and details concerning its function and 
structure are covered in section 1.5). BMAL1 was identified as a component of the 
core circadian machinery due to its interaction with CLOCK protein (Gekakis et al., 
1998). The remaining genes thought to be involved in the generation of circadian 
rhythms have been discovered due to their similarity with genes involved in circadian 
rhythm generation in Drosophila. This organism has proved to be an excellent model 
for the identification and analysis of core clock genes and indeed many conserved
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features of the mechanism responsible have been discovered in this organism. Both 
the mammalian and Drosophila circadian systems rely on positive and negative 
feedback loops and most components of this system are the same. However, there are 
some differences as shown in Figure 1.2 (Shirasu et al., 2003). The interactions 
observed between the core components of the mammalian circadian system are 
highlighted in figure 1.3.
Figure 1.2 Comparison of the components of circadian rhythm generation in 
mammals and Drosophila (adapted from Shirasu et al., 2003)
Drosophila protein Functions Mouse protein Function
PERIOD Interacts with 
TIMELESS. Inhibits 
CLOCK: CYCLE 
activity.
PERIOD 1,2 and 3 Interacts with 
CRYPTOCHROME and 
PERIOD and translocates 
into the nucleus.
TIMELESS Interacts with 
PERIOD. Inhibits 
CLOCK:CYCLE 
activity. Rapidly 
degrades in response 
to light.
TIMELESS No clock role. Closest 
Drosophila relative is 
TIMEOUT.
CLOCK Interacts with 
CYCLE. Promotes 
transcription of per 
and tim. Inhibits own 
transcription.
CLOCK and NPAS2 Interacts with BMAL1. 
Promotes transcription of 
Per and Cry.
CYCLE Interacts with 
CLOCK.
BMAL1 and MOP9 Interacts with CLOCK.
DOUBLETIME Phosphorylates 
PERIOD promoting 
its degradation.
CASEIN KINASE Is 
and 15
Phosphorylates PERIOD 
affecting its stability and 
subcellular localisation.
CRYPTOCHROME Circadian 
photoreceptor. 
Promotes light 
dependent 
degradation of 
TIMELESS.
CRYPTOCHROME 1
and 2
Binds to PERIOD. 
Inhibits Per and Cry.
VRILLE Represses Clock 
transcription.
REV-ERBa Represses BMAL1 
expression.
SHAGGY Phosphorylates 
TIMELESS 
facilitating nuclear 
localisation of 
PERIOD.TIMELESS.
Glycogen Synthase 
Kinase 30
Molecular relative of 
SHAGGY- no clock 
function elucidated.
Comparison of the core components of the circadian system in Drosophila and mouse 
highlighting similarities and differences.
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The core circadian genes and their products appear to interact with more general 
regulating factors within cells and these factors appear to influence circadian 
rhythmicity. The Rev-Erba gene product has been shown to regulate Small 
expression negatively. This protein is generated in response to positive regulation by 
CLOCK:BMALl. Complexes containing PER2 are thought to increase Small 
expression by binding to CLOCK:BMAL 1 dimers thus reducing Rev-Erba expression 
(Preitner et al., 2002). Another protein shown to coprecipitate with CLOCK is histone 
acetyltransferase p300, and it appears that H3 histone acétylation (which is rhythmic) 
is a potential target of CRY inhibition. The promoter regions o i Perl, Per2 and Cryl 
all exhibit circadian rhythmicity in H3 acétylation and RNA polymerase II binding 
(Etchegaray et al., 2003) suggesting that their transcription is regulated at this level.
DNA binding activity of CLOCK:BMALl and NPAS2:BMAL1 has been shown to be 
influenced by the redox states of NAD/NAD(H) and NADP/NADP(H). The reduced 
forms of these cofactors appear to enhance DNA binding whereas the oxidised forms 
act as inhibitors (Rutter et al., 2001). Rutter and colleagues, 2001 suggest that this 
could provide a potential pathway for entrainment via food.
In addition to DNA binding of CLOCK:BMALl, it appears that transcriptional 
activation by these dimers can be influenced by certain factors. The nuclear receptors 
RARa and RXRa have been reported to interact with CLOCK:BMALl and inhibit 
transcriptional activation (McNamara et al., 2001). These nuclear receptors are 
activated in response to hormones docking at receptor sites and so this could be a 
hormone mediated control pathway in circadian rhythm generation (McNamara et al.,
2001).
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Another important aspect of control of circadian rhythm generation appears to be 
regulation through posttranslational mechanisms. One such pathway is shown in 
figure 1.3 involving the phosphorylation of proteins by CKle. A study by Lee and 
colleagues (2001) showed that phosphorylation in addition to protein-protein 
interactions and subcellular localisation are essential to the mammalian circadian 
system. The findings of this study indicated that CRY was essential for nuclear 
localisation of PER and that phosphorylation had differing effects on PER 1 and 
PER2. When PERI is phosphorylated it requires interactions with CRY to remain 
stable whereas phosphorylation of PERI does not destabilise the protein but nuclear 
entry is prevented. CKlô was suggested as another important kinase involved in the 
regulation of circadian rhythm generation (Lee et al., 2001). Studies have shown that 
both CKle and CK1Ô are constantly expressed at moderate levels in the SCN in 
constant darkness and lightdark conditions (Ishida et al., 2001). Ishida and colleagues 
(2001) also showed that light exposure during the subjective night caused a delayed 
increase in the mRN A levels of both kinases in the SCN (Ishida et al., 2001). Another 
investigation has shown that human CKls and CKlô are both able to phosphorylate 
human PERI and 2 affecting the stability of the proteins (Camacho et al., 2001).
To date, 11 mammalian genes have been identified that could be involved in circadian 
rhythm generation. These genes are summarised in Table 1.2.
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Table 1.2: Mammalian clock genes
Gene Characteristics Proposed role Phenotype when gene is disrupted
Period 1 
(Tei et al., 1997)
PAS protein binding 
domain
Interacts with other 
PERIOD and 
CRYPTOCHROME 
proteins 
Responsive to light during 
dark phase
In Perl deficient mice the diurnal 
oscillation of Period 2 and the circadian 
rhythm in behaviour are not affected.
Period 2 
(Albrect et al., 
1997)
PAS protein binding 
domain
Positive regulator of 
Bmah transcription 
Interacts with other 
PERIOD and 
CRYPTOCHROME 
proteins 
Responsive to light in the 
early subjective night
mPer2 mutant results in a shorter 
circadian period, during which RNA 
transcripts of mPerl, 2 and mCryl are 
rhythmic but peak levels are reduced, 
followed by arrhythmicity (Zheng et al., 
1999).
Period 3 
(Zylka et al., 
1998)
PAS protein binding 
domain
Interacts with other 
PERIOD and 
CRYPTOCHROME 
proteins 
Not responsive to light
Period 3 deficient mice have a slightly 
shortened circadian period but remain 
rhythmic in constant darkness (Shearman 
et al., 2000).
Cryptochrome 1 
(Hsu et al., 1996)
Pterin/flavin containing 
protein- structural 
similarities with DNA repair 
enzyme photolyase
Negative feedback 
Interacts with PERIOD 
proteins
Targeted deletion shortens circadian 
period (van der Horst et al., 1999).
Cryptochrome 2 
(Hsu et al., 1996)
Pterin/flavin containing 
protein- structural 
similarities with DNA repair 
enzyme photolyase
Negative feedback 
Interacts with PERIOD 
proteins
Targeted deletion lengthens period.
Targeted deletion of cryl and cry 2 
causes arrhythmicity. Perl and Pei2 RNA 
levels moderate to high but arrhythmic 
(van der Horst et al., 1999).
Clock 
(King et al., 1997)
Basic helix-loop-helix DNA 
binding domain, PAS 
protein binding domain
Positive regulator 
Interacts with BMAL1 and 
MOP9 proteins
Clock/Clock m ouse displays lengthened 
circadian period, during which peak levels 
of Perl-3 and Cry 1 RNA levels are 
reduced, leading to arrhythmicity (Jin et 
al., 1999). In addition, Cry2 RNA levels 
are lower in Clock/Clock mice (Kume et 
al., 1999).
Npas2 Basic helix-loop-helix DNA 
binding domain, PAS 
protein binding domain
Positive regulator 
Interacts with BMAL1 and 
MOP9 proteins
Primarily expressed in the forebrain and 
so it is thought that any circadian role is 
restricted to this site outside of the master 
oscillator (Reick et al., 2001). Mice 
deficient in NPAS2 have altered sleep and 
behaviour adaptability, identifying NPAS2 
as being critical for adaptability to food- 
driven entrainment (Dudley et al., 2003.
Bmall
(Gekakis et al., 
1998)
Basic helix-loop-helix DNA 
binding domain, PAS 
protein binding domain
Positive regulator 
Interacts with CLOCK 
protein
Bmall deficient mice exhibit immediate 
and complete loss of circadian rhythmicity 
in constant darkness. Locomotor activity is 
impaired in light-dark cycles and activity 
levels are reduced (Bunger et al., 2000).
Mop9/Bmal2 
(Hogenesch et al., 
2000)
Basic helix-loop-helix DNA 
binding domain, PAS 
protein binding domain
Interacts with CLOCK 
protein
N/A
Casein kinase 16 
(Lee et al., 2001)
Phosphorylating enzyme Phosphorylates PERIOD 
proteins affecting their 
stability
N/A
Casein kinase 1 e 
(Lowrey et al., 
2000)
Phosphorylating enzyme Destabilises PERIOD 
protein by 
phosphorylation.
Tau hamster- disruption cau ses a 
shortened circadian period (Ralph and 
Menaker, 1988).
Rev-Erba
(Preitner et al., 
2002)
Orphan nuclear receptor REV-ERBa protein 
negatively regulates 
Bmall expression.
N/A
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In addition to the interactions occurring daily between the components of the 
circadian system, it appears that factors that interact with the central core mechanism 
during development can have an impact on resulting circadian phenotype. Mice 
homozygous for a mutation in NO AM-180 were shown to have a shortened circadian 
period in constant conditions and became arrhythmic after 3 weeks (Shen et al., 
1997). Analysis of the SCN in these mice showed that the number and distribution of 
VIP producing neurones was abnormal suggesting that NCAM-180 influences the 
development of the SCN. NCAM-180 was shown to bind polysialic acid and removal 
of this substance was shown to result in a shortening of circadian period (Shen et al.,
1997). Further investigations by Shen and colleagues (2001) showed that polysialic 
acid and NCAM are required for stable free-running circadian period and that NCAM 
is required for synchronisation to the light-dark cycle.
1.5.1 The Clock gene
Using a forward genetic approach involving mutagenesis screens. Clock, the first 
mammalian clock gene, was identified (Vitaterna et al., 1994). It was discovered 
following the analysis of wheel-running activity (a behavioural output of the circadian 
system) in the offspring of B6 male mice who had been treated with the mutagen N- 
ethyl-N-nitrosourea (ENU), and then crossed with untreated B6 females. Analysis was 
conducted during exposure to a light dark cycle (LD) and also in complete darkness 
(DD). Usually, B6 mice display a circadian period (t) of between 23.3 and 23.8 hours
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(DD). However, one of the offspring displayed an activity rhythm that stabilised at 
24.8 h (DD). The mutation was designated Clock. Interbreeding between 
heterozygotes {Clock!+) produced three phenotypes, one of which was homozygous 
for the Clock mutation. The circadian period of these Clock/Clock animals was shown 
to be between 26-29 h. However, after approximately two weeks in DD, the circadian 
rhythm was abolished (but could be restored by exposure to light), and ultradian 
periodicity of 6 to 9 h was observed (Vitaterna et al., 1994). Further investigations 
mapped mouse Clock to the mid-portion of chromosome 5. The Clock allele was 
shown to be a semi-dominant negative mutation (King et al, 1997a) and was 
subsequently cloned (King et al., 1997b). More recently investigations have been 
conducted to address the impact of the Clock mutation at the level of individual 
neurones in the SCN. Low-Zeddies and Takahashi (2001) generated mouse chimaeras 
containing varying proportions of SCN cells containing the Clock/Clock genotype and 
calls containing wildtype genotype. Circadian phenotype was shown to be associated 
with the proportion of mutant versus normal cells, demonstrating that circadian output 
is generated as a result of interaction between individual SCN neurones (Low-Zeddies 
and Takahashi, 2001). Another study (Nakamura et al., 2002) investigated neuronal 
firing of individual neurones and slices from the SCN of Clock mutant mice in vitro. 
A high proportion of slice cultures displayed the longer 27 h period whereas only 15% 
of dispersed cells exhibited this period. The authors concluded that the interaction 
between individual SCN neurones is important in rhythm generation and that Clock 
lengthens the circadian period (Nakamura et al., 2002).
The region of DNA containing Clock spans 88,000 bp, of which 7328 bp contributes 
to the mRNA sequence containing an open reading frame of 2,565 bases situated in
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23 exons (la, lb, 2-23) (Wilsbacher et al., 2000). Exons la, lb  (alternatively spliced),
2 and 3 were shown to contain the 5’ untranslated region (5’UTR) with a CpG island 
situated between lb  and 2, characteristic of promoter regions. Within exon 4, two 
methionine codons were observed and following analysis of the surrounding regions 
the first was identified as being the more likely start codon. A termination codon was 
identified in exon 23 followed by approximately 6 kb of 3’ untranslated region 
containing ATTTA sites characteristic of transcripts with short half-lives. Two 
polyadenylation sites were identified, one through cDNA clone analysis at 
approximately 7,450 bases and the other identified in genomic sequence and verified 
by its presence in expressed sequence tags (ESTs) at approximately 10,000 bases. 
Through analysis of the identified cDNA clones, it was observed that none of them 
contained exons la  and lb together indicating alternate use of these two exons. In one 
of the full length clones identified during the screen and starting with exon la  it was 
discovered that exons 19-22 and part of exon 23 were missing. Another partial clone 
appeared not to contain exons 18 or 19 (King et al., 1997b).
The open reading frame of the gene encodes a protein consisting of 855 amino acids. 
Of these, 112 are glutamine and 100 are serine. Multiple phosphorylation sites and 
two glycosylation sites were identified and support its role as a transcription factor. 
The CLOCK protein also contains a basic helix-loop-helix (bHLH) DNA binding 
domain and a PAS (named for the first three proteins in which it was discovered: 
PER-ARNT-SM) protein dimérisation domain, placing it in the family of bHLH-PAS 
proteins.
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Using bacterial artificial chromosome (BAG) transgenesis, the mutant circadian 
phenotype of Clock mice was rescued, confirming the role of Clock as an element 
controlling the periodicity and persistence of circadian locomotor rhythms (Antoch et 
al., 1997). In addition, it was shown that Clock mice have altered sleep (Naylor et al., 
2000) and respond differently to non-photic stimuli compared to wild type mice 
(Challet et al., 2000). More recently, it has been reported that Clock mice are more 
likely to retain their rhythmicity when placed into constant light conditions compared 
to wild type which are more likely to become arrhythmic (Spoelstra et al., 2002).
Homologues o ï Clock have now been identified as core circadian components in other 
model species including Drosophila (Allada et al., 1998) and zebrafish (Whitmore et 
al., 1998).
1.5.1.1 The human Clock gene
The cDNA sequence of human Clock was elucidated by screening both the human 
EST database and a human cDNA library (derived from hypothalamus) using mouse 
Clock cDNA (Steeves et al., 1999). A number of positive matches were identified 
which, when sequenced and aligned, were found to define the entire coding region of 
human Clock Further studies enabled the exon structure of Clock to be determined 
via the isolation of a genomic clone (BAG) containing the entire coding region of 
Clock. Chromosomal mapping techniques had located the human Clock gene to 4ql2- 
a locus homologous to a region of mouse chromosome 5 where, in addition to Clock, 
three other genes which are members of a receptor tyrosine kinase family are located 
(Steeves et al, 1999). The genomic sequence of Clock has recently been made 
available (Genbank accession number AC69200).
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The coding sequence of human Clock extends for 2,538 bp compared to 2,565 bp in 
the mouse. There is 89% similarity between the two sequences with identical intron/ 
exon structure. According to the numbering system devised by Steeves and 
colleagues, (1999), human exon 2 corresponds to mouse exon 4, the codon in which 
the start codon is present. The human and mouse proteins show 96% similarity 
(Steeves et al., 1999).
1.5.1.2 Expression of Clock
No research has been published regarding the nature of the promoter of Clock and so 
nothing is known regarding the regulation of transcription at this site. The expression 
of Clock mRNA has been investigated both in mouse (King et al., 1997b) and human 
tissue samples (Steeves et al., 1999). Each investigation used a combination of in situ 
hybridisation and Northern blot analysis.
In mice, Northern blot analysis revealed two transcripts of ~8 and -11 kb present in 
virtually all tissues studied, but at higher levels in the retina. These sizes correspond 
to those predicted from sequence analysis using alternate polyadenylation signals 
(King et al., 1997b). In addition, in situ hybridisation experiments showed elevated 
expression of Clock in the mouse SCN (King et al., 1997b).
In human tissues, three transcripts of ~4, ~8 and -10 kb were shown to be present. 
However, significant expression of the -4  kb transcript was only found in the testis. 
The -8  and -10 kb transcripts are the sizes expected from using alternate 
polyadenylation signals as observed in the mouse. However, the origin of the -4  kb
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fragment in the testis is less clear. It could possibly be due to the alternate use of 
either exon la  or lb and the skipping of exons as described in Chapter 1.5.1.
The two larger transcripts were shown to be expressed in more or less all tissue 
studied, with the -10 kb transcript being predominant. The highest levels of 
expression were observed in the cerebellum, and in situ hybridisation analysis 
supported this finding with intense staining observed in the granule cell layer, and 
light staining in the Purkinje cell layer. In addition, the SCN and the supraoptic 
nucleus were densely labelled using this Clock antisense probe. It has been reported 
that levels of Clock mRNA do not cycle in the mammalian SCN, eye or hypothalamus 
(Shearman et al., 2000). However, as no other tissue type has been investigated in this 
regard, it may be possible that Clock mRNA is regulated in an oscillating fashion in 
the presence of other tissue specific factors. No studies assessing whether protein 
levels oscillate in a circadian fashion have been published.
1.5.1.3 The structure and function of human CLOCK
The coding region of the human Clock gene (2,538bp) is predicted to start from an 
ATG codon at cDNA position 358 (Genbank Accession number AFO11568) and gives 
rise to a protein containing 846 amino acid residues which is highly similar to mouse 
CLOCK (Steeves et al., 1999) (Figure 1.4).
Studies have shown that BMAL1 is co-expressed with CLOCK in the brain and 
retina, and that these two proteins are capable of forming a heterodimer which can 
activate the transcription of Per by binding to an E-box motif (enhancer- CACGTG) 
in the promoter region of Per (Gekakis et al., 1998). This mechanism is mirrored in
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Figure 1.4: Alignment of the mouse and human CLOCK proteins (Steeves et al., 1999)
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Amino acid sequence and alignment of the mouse and human CLOCK proteins. The 
deduced amino acid sequence of the CLOCK protein (human) is 846 residues long a n d  is 
96% identical to that of the mouse. Boxed amino acids are identical. The bHLH, PAS A, 
PAS B and novel repeat domains A and B are shown.
Drosophila showing the similarities between circadian rhythm generation in the two 
organisms (Darlington et al., 1998). More recently, paralogues of CLOCK and 
BMAL1 have been identified. BMAL2 (MOP9) is a paralogue of BMAL1 that is 
expressed in regions of the brain including the SCN. It is capable of binding with 
CLOCK and the heterodimer formed has been shown to be capable of driving 
transcription (Hogenesch et al., 2000). NPAS2 (MOP4) (a paralogue of CLOCK) has 
been shown to be capable of binding with BMALL It is primarily expressed in the 
forebrain (responsible for sensations such as touch, pain, temperature, hearing, vision, 
smell, and emotions such as fear and anxiety) and so it is thought that any circadian 
role this homologue has is restricted to this site outside of the master oscillator (Reick 
et al., 2001). Indeed, recent work has shown that mice deficient in NPAS2 have 
altered sleep and behaviour adaptability, identifying NPAS2 as a key component in 
the maintenance of circadian behaviour in normal light-dark and feeding conditions 
(Dudley et al., 2003). In this study NPAS2 was shown to be critical for adaptability to 
food-driven entrainment. Application of lactate to cultured neuroblastoma cells was 
shown to activate NPAS2-BMAL1 -dependent gene expression (Reick et al., 2001) It 
was suggested that application of lactate causes an increase in NADH through the 
actions of lactate dehydrogenase (Rutter et al., 2002).
Expression of either CLOCK or NPAS2 and BMAL1 or BMAL2 appears to be 
dependent on tissue type and therefore tissue specific factors. In the forebrain 
NPAS2:BMAL1 is responsible for enhancing Per2 expression. In the vasculature 
NPAS2:BMAL1 or CLOCKBMALl are responsible and in peripheral tissues 
CLOCKBMAL2 dimers are required for circadian gene expression (Hastings et al., 
2003).
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The Clock mutant phenotype produced in mice during mutagenesis screens for novel 
mammalian clock genes was found to be caused by an A to T transversion at a splice 
site causing the loss of exon 19 sequence from mRNA and resulting in a protein 
lacking the 51 amino acids encoded by this region (King et al., 1997a). In vitro studies 
investigating the functionality of CLOCK showed that the mutant CLOCK protein 
was still able to bind to BMAL1 and Per promoter elements but transcriptional 
activation of per was hindered implying that the missing part of CLOCK was an 
activation domain (Gekakis et al., 1998). A more recent study has suggested that this 
region itself is not an activation domain, but it allows an activation domain within the 
BMAL1 protein to function correctly and activate Per transcription (Takahata et al.,
2000). It has been suggested that it may do this by binding an inhibitor that regulates 
activation by BMAL1 (Takahata et al., 2000). Indeed, it was previously noted that this 
glutamine-rich region contains an uncharacterised single repeat (Steeves et al., 1999). 
Investigations are required to characterise the function of this region since it appears 
to play a crucial role in sustaining an endogenous circadian rhythm as displayed by 
the Clock mice (Vitaterna et al., 1994).
Other proteins thought to interact with CLOCK or CLOCK heterodimers include 
histone acetyltransferase p300 (Etchegaray et al., 2003), RARa and RXRa 
(McNamara et al., 2001) and Rev-Erba (Preitner et al., 2002) as described in section 
1.5. Additionally, in vitro studies have shown that CLOCK can be phosphorylated at 
specific serine residues by p45PFK (a histone HI kinase). However, the role in vivo of 
this phosphorylation process has not been investigated (Tamaru et al., 1999).
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Because CLOCK mRNA and protein levels do not appear to show circadian variation, 
posttranslational mechanisms such as protein-protein interaction, phosphorylation 
state and subcellular localisation could be of great importance in maintaining or 
regulating circadian rhythm generation in the case of this protein. Indeed, Lee and 
colleagues (2001) reported that a number of the core clock proteins do undergo 
phosphorylation and that this affects stability and subcellular localisation. In addition, 
this study reported that CLOCK:BMALl dimers remain bound to DNA throughout 
the circadian cycle, suggesting that the regulation of the CLOCKBMALl activity is 
conducted by the binding of additional proteins or factors to the dimer or modification 
of the complex such as phosphorylation. A study conducted by Rutter and colleagues 
(2001) showed that DNA binding activity was regulated by NAD cofactors in either 
reduced (enhanced) or oxidised (inhibited) forms.
1.6 Genotype and circadian phenotype in humans
A number of mutations have been identified in core clock genes, some of which have 
been associated with specific circadian phenotypes. A silent polymorphism in Perl 
was identified and its frequency assessed in a control population with characterised 
diurnal preference (as assessed by the Home-Ostberg questionnaire). However, no 
association was observed between this polymorphism and either morning or evening 
tendencies (Katzenberg et al., 1999). This mutation has not been investigated in 
population groups with other defined circadian phenotypes, probably due to the fact 
that it is a silent mutation and so does not alter the amino acid sequence of PERI 
protein. However, it is possible that a silent mutation could alter the rate of translation 
due to preferred codon usage (Hartl and Clark, 1989). Because levels of the mRNA 
and resulting protein expressed from the Perl gene exhibit circadian variation, a
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genetic change that could alter the speed of translation could ultimately affect the 
speed at which PERI protein is produced and possibly the maximum amount of PERI 
that is produced.
Polymorphisms and mutations identified in other clock genes have been associated 
with specific phenotypes. A mutation in Per2 has been shown to be associated with 
familial ASPS (FASPS) and a haplotype of Per3 has been reported to be associated 
with DSPS. In addition, a polymorphism in Clock was found to be associated with 
diurnal preference (Katzenberg et al., 1998).
1.6.1 The Per2 mutation and Familial advanced sleep phase syndrome
The Per2 mutation associated with familial advanced sleep phase syndrome (FASPS) 
has only been identified in three of four branches of a large family, in which ASPS 
appears to segregate as an autosomal dominant characteristic (Jones et al., 1999). In 
this study, sufferers and non-sufferers were strictly classified by a structured interview 
that focussed on preferred sleeping schedules. In addition, the Home-Ostberg (HO) 
questionnaire showed that family members who had been classified as ASPS sufferers 
had an increased HO score of approximately 16 points (increased morningness) 
compared to unaffected relatives. Sleep, melatonin and core body temperature 
rhythms were measured in six of the affected individuals and these were shown to be 
advanced by approximately 4 hours when compared to six control subjects. In 
addition, free-running t  was assessed for one FASPS subject and found to be 
extremely short (23.3 h) (Jones et al., 1999) compared to the average for humans of 
just over 24 hours (Arendt, 1998a, Czseisler et al., 1999). These results support the
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observation that momingness is correlated with shorter x values as shown by Duffy 
and colleagues (2001).
Linkage analysis identified a locus on chromosome 2 as a candidate region for all 
affected family members apart from those in one branch of the family. This mutation 
was found to be a single nucleotide substitution in exon 17 of Per2 causing an amino 
acid change of serine to glycine. In vitro studies showed that this site was located in 
the CKle binding region of PER2 and that the original serine residue present was a 
target for this enzyme. Through this mechanism, altered phosphorylation of PER2 
could be responsible for the extreme phase advance observed in the identified 
sufferers in three branches of this family (Toh et al., 2001).
Because ASPS sufferers in one branch of the family did not carry this mutation, it is 
clear that this is not the only factor responsible for ASPS. In the cases of some 
sufferers, there may be more than one contributing factor and it is possible that both 
environmental and genetic factors acting together could result in ASPS. However, it 
appears that the Per2 mutation alone can cause ASPS. It would be of interest to see if 
this mutation is prevalent in the normal population or in sufferers of other disorders 
with a circadian component.
1.6.2 ferJ haplotype and delayed sleep phase syndrome
In a study screening the human Per3 gene for polymorphisms in DNA from subjects 
with DSPS and non-24 hour sleep cycle disorder, Ebisawa and colleagues (Ebisawa et 
al., 2001) identified 20 polymorphisms, 14 of these were situated within exons - 13 
SNPs (of which five resulted in amino acid substitutions) and one variable number
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tandem repeat (VNTR) region with either four or five copies of a 54-bp motif. Six 
polymorphisms were identified within the intronic regions studied — four SNPs, one 
insertion and one deletion. The study focussed on assessing the prevalence of the six 
variations that resulted in altered amino acid sequences in control subjects (n=100), 
DSPS patients (n=48) and individuals with non-24 hour sleep-wake syndrome (non- 
24 h, n=30). The polymorphisms that were investigated are summarised in Table 1.3.
Table 1.3: Coding polymorphisms assessed  in control, DSPS and non-24 hour sleep  
cycle disorder subjects (Ebisawa et al., 2001)
Polymorphic site Nucleotide change Amino acid change
Exon 11 1258 G to A V420M
Exon 15 1940 T to G V647G
Exon 17 2590 C to G P864A
Exon 18 Del (3031-3084) Del 1001-1028
Exon 18 3110 T to C M1037T
Exon 20 3473 A to G H1158R
The six coding polymorphisms observed in the screen of Per3 conducted by Ebisawa and colleagues, 
2001 .
The polymorphism in exon 11 was only observed in the Per3 gene of one DSPS 
patient and so was excluded from any further analysis in the study described, 
although, this could be a cause of DSPS in this subject and it would have been 
interesting to investigate its prevalence in relatives of the subject after assessment of 
their sleep habits. The haplotypic association of the remaining 5 variations was such 
that if a valine residue was observed at 647 then this would always be associated with 
histidine at 1158. Likewise glycine at 647 was always associated with arginine at 
1158. In addition, if methionine was found at 1037, this was always accompanied by 
valine at 647, proline at 864 and histidine at 1158. A threonine residue at 1037 was 
always accompanied by a 4-repeat locus, and either [V647, A864, HI 158] or [G647, 
P864, R1158]- the proline at 864 was not associated with valine at 647 and histidine
39
at 1158 as observed when methionine (instead of threonine) was present at 1037. Of 
the 32 potential combinations in which these five polymorphisms could be arranged, 
due to the particular associations observed, only four haplotypes exist in this 
population(Table 1.4).
Table 1.4: Actual haplotypes observed in the Per 3 gene for the 5 coding 
polymorphisms
Haplotype
number
V647G P864A 4 or 5 repeat M1037T H1158R
H1 V P 4 M H
H2 V P 5 M H
H3 V A 4 T H
H4 G P 4 T R
The actual haplotypes observed, numbered according to Ebisawa and colleagues, 2001.
The frequencies of the four possible haplotypes were determined in the three 
population groups studied by Ebisawa and colleagues. However, the actual genotypes 
of the subjects (i.e. the combinations of haplotypes observed in each individual) were 
not shown in their report. From the data presented concerning haplotype/carrier 
frequencies, it is possible to calculate the number of homozygotes for each haplotype 
and the number of subjects remaining who are heterozygous for each haplotype. 
However, the actual genotypes of the heterozygous subjects cannot be determined 
(Table 1.5).
Table 1.5: Number of subjects homozygous and heterozygous for each Per3 haplotype
DSPS Non-24 h Control Total
Haplotype homo hetero homo hetero homo hetero homo hetero
H1 22 18 14 14 48 41 84 73
H2 3 13 0 7 5 29 8 49
H3 1 6 0 10 3 16 4 32
H4 0 7 0 1 0 2 0 10
Number of subjects homozygous and heterozygous for each Per3 haplotype in the study conducted by 
Ebisawa and colleagues, 2001, determined from haplotype frequencies and number of carriers 
presented.
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From these data, Ebisawa and colleagues concluded that the H4 haplotype is 
associated with increased susceptibility to DSPS with 7/48 DSPS subjects being 
heterozygous carriers compared to 1/30 non-24 h patient and 2/100 control subjects. 
Interestingly, no homozygotes were observed for H4 in any of the population groups 
studied. However, it was the least frequent of the 4 haplotypes observed overall 
(10/356 haplotypes). The majority of the DSPS subjects studied were carriers of HI 
(83 %). It may be possible, therefore, that the H4 haplotype is associated with a DSPS 
parameter specific to the subset of subjects who were carriers, for example delayed 
melatonin rhythm in addition to the delayed sleep-wake cycle, or a larger phase delay 
of sleep-wake than observed in other patients. This was not investigated.
Only two of the five polymorphic sites were specific to the H4 haplotype - G647 and 
R1158. Ebisawa and colleagues suggested that G647 was more likely to be the 
causative variant since this is situated within 5 amino acids of a potential CKle 
phosphorylation site in PER3.
Obviously, coding polymorphisms are of the greatest interest in studies of this kind 
since these affect the resulting protein sequence. However, a number of the other 
polymorphisms that were identified by Ebisawa and colleagues, but were not 
investigated in the reported study, could also be of interest. As previously noted, 
preferred codon usage may theoretically lead to a delay in translation that could affect 
the speed of protein production or the level of protein produced. This could have an 
ultimate effect on circadian output, and so the silent polymorphisms in Per3 could 
influence circadian output. In another field, a silent mutation in the phenylalanine 
hydroxylase gene was shown to cause exon skipping and was linked to the disorder
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phenylketonuria (Chao et al., 2001). A number of the intronic polymorphisms 
identified by Ebisawa and colleagues lie within 25 nucleotides of the intron-exon 
boundary. This might have an effect on splicing perhaps leading to the loss of an 
intron or the inclusion of intronic material to be translated into protein.
Although the H4 haplotype was observed at an increased frequency in the DSPS 
subjects, this alone cannot be a causative agent for DSPS since 2/100 control (selected 
via a questionnaire which excluded those with a history of sleep disorders or other 
psychoses) and 1/30 non-24 h subjects were also carriers of this haplotype. Other 
factors, genetic and/or environmental, are likely to be required.
1.6.3 The 3111 Clock mutation and diurnal preference
Katzenberg and colleagues (1998) identified a SNP by aligning expressed sequence 
tags (ESTs) with the sequence of the human Clock gene. The polymorphism (C to T) 
is situated in the 3’ untranslated region (3’UTR) of Clock. This locus was assessed in 
410 control subjects who had completed the HO questionnaire to assess diurnal 
preference. The authors found that individuals who were C positive (i.e. had the C/C 
or C/T genotypes) had an increased evening tendency compared to those with the T/T 
genotype. The 3111 C positive group had a mean HO score that was three points 
lower than that observed for the 3111 T/T group. The authors concluded that this was 
equivalent to a 10-44 minute difference in preferred timing of activities. This 
polymorphism due to its location in the 3’UTR region of Clock does not alter the 
amino acid sequence of the resulting CLOCK protein. However, it could have an 
effect on the stability or translatability of Clock mRNA either by altering a 
recognition site for a RNA binding protein or altering a sequence involved in mRNA
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stability such as a hairpin loop. Such effects have been observed in other genes. For 
example, the 3’UTR region of the Clock gene is an AT-rich region. These regions are 
thought to regulate mRNA degradation through the binding of proteins to specific 
sites (Wilson and Brewer, 1999). Other 3’UTR regions have been linked with poly-A 
tail shortening, again mediated through binding sites for proteins (Staton et al., 2000). 
Degradation could also be mediated through the accessibility of endonucleic target 
sites present in the 3’UTR. Degradation via this route may or may not require specific 
proteins to bind. For example, the iron response element within TER mRNA regulates 
decay in response to iron and other stimuli (Posch et al., 1999). In some cases, 
hormones have been identified as mediators of mRNA stability through specific target 
sequences in the 3’UTR. For example, glucocorticoid destabilisation of cyclin D3 
mRNA is mediated through protein interaction in the 3’UTR (Garcia-Gras et al., 
2000).
1.7 Aims of this study
The human Clock gene is an excellent candidate gene for inter-individual differences 
observed in t  and the sleep-wake cycle and for disorders with a circadian component 
such as DSPS. It is a core component of the molecular machinery and studies in other 
organisms such as the mouse have shown that mutations in the Clock gene cause 
altered circadian phenotypes (Vitatema et al., 1994, Naylor et al., 2000).
The aim of the work presented in this thesis was to screen for polymorphisms in the 
human Clock gene and to assess their prevalence in human subjects with defined 
circadian phenotypes. In order to achieve this aim the following hypotheses were 
tested:
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1) Polymorphisms are present in the human Clock gene
Screening for polymorphisms was conducted using two approaches: (i) screening 
genetic databases and then sequencing of cDNA clones identified as containing 
potential polymorphisms; (ii) direct sequencing of DNA from human subjects.
2) Polymorphisms identified in Clock are associated with variation in circadian 
phenotype
Three subject groups were recruited to assess the prevalence of polymorphisms:
i) blind subjects with free-running circadian rhythms and characterised t 
values
ii) subjects clinically diagnosed with DSPS
ii) control subjects with characterised diurnal preference as assessed by
the Home-Ôstberg questionnaire
3) The polymorphism at the 3111 locus previously associated with diurnal 
preference is also associated with variation in t  and/or DSPS
The 3111 Clock locus which was previously associated with diurnal preference 
(Katzenberg et al., 1998) was also assessed in the three subject groups described. Tau 
(t) has been associated with diurnal preference (long x with eveningness and short x 
with momingness, Duffy et al., 2001) and so one may predict that an allele of Clock 
associated with eveningness would also be associated with longer x. In addition, since 
DSPS is characterised by a larger than usual phase delay of the sleep-wake cycle 
(Weitzman et al., 1981), the 3111C allele could be present at a higher frequency in 
these subjects.
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£ J P e polymorphism at the 3111 locus alters mRNA stability/ translatability
In order to assess the functional effects of the 3111 polymorphism an in vitro assay 
was developed using COS-1 cells transfected with pGL3-promoter vector constructs 
containing inserts with either the Clock 3111C or 311 IT locus in the 3TJTR region of 
the vector’s reporter gene {luciferase).
Work towards testing all four hypotheses was conducted simultaneously. However, in 
this thesis the work is presented in chapters in the following order:
Chapter 2 describes the subject populations recruited for their study and how their 
circadian phenotype had been previously characterised.
Chapter 3 outlines standard procedures conducted throughout the study.
Chapter 4 describes the subject population who were characterised (diurnal 
preference) as part of this thesis.
Chapter 5 describes the screening procedures used to identify polymorphisms in 
Clock.
Chapter 6 describes the assessment of the identified polymorphisms in the subject 
populations recruited with defined circadian phenotype.
Chapter 7 describes the assessment of the prevalence of the 3111 locus 
polymorphism in the subject populations recruited.
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Chapter 8 describes the functionality assay developed to test whether this 
polymorphism alters mRNA stability/ translatability.
Chapter 9 discusses the conclusions drawn from the work conducted in this thesis 
and suggestions for future work.
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2. SUBÆCT INFORMATION
Ethical permission for this study was obtained from the University of Surrey Advisory 
Committee on Ethics. Informed consent was obtained from all subjects for the 
collection of either a blood sample or buccal swab for genetic analysis of the Clock 
gene. The free-running blind subjects’ and DSPS patients’ phenotypes had been 
characterised previously. Individuals who were recruited as part of the control 
population were asked to complete the HO questionnaire in order to characterise their 
diurnal preference, and in most cases a one-night sleep diary (Appendix 2).
2.1 Blind subjects with free-running circadian rhythms and characterised t
values
A total of 26 blind subjects (21 males, 5 females aged 46 ± 12 years, mean ± SD) with 
free-running circadian rhythms and characterised t values were recruited from two 
cohorts - the database compiled at the University of Surrey by Dr. Steven Lockley 
(Lockley et al., 1997) and Ms Lisa Hack (Robilliard et al., 2002) and the other was 
compiled by Dr. Damien Leger (Centre du Sommeil, Hotel-Dieu de Paris, France) on 
behalf of Sender (Robilliard et al., 2002). All the t values for these subjects were 
determined using standardised techniques at the University of Surrey. AMT6s levels 
were measured in urine for a period of 48 hours each week over 3-5 weeks. Subjects 
were asked to collect urine samples every four hours, with the exception of an eight 
hourly collection overnight, recording either the weight or volume and then storing a 
5 ml aliquot at -20 °C for analysis. The concentration of amT6s in each sample was 
assessed using radioimmunoassay and converted into ng/h. Cosinor analysis was then 
completed for each 48-hour assessment period to determine acrophase time (peak of
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amT6s production). Linear regression analysis was performed on the acrophase times 
of each subject with t being calculated as 24 h + the slope of the regression line, x can 
be calculated in a similar manner using melatonin concentration values that have been 
determined from plasma or saliva samples.
Subject information is shown in Table 2.1. The cause of blindness and the number of 
eyes were recorded for the subjects from the Surrey database but not for the other 
subjects, t was characterised by the measurement of 6-sulphatoxymelatonin in urine 
samples as described in Chapter 1.3.1.2 and for the second cohort melatonin onset and 
offset in saliva was also measured (Robilliard et al., 2002).
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Table 2.1: Subject information for free running blind subjects with no light perception 
and characterised % values (n=26)
Subject
number
Gender Age
(years)
t  (hours) Cause of blindness No
of
eyes
S14 M 32 24.79 Measles keratitis 1
S17 M 44 24.34 Microphthalmia 2
S18 M 44 24.68 Retinopathy of prematurity, glaucoma 0
S20 M 66 24.68 Penetrating ocular trauma 1
S24 M 68 24.59 Retinal detachment 0
S26 M 44 24.39 Buphthalmos, glaucoma 1
S31 M 35 24.68 Retinoblastoma 0
S33 M 55 24.60 Penetrating ocular trauma 0
S43 M 35 24.35 Retinoblastoma 0
S44 M 59 24.35 Measles and penetrating ocular trauma 1
S45 M 42 24.95 Penetrating ocular trauma 0
S48 F 54 24.41 Retinoblastoma 0
S51 M 60 24.37 Retinoblastoma 1
S62 M 38 24.81 Retinoblastoma 0
S67 F 49 23.92 Detached retina 2
S68 M 64 24.71 Measles keratitis 0
S70 M 38 24.30 Uveitis 2
S76 M 54 24.60 Secondary glaucoma 1
S78 M 49 24.58 Retinopathy of prematurity 2
F01 F 35 24.21 - -
F02 F 26 24.62 - -
F04 M 38 24.69 - -
F05 F 44 24.04 - -
F07 M 59 24.88 - -
FOB M 33 24.60 - -
F11 M 26 24.57 - -
The t values present in this study population range from 23.92 h to 24.95 h (mean ± 
SD = 24.53 ± 0.25 h). These values displayed a normal distribution (Kolmogorov- 
Smimov). Subjects from the Surrey database have differing causes of blindness and 
either 0,1 or 2 eye(s) present. These factors do not appear to show a correlation with 
t  (Lockley et al., 1997). It has been reported that t  decreases with age (Czeisler et al., 
1986). However, subjects from the Surrey database have been assessed over a number 
of years including one who has been assessed over 10 years and no significant 
variation has been observed (Arendt, 1997). In addition, recent studies from other 
groups also suggest that this is not the case (Kendall et al., 2001, Dufry et al., 2002).
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Figure 2.1 shows t plotted against age for the subjects recruited for this study. Linear 
regression analysis showed no association between age and t (P = 0.98, appendix 6).
Figure 2.1: x plotted against age for the free running blind subjects with no light 
perception (n=26)
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Linear regression analysis shows that there is no association between x and age in 
the 26 free-running blind subjects with no light perception studied. Female subjects 
are shown as squares inside an oval, male subjects are shown as squares not 
surrounded by an oval (data from Lockley et al., 1997 and Robilliard et al., 2003)
Interestingly, however, there was a difference between t in the males and females 
studied here. Females had a significantly shorter x than males (Female x = 24.2 ± 
0.28, Male x = 24.6 ± 0.19, Mean ± SD, Mann- Whitney U test, P < 0.05, appendix 6). 
The distributions of x values for both male (n = 21) and female (n = 5) subgroups are 
shown in Figure 2.2. This result could be misleading since only five female subjects 
had been recruited. However, previous studies suggest that females have an increased
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morning tendency compared to males (Cheminski et al., 1997) and if t is associated 
with diurnal preference determined by the HO questionnaire as reported by Duffy and 
colleagues (2001), then one would predict that females would have shorter t values.
Figure 2.2: x values plotted for both male (n=21) and female (n=5) free-running blind 
subjects with no light perception
x value 
(hours)
25.00
24.80 
24.60 
24.40 
24.20
24.00 i "
| ™
23.80 J--------------------------------- --------------------------------- ----------------------------------
Female Male
Gender
A significant difference was observed between the x values of male and female 
subgroups with females exhibiting shorter values than males.
2.2 DSPS subjects
Sixteen unrelated subjects (8 males, 8 females, aged 27 ± 16 years, mean ± SD) 
clinically diagnosed as DSPS sufferers were recruited from two sources: Dr. Marcel 
Smits (Department of Neurology and Sleep-Wake Disorders, Hospital De Gelderse 
Vallei, Ede, The Netherlands) and Dr. Adrian Williams (Lambeth Healthcare NHS 
Trust, St. Thomas Hospital, London, UK).
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2.3 Control subjects
Initially, thirty subjects (8 males, 22 females, aged 32 ± 13 years, mean ± SD) were 
recruited at the University of Surrey and asked to donate a blood sample for genetic 
analysis. These subjects were used initially to assess whether a polymorphism was 
prevalent in the population.
A larger population group (n=484) was recruited and their diurnal preference was 
characterised using the HO questionnaire and one-night sleep diary (Appendices 1 
and 2) in order to assess if any polymorphisms identified in the initial normal 
population were associated with diurnal preference. A buccal swab was donated for 
genetic analysis. The characterisation of this population is described in more detail in 
Chapter 4.
2.4 Summary of recruited subjects
Table 2.2 summarises the populations recruited for this thesis.
Table 2.2: Population groups recruited for analysis
Population name Number of subjects 
(male:female)
Age (mean ± SD) Phenotype
characterised
Free running blind 21:5 4 6 ±12 T
DSPS 8:8 2 7 6  16 DSPS
Uncharacterised
Control 8:22 32 6 13 none
Characterised control 
(extreme morning, 
evening and control 
groups)
217:267 35 6  13 Diumal preference
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3. MATERIALS AND METHODS
3.1 Assessment of diurnal preference
The Home-Ôstberg (HO) questionnaire (Appendix 1) was used to assess diumal 
preference in the characterised control subjects (section 2.4). Volunteers were asked 
to read each question carefully before answering them as accurately as possible, 
completing the questions in numerical order without returning to previous questions 
to alter their answers. The questions are either multiple choice, with subjects required 
to choose one answer from a possible four, or a time line was provided for subjects to 
mark with the appropriate time for their answer (Appendix 1). Questionnaires were 
scored using the marking scheme provided (Appendix 1).
3.2 Genomic DNA extraction from blood samples
Peripheral blood samples were collected into EDTA-coated tubes at either the 
subject’s doctor’s surgery or elsewhere by a trained phlebotomist. Within 48 hours of 
collection, samples were either processed or frozen at -20 °C to be processed at a 
later date.
Genomic DNA was extracted from a 200 pi aliquot of whole blood using the QIAamp 
Blood Kit (QIAGEN, Hilden, Germany). The extraction procedure was comprised of 
a number of stages, which were performed using a QIAamp spin column in a standard 
microcentrifuge and the kit reagents according to the manufacturer’s recommended 
protocol. A lysis stage was followed by a binding step in which DNA became bound 
to the QIAamp silica membrane. Residual contaminants were removed during a
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washing stage, and finally bound DNA was eluted from the membrane to give an 
extract ready for amplification.
3.3 Genomic DNA extraction from buccal swabs
Subjects were asked to refrain from drinking coffee (where possible) and to rinse their 
mouth out with water prior to buccal cell collection which was conducted by rolling a 
buccal collection swab (Epicentre, Madison, WI) three or four times firmly on the 
inner lining of each cheek. The swab was then dispensed into a 1.5 ml 
microcentrifuge tube. Within 24 hours of collection the swab was either processed or 
frozen at -20°C to be processed at a later date.
Genomic DNA was extracted from the swabs using the QuickExtract DNA Extraction 
Solution 1.0 (Epicentre) and the manufacturer’s recommended protocol. Briefly, the 
swab was placed in 0.5 ml of the extraction solution and vortexed for 10 seconds. 
Incubations were then conducted at 65°C for 30 minutes and twice at 98°C for 8 
minutes with the sample being vortexed in between each stage. Finally, the swab was 
removed from the tube to leave a solution containing DNA ready for amplification.
3.4 General PCR procedure and agarose gel electrophoresis
PCR was performed for DNA extracts using the Proofsprinter (TaqfPwo) DNA 
Polymerase Mixture (Hybaid, Ashford, Kent) and specific primers designed to 
amplify the desired regions of Clock. These were designed using DNAStar 
PrimerSelect software (Lasergene, DNAStar, Madison, WI). All PCRs were 
conducted using a Robocycler PCR machine (Stratagene, La Jolla, CA). Although the
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concentration of each DNA sample was not determined, 5 pi of DNA extract 
appeared to be sufficient for successful amplification. Using this quantity, a clean 
sequence read was generated indicating the absence of non-specific material. 
Amplification was conducted in a final volume of 50 pi containing 5 pi of lOx 
Reaction Buffer complete (final MgCl2 concentration = 1.75 mM), 200 pM dNTPs 
(Promega), 300 nM of each primer and 2.5 units of the Proofsprinter DNA 
polymerase mix (Hybaid).
General cycling parameters were:
Ix 94°C for 2 minutes
 ^ 94°C for 45 seconds 
35x^  T°C for 45 seconds 
72°C for 1 minute
The annealing temperature (T) was optimised for each primer pair with each extract 
type. In certain PCR reactions, the number of cycles was increased to either 38 or 40.
Following amplification, 10 pi of each PCR product was combined with 2 pi of 
loading buffer (Promega) and loaded into a 1.2 % agarose gel with 0.625 pl/ml 
ethidium bromide. The gel was electrophoresed at lOV/cm in 1 x Tris-Acetate-EDTA 
(TAE) buffer. The presence of product for each sample was verified with the use of 
short-wave UV transillumination. Size determination was conducted by loading a 
molecular weight marker (either 100 bp or 200 bp or 1 kb ladder, Promega depending 
on expected product size) into one of the wells on the gel.
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3.5 PCR product purification
PCR products were purified using the Wizard PCR Preps DNA Purification System 
(Promega) according to the manufacturer’s recommended protocol for direct 
purification of PCR products or for purification of PCR products which had been 
electrophoresed on a 1.0% low-melting-point agarose gel (Promega), from which 
agarose containing the desired band had been excised and then melted at 70°C. The 
PCR product or melted agarose containing the product was added to the solutions 
provided in the kit, prior to loading onto a Wizard minicolumn (Promega). The 
double-stranded DNA remained bound to the column membrane whilst contaminants 
were washed through using an 80% isopropanol solution. The bound product was then 
eluted from the membrane using sterile distilled water. Verification of successful 
purification was conducted using agarose gel electrophoresis as described in Chapter 
3.4.
3.6 IMAGE clone analysis: overnight culture and plasmid purification
IMAGE clones were obtained from the UK Human Genome Mapping Project, 
Hinxton, Cambs. Colonies were grown overnight in 10 ml of LB broth containing 
0.1% ampicillin at 37°C. Plasmid DNA was extracted from bacterial culture using 
Wizard Plus SV Miniprep DNA Purification Systems (Promega) and the 
manufacturer’s recommended protocol. Briefly, 3 ml of the culture were pelleted by 
centrifugation in a microcentrifuge. Following the removal of the residual medium, 
the pellet was resuspended. An alkaline lysis step was followed by neutralisation. 
Chromosomal DNA and cell wall debris were removed from the solution by 
centrifugation, after which the cleared lysate was transferred to a minicolumn. During
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centrifugation of the minicolumn, plasmid DNA bound to the membrane in the 
column whilst the solution passed through and was discarded. A number of ethanol 
washes were conducted prior to the elution of the DNA from the membrane using 100 
pi of sterile distilled water. Successful extraction was confirmed by electrophoresis of 
an aliquot of the purified plasmid sample (Chapter 3.4) using a supercoiled ladder 
(Promega) as a size marker.
3.7 Sequencing
Sequencing was performed using either the ABI PRISM dye terminator cycle 
sequencing ready reaction kit with AmpliTaq DNA Polymerase, FS (Applied 
Biosystems, Foster City, CA) or by using the Thermo Sequenase Cy5 or 5.5 dye 
terminator kit (Amersham Biotech, Little Chalfont, Bucks). DNA was sequenced 
using either one of the primers used for amplification of PCR product or a universal 
primer or site-specific primer.
3.7.1 ABI PRISM dye terminator cycle sequencing
This reaction was performed in the School’s in-house sequencing facility by the 
technician responsible using the manufacturer’s protocol. A final volume of 20 pi per 
sample containing 0.9 pi of primer (100 nM), 11.1 pi DNA sample (not quantified) 
and 8 pi of ready reaction mix (Applied Biosystems) was prepared, prior to thermal 
cycling. The programme consisted of 25 cycles of 96°C for 30 seconds, 50°C for 15 
seconds, and 60°C for 4 minutes. Purification of the extension products was 
performed using ethanol precipitation. The pellet obtained was denatured at 90°C for 
2 minutes in 4 pi of loading buffer after which the sample was snap-cooled on ice. It
was then loaded onto a 6 % polyacrylamide gel and electrophoresed using 1 x Tris- 
Borate-EDTA (TBE) on an automated 373A DNA Sequencer (Applied Biosystems) at 
1680 V for 7 h. Data were collected during electrophoresis using ABI Prism 373 
Collection Software and analysed using Genescan Analysis version 2.1.1.
3.7.2 Thermo Sequenase Cy5 or 5.5 dye terminator kit
The manufacturer’s recommended protocol (Amersham Biotech) was used to prepare 
samples for sequencing. A terminator mix for each Cy 5/5.5 ddNTP was aliquoted 
into one of four sample tubes. The template/primer mix was prepared to which 
reaction buffer and ThermoSequenase were added. A 6 pi aliquot of this mixture was 
then added to each of the four sample tubes. Thermocycling was performed consisting 
of 30 cycles of 95°C for 45 seconds, 60°C for 45 seconds and 72°C for 2 minutes, 
after which ethanol precipitation was completed. The resulting pellet was resuspended 
in 6 pi of formamide loading dye and denatured at 72°C for 3 minutes. A Short gel 
cassette (Visible Genetics, Toronto, Canada) was prepared using 6% Surefill 
Sequencing Gel (Visible Genetics). After UV crosslinking, sequencing was conducted 
using the Open Gene Long Read Tower System (Visible Genetics). A pre-run was 
performed using 1 x TBE after which 2 pi of each sample was loaded. Electrophoresis 
was conducted at 53°C for 45 minutes at 1350 V and 50% laser power. Data were 
collected and then analysed using the OpenGene software (Visible Genetics).
3.8 Restriction enzyme digest
Restriction digest experiments were conducted at 37°C overnight in a final volume of 
20 pi with 5-10 units of required restriction enzyme, the supplied buffer and bovine
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serum albumin (BSA) (if required) added according to the manufacturer’s 
recommended protocol (Promega). Enzymes used were Xba I and Àcc I (Promega).
3.9 Ligation
Linearised vector fragments for use in ligation experiments were dephosphorylated 
using calf intestinal alkaline phosphatase (CIAP) (Promega) at a concentration of 0.01 
units/pmol ends and the manufacturer’s protocol in a final volume of 10 pi. An initial 
incubation was conducted at 37°C for 30 minutes, after which another aliquot of 
enzyme was added. This was followed by an additional incubation for 30 minutes at 
37°C. The reaction was terminated by adding CIAP stop buffer and incubating at 
65°C for 20 minutes. DNA was purified by adding one volume of neutralised 
phenoh chloroform ! isoamyl alcohol (50:49:1 v/v %) to the reaction mix and applying 
the whole mixture to a phase lock gel light tube (Eppendorf, Hamburg, Germany). 
After shaking, the tube was spun in a microcentrifuge at 13,000 rpm for 5 minutes. 
The top layer was then removed to a clean tube and 0.5 volume of chloroform: 
isoamyl alcohol (49:1 v/v %) was added. After centrifugation, the top aqueous layer 
was transferred to a clean tube. The DNA was precipitated by the addition of 150 pi 
of 3M sodium acetate and 1 ml of 96% ethanol followed by overnight incubation at - 
20°C. Centrifugation was performed in a microcentrifuge at 13,000 rpm for 30 
minutes to pellet the DNA. The pellet was then washed in 1 ml of 70 % ethanol by 
centrifugation at 13,000 rpm for 15 minutes. The ethanol was removed and the pellet 
was resuspended in 20 pi of sterile distilled water.
DNA fragments were ligated using T4 DNA Ligase (Promega) and the 
manufacturer’s recommended protocol with a 1:1 molar ratio of vector to insert. 
Incubation was completed at 4°C overnight in a final volume of 50 pi containing 5 
units of enzyme. The success of the ligation experiments was assessed using agarose 
gel electrophoresis as described in Chapter 3.4.
3.10 Transformation and purification of vector (transfection quality)
Successfully ligated DNA was transformed into Epicurian Coli XL 1-Blue competent 
cells (Stratagene) using the manufacturer’s rapid transformation protocol. A 50 pi 
aliquot of the cells were defrosted on ice, to which 5 pi of ligated DNA sample was 
added. A 20-minute incubation at 4°C was conducted after which the cells were heat 
pulsed at 42°C for 45 seconds. The tubes were placed on ice for 2 minutes and then 
0.9 ml of SOC medium was added, followed by shaking (250 rpm) at 37°C for 30 
minutes. The transformation mixture was plated on LB agar containing ampicillin 
(0.05 mg/ml). Plates were incubated at 37°C overnight. Single colonies from each 
transformation reaction were selected and grown as overnight cultures in LB broth 
containing ampicillin (0.05 mg/ml) followed by plasmid purification using the Wizard 
Purefect Purification Kit (Promega).
3.11 Quantitation of vector DNA
The concentration of vector DNA samples was measured using the fluorescent DNA 
quantitation kit (Bio-Rad, Hercules, CA). A standard curve with a 1.0-2.4 pg DNA 
range was prepared using pBR322 DNA (MBI Fermentas, Vilnius, Lithuania) diluted 
in sterile distilled water. Using 2 ml of 0.1 pg/ml Hoechst 33258 dye (supplied in kit)
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the DNA standards and vector samples were analysed on a fluorometer (Packard 
Instruments, Perkin Elmer, Wellesley, MA) using an excitation filter of 360 nm and 
an emission filter of 460 nm according to the manufacturer’s instructions. All test 
samples were assessed twice using different volumes of the sample in some cases.
3.12 Cell culture for transfection experiments
Cynomolgus monkey kidney Cos-1 cells (Gluzman, 1981) were maintained at 37°C, 
5% C 02 for 24 hours in a 96-well plate (1 x 104 cells per well in monolayer culture) 
with 200 pi Dulbecco’s modified Eagle’s medium supplemented with 10% fetal calf 
serum and 1% penicillin, streptomycin and glutamine solution.
3.13 Transfection
The COS-1 cells were transiently infected using Transfast Transfection Reagent 
(Promega) as described by the manufacturer. A 1:1 charge ratio of DNA: transfection 
reagent was used and cells were co-transfected with 150 ng experimental vector and 
15 ng control vector which had been transformed into XL 1-Blue competent cells and 
purified in an identical way to the experimental vector. All transfections were 
completed in quadruplicate. Briefly, the serum containing medium was removed from 
the cells and they were incubated with 10 pi of serum and antibiotic-free medium 
containing the transfection reagent and DNA at 37°C, 5% C 0 2. After 1 hour, 200 pi 
of serum containing medium was added to the cells that were then incubated for an 
additional 24 hours.
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3.14 Luciferase reporter gene assay
Luciferase activity was measured using the Dual-Luciferase Reporter Assay System
(Promega) and a Lumicount (without injector) luminometer (Packard
Instrument Company). The manufacturer’s recommended protocol was followed with
an initial passive lysis of the cells being conducted using 20 pi of the Passive Lysis
Buffer provided. The cell lysate was added to 100 pi of Luciferase Assay Reagent II
in a 96-well plate and plate reading was initiated on the luminometer. A second
reading was conducted after the addition of 100 pi of Stop & Glo Reagent to measure
transfection efficiency.
3.15 Statistical analysis
All statistical analysis was conducted using Instat software (Graphpad, San Diego, 
CA, USA). The tests and conditions in which the tests were performed are shown in 
appendix 6.
4. CONTROL POPULATION
4.1 Introduction
In order to assess any linkage between diurnal preference and polymorphisms 
identified as being present in the control population, a large population group was 
recruited and phenotypically characterised prior to genetic analysis. This was 
conducted at the Science Museum in London after applying to the museum to take 
part in their Live Science exhibition that promoted interaction between real scientists 
and the public. Visitors were invited to take part in the study after they had received 
information about the work in the form of a prepared leaflet and presentation. The 
- exhibition was conducted for 2-3 days a week over a four-week period. Because the 
study conducted by Katzenberg and colleagues consisted of a population sample of 
410 individuals, this number was set as a minimum population size.
4.2 Materials and Methods
Informed consent was obtained from all visitors who agreed to participate in the study 
(484 individuals, 217 males and 267 females, aged 35 ± 13 years, mean ± SD). 
Volunteers were asked to complete a HO questionnaire (Appendix 1) to assess their 
diurnal preference. This was scored using the marking scheme defined by Home and 
Ôstberg (1976). In addition, subjects were asked to complete a one-night sleep diary 
(Appendix 2) for a typical night- the night prior to study participation was used if this 
was typical of the subject’s sleep habits. This included bedtime, the time that they 
started to try to go to sleep, how long it took to fall asleep, the number of night-time 
awakenings, wake time and get up time. Subjects were also asked to rate the quality 
of their sleep on a scale ranging from 1 (best sleep ever) to 9 (worst sleep ever).
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In order to select the most extreme morning and evening subjects, irrespective of age 
and gender, for genetic analysis, HO score was plotted against age for both female 
and male subject groups separately since the trend observed in males and females was 
slightly different (Figure 4.1). In addition, by selecting subjects in this way, equal 
numbers of males and females were present in each group. Linear regression analysis 
was performed and subjects furthest away from the regression line (7% from each 
extreme) were selected (i.e. those with the most pronounced momingness or 
evenihgness for their age). An intermediate group with an equal number of subjects (n 
= 35) were chosen whose scores lay on the regression line itself. Plots lying on the 
regression line itself presented individuals who had average HO scores for their age. 
The plots which had the largest perpendicular distance from the regression line 
represented individuals with extreme morning (above line) or evening (below line) 
HO scores for their age. In total 105 subjects (48 male, 57 female) were selected of 
which 90% had completed a sleep diary.
4.2 Results
The average HO score for the total population (n = 484) from which the three groups 
were selected was 52 ± 11 (mean ± SD). The distribution for this population did not 
differ significantly from normal (Kolmogorov-Smimov, HO score range 25-80). 
Multiple regression analysis showed that there was a significant relationship between 
HO score and age (P < 0.001) with older individuals tending towards momingness as 
noted previously in other studies (Carrier et al., 1997). In addition, as observed 
previously (Vink et al., 2001, Cheminski et al., 1997), a trend was observed between 
HO score and gender (P = 0.13) with females exhibiting greater momingness than 
males (Figure 4.1).
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Figure 4.1: HO score plotted against age for both male (n=217) and female (n=267) 
groups
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The regression lines are shown for each plot and these and lines lying parallel to each 
regression line were used to select subjects for the morning, intermediate and evening 
groups. HO score significantly increased with age, in addition females had higher HO 
scores overall when compared to males.
The HO questionnaire and one-night sleep diary were used to characterise the three 
selected subject groups. Data from questions requiring a time as a response are shown 
in Figure 4.2 with the evening group displaying the latest timing for all activities and 
the morning group the earliest. Table 4.1 shows information obtained from the HO
a +
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20 30 40 50
Age (years)
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questionnaire and sleep diary in tabulated form in addition to statistical analysis of 
these data (Instat). The most pronounced differences in timing were observed in the 
mean preferred time to start work and the time at which subjects thought that they 
were at their best (items 17 and 18 respectively on the HO questionnaire). The 
bedtime data showed that the mean preferred times were within 10-20 minutes of the 
mean actual bedtimes for the morning and intermediate groups. The difference in 
preferred and actual bedtime for the evening group was much greater with these 
subjects retiring to bed on average approximately one hour earlier than they would 
prefer to. Actual sleep onset time for the evening group agreed more closely with 
preferred bedtime. Analysis of rise times showed that the difference in preferred and 
actual times was much greater than that observed in the bedtime data. All three 
subject groups would prefer to rise later than they actually did. The total sleep 
opportunity time (determined by subtracting the time of sleep onset from the wake up 
time) was significantly less in the evening group when compared to either the 
intermediate or morning group. The average time taken to fall asleep was significantly 
longer (almost double) in the evening group compared to the other two groups. 
Analysis of sleep quality data showed that the evening group reported significantly 
worse sleep quality than the intermediate or morning groups.
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Table 4.1: HO questionnaire and sleep diary data obtained for the morning, intermediate and 
evening groups selected from the characterised control population for genetic analysis
HO score
Preferred 
bedtime (h:min)
Preferred rise 
time (h:min)
Preferred work 
start time 
(h:min)
Feeling best 
peak (h:min)
Time feel tired + 
need to sleep  
(h:min)
Actual bedtime 
(h:min)
Actual time 
taken to fall 
asleep (min)
Sleep onset 
(h:min)
No. of night 
awakenings
Actual wake up 
time (h:min)
Total sleep 
opportunity time 
(h:min)
Actual rise time 
(h:min)
Total time in bed 
(h:min)
Sleep quality
MORNING
(M)
(mean ± SD)
69 + 5
22:25 + 1:04
7:32 + 0:53
7:40 + 0:56
9:56 + 1:52
21:59 ±0:53
22:18 + 0:47
11 ± 11
22:37 + 0:46
1.0 +  1.0
6:26 ± 0:53
7:46 ± 1:02
6:46 ± 0:41
8:28 ± 0:52
3.4+ 1.4
INTERMEDIATE
(i)
(mean ± SD) 
52 + 4
23:43 ±1:02
8:47 ±1:01
10:02 ±3:06
11:54 ±3:30
23:03 ±1:17
23:24 ± 0:44 
13 ± 14
23:49 ± 0:46 
1.2 ± 1.2
7:19 ±1:02 
7:32 ±1:13
7:48 ±1:08
8:26 ± 1:18 
3.6 ±1.9
EVENING
(E)
(mean ± SD)
32 ±6
1:32 ±1:06
10:04 ±1:09
14:34 ±3:56
15:43 ±5:41
0:57 ±1:26
0:29 ±1:07 
26 ±25
1:18 ±1:08 
1.5 ± 1.6
8:03 ±1:49 
6:41 ±1:37
8:38 ±1:36
8:09 ±1:17 
4.8 ±2.1
Statistical
analysis
P<0.001 (S)
P<0.001 (S)
P0.001 (S)
P< 0.001 (D)
P<0.001 (D)
P<0.001 (S)
P<0.001 (S)
M vs E P<0.05 
I vs E P<0.05 
M vs I NS (D)
P<0.001 (S)
NS (S)
M vs E P<0.001 
M vs I P<0.05 
I vs E NS (D)
M vs E P<0.05 
I vs E PO.05 
M vs I NS (S)
M vs E P<0.001 
M vs I P<0.01 
I vs E NS (D)
NS
M vs E P<0.05 
I vs E PO.05 
M vs » NS (D)
HO questionnaire (overall score first item followed by four question responses) and sleep diary data 
(lower section of table) for each of the three groups (morning (M), intermediate (I) and evening (E)). 
Statistical analysis (appendix 6) was conducted using one-way ANOVA followed by Student-Newman- 
Keuls Multiple Comparison Test (S) or the Dunn's Multiple Comparison Test (D) in instances where the 
values from at least one subgroup displayed a non-gaussian distribution or the standard deviations 
were not equal between the three groups. Not significant (NS)
4.3 Discussion
The HO questionnaire was used successfully to select control subjects with specific 
diurnal preferences for genetic analysis -  moming-preference, intermediate, and 
evening-preference subgroups. The mean HO score of the evening group was 
substantially lower than that of the morning and intermediate groups by 37 and 20 
points, respectively. Their selection was validated by the data obtained from the one- 
night sleep diaries. No significant differences were observed between data obtained 
from the HO questionnaire and sleep diaries (appendix 6). The actual timing of their 
sleep-wake cycle agreed extremely well with the data obtained from the HO 
questionnaire supporting the fact that this is a good predictor of actual diurnal 
preference. In all instances, the evening group preferred to carry out or actually 
carried out activities at a later time of day than the intermediate and morning groups. 
The morning group exhibited the earliest timing of activities, with the difference in 
timing between this group and the evening group being on average at least 1.5 hours. 
The intermediate group displayed timings between the morning and evening groups. 
Additionally, the data showed that the evening group had the most disrupted sleep- 
wake cycle in terms of the discrepancy between preferred and actual timing of sleep- 
wake, and self assessment of sleep quality compared to the morning and intermediate 
groups.
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5. SCREENING FOR POLYMORPHISMS IN HUMAN CLOCK
5.1 Introduction
To date, only one polymorphism identified in Clock has been reported to be 
associated with a circadian phenotype- the 3111 C to T polymorphism and diurnal 
preference, as described earlier in the thesis (Katzenberg et ah, 1998). In the present 
investigation two approaches were used to screen for additional polymorphisms in the 
human Clock gene, namely (i) genetic database screening to identify potential 
polymorphisms to be verified experimentally, (ii) direct sequencing of subject DNA 
using optimised PCR conditions- this was specifically used for a number of the t  
characterised blind subjects. Any polymorphism found could then be assessed in the 
three characterised population groups.
5.2 Screening using sequence alignment and the NCBI BLASTsearch database
5.2.1 Materials and methods
NCBI BLAST (Altschul et al., 1997), a genetic database screening tool, was used to 
screen the human expressed sequence tag (hEST) database (Genbank) for sequences 
that aligned with the published human Clock cDNA sequence (Accession number 
AF011568). Any sequences that aligned with this sequence but displayed apparent 
differences were investigated further.
Clones containing ESTs with sequence differences to that of the published Clock 
cDNA (Accession number AFO11568) were obtained from the UK Human Genome 
Mapping Project. Colonies were then grown and plasmid was extracted from bacterial
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culture as described in Chapter 3.6. Plasmids were then sequenced as described in 
Chapter 3.7 using either universal forward or reverse primer (Amersham Biotech), or 
a site-specific primer if sequencing with universal primers failed or did not produce 
enough sequence data for the polymorphism to be confirmed. The sequence data 
generated were compared to the published human Clock sequence to investigate if the 
changes observed were actually present.
5.2.2 Results
Fifteen clones were identified in which polymorphisms were observed (Table 5.1). Of 
these, ten were obtained as IMAGE clones and were processed and sequenced using 
the primers shown in Table 5.1. Two of these cDNA clones had apparent changes in 
the 3’ UTR region of Clock, and the remaining 8 had changes in the coding region.
Sequencing revealed that only one of the ten clones (AM 19452, Table 5.1) that were 
sequenced contained a real polymorphism. Two of the clones contained inserts with 
different sequence to that deposited in the database and the apparent changes in the 
remaining seven clones were false and due to the fact that EST sequences are based 
on a non-verified single read.
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Table 5.1: (i) Human ESTs identified as containing potential polymorphisms in hClock 
and (ii) List of the site specific primers used for the sequencing of certain vectors
(i)
Genbank
name
(database)
Putative difference 
observed
IMAGE
clone
number
Source Primer
used
Outcome of 
sequencing
AI357563 Deletions/ insertions/ 
substitutions in exons 20 
and 21
2011998 NCI_CGAP_Brn23 
Homo sapiens 
cDNA clone
rev and site 
spec (MVS 
122)
Variation not 
detected
AI419176 Insertion of A and 
deletion of C in exon 13- 
4 amino acid changes
2106348 NCI_CGAP_Brn23 
Homo sapiens 
cDNA clone
rev Variation not 
detected but contains 
intronic sequence
AA661704 C to A substitution in 
exon 15 - Pro to His 
change
1217698 NCI_CGAP_Alv1 
Homo sapiens 
cDNA clone
rev Variation not 
detected
AA429292 Insertion of C in exon 11- 
changes in amino acid 
leading to a premature 
stop codon
768552 Soares 
NhHMPv_S1 Homo 
sapience cDNA 
clone
rev Wrong EST present 
in clone
AA657639 Insertion of G in exon 16 
leading to a premature 
stop codon
1215402 NCI_CGAP_Alv1 
Homo sapiens 
cDNA clone
for Variation not 
detected
AI361447 G to A change in exon 13 
- Glu to Lys change
2014103 NCI_CGAP_Brn23 
Homo sapiens 
cDNA clone
rev Wrong EST present 
in clone
AI419452 Same as AI361447 2097564 NCI_CGAP_Brn23 
Homo sapiens 
cDNA clone
site spec 
(DLR 44)
Variation confirmed. 
Also contains intronic 
material
AI423466 Same as AI361447 2104850 NCI_CGAP_Brn23 
Homo sapiens 
cDNA clone ............ ............ ..
AW015338 Same as AI361447 IMAGE clone not available - i
AI824501 Base substitutions and 1 
base deletion in exons 18 
and 19
2274985 NCI_CGAP_Ut1 
Homo sapiens 
cDNA clone
Site spec 
(DLR 28)
Variation not 
detected
H000777 12 base insertions in 
3'UTR region
150248 Soares placenta 
Nb2HP Homo 
sapiens cDNA 
clone
rev Variation not 
detected
W45459 Changes in 3’UTR 328936 Pancreatic islet 
Homo sapiens 
cDNA clone
for Variation not 
detected
N87699 Changes in 3’ UTR region IMAGE clone not available
AF097451 C to T change in exon 14 
- Pro to Ser
IMAGE clone not available 1
j-
i
AF260318 Insertion of ACA - an 
additional amino acid 
residue in exon 20 -  Gin
IMAGE clone not available
........
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(ii)
p^mer Sequence (S’ -  3’)
MVS 122 CCTCCTGCTGGCTGGTATT
DLR 44 TTTTCCTATTAATTATTGAGTATC
DLR 28 ATGTTTTT GC AAC AATC A
REV CAGGAAACAGCTATGAC
FOR GTAAAACGACGGCCAG
The actual sequence data generated for the clone (AI419452) in which the putative 
exon 13 polymorphism were found to be real are shown in Figure 5.1.
Figure 5.1: Exon 13 polymorphism
ii)
The A to G exon 13 polymorphism (position 1495- numbered according to Genbank 
accession number AF011568) in IMAGE clone number AI419452 (figure i) sequenced 
with primer DLR 44 (reverse direction) shows a T at the site of interest which is C in the 
published Clock sequence (figure ii).
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A number of the IMAGE clones identified during database screening including 
AI419452 contained intronic sequence that is not normally present in cDNA clones. 
The fact that it is present could be due to genomic/heteronuclear RNA contamination 
during cDNA library preparation, or due to a splice variant. The identified sequences 
containing intronic material are shown in Appendix 3.
5.3 Direct sequencing of hClock in subject DNA
5.3.1 Introduction
Four of the t  characterised subjects from the Surrey database (Chapter 2.1) were 
selected for analysis of the major functional regions of hClock in addition to other 
regions of this gene for which PCR conditions had been optimised. Two subjects with 
the longest t  and two subjects with the shortest t  values were selected from the cohort 
to try to identify polymorphisms that could contribute to a variation in t  (Table 5.2).
Table 5.2: Details of subjects selected for hClock analysis
Subject
number
Gender Age
(years)
t (hours) Cause of blindness
S45 M 42 24.95 Penetrating ocular trauma
S62 M 38 24.81 Retinoblastoma
S67 F 49 23.92 Detached retina
S70 M 38 24.30 Uveitis
Subject S70 exhibits the second shortest t  value in the Surrey group- this is also the shortest t  
value exhibited by a male subject in this group
5.3.2 Materials and methods
Genomic DNA was extracted from blood samples provided by each subject as 
described in Chapter 3.2. The DNA was then subjected to amplification using the 
standard PCR conditions described in Chapter 3.4 with intronic primers (appendix 8)
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that had been designed using the DNAStar PrimerSelect software (Lasergene, 
DNAStar, Madison, WI) and the human genomic DNA sequence for Clock (Genbank 
accession number AC069200). The annealing temperature for each primer pair was 
initially optimised using commercially available human genomic DNA (Promega) as 
a template. For exon 13, a semi-nested PCR using the product of the first PCR 
reaction as a template for a second PCR was required, and this was also optimised. 
For exon 20, a simple size selection procedure was required prior to nested PCR. A 10 
pi aliquot of the primary PCR product was electrophoresed in the manner described in 
Chapter 3.4. After electrophoresis was completed, and while the gel was being 
observed under UV transillumination so that the size marker could be observed a 
sterile pipette tip was used to remove agarose from the gel at approximately 1,200 bp 
for each sample. The tip was then dispensed into a 1.5 ml centrifuge tube containing 
50 pi of sterile distilled water, which was closed and vortexed. The tube was left at 
60°C for 5 minutes to enhance the removal of the agarose collected in the tip. 
Centrifugation was conducted in a microcentrifuge for 2 minutes at 13,000 rpm and 
the agarose was deposited as a pellet. The pipette tip was removed from the tube, after 
which vortexing and a further centrifugation step was conducted. The supernatant was 
then used as a template for the nested PCR reaction.
The primers used for each region of Clock and their optimised annealing 
temperatures are shown in appendix 8. Figure 5.2 shows the functional regions that 
were amplified using these primers and also the other regions investigated.
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The amplification reactions for exons 4, 6,13 and 20 resulted in the production of two 
fragments. In each case one of these fragments was of the expected size. The fragment 
of the correct size was purified using low melting point gel electrophoresis and the 
Wizard PCR preps method (Promega) (Chapter 3.5). For the other reactions only the 
fraction of the correct size was produced and this was purified using the direct PCR 
product purification method (Chapter 3.5). Photographs of UV illuminated agarose 
gels of the purified products are shown in Figure 5.3. Sequencing was conducted as 
described in Chapter 3.7 using one PCR primer in each reaction followed by sequence 
data analysis as described in Chapter 3.7 The sequence data generated for each subject 
was then compared to identify polymorphisms.
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Figure 5.3: Purified products of PCR for specific exons of Clock
Exon 2 Exon 4 Exon 6 Exon 8-9
Exon 18Exon 17Exon 10-11
Exon 19
One purified product of amplification from subject DNA for each exon is shown with a 
ladder in lane one (200 bp ladder, Promega) in all except exon 4 (100 bp ladder, 
Promega), 18 (100 bp ladder, Promega) and exon 19 (X,DNA/ EcoRI + Hindlll, Fermentas)
5.3.3 Results
The regions that were amplified and contained functional regions of the CLOCK 
protein, i.e. exon 4 (bHLH), exon 6 (PAS A) and exons 10-11 (PAS B) did not exhibit 
any sequence variation between the four i-characterised subjects. In addition, no 
sequence variations were observed in exons 2 (containing the translational start site).
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8, 9, 13, 17 (exon corresponding to that missing in the Clock mouse), 18, 19 or 20 
(both containing sections of the unidentified repeat regions). A silent mutation, a C to 
T transition positioned at 2121 (numbered according to Genbank accession no. 
AF011568) was observed in exon 18. The subject with the longest i  (24.95 h) value 
was homozygous for C and the subject with the shortest t  was heterozygous. The 
subjects with the i  values of 24.13 and 24.8Ih were homozygous for T at this site. 
The three possible genotypes are shown in Figure 5.4.
Figure 5.4: Silent mutation in exon 18
t t
1241001102
Position 2121 (numbered according to Genbank accession number AF011568) in exon 
18 in (a) the subject with the longest x value (homozygous for C), (b) subject with the 
shortest x value (heterozygous C/T) and (c) two remaining subjects (homozygous for T)
5.4 Discussion
Through genetic database screening and analysis ten IMAGE clones were obtained; 
however, only one of the potential variations observed during the database search was 
confirmed as actually being present (EST sequences are based on a non-verified 
single read and so there is a high chance of error being present in sequence data 
deposited, particularly at the end of the sequence read). The clone in which variation 
was confirmed showed a G to A transversion in exon 13 of Clock resulting in a 
change of amino acid from glutamate to lysine. Glutamate is an acidic residue and can 
be potentially modified by y-carboxylase whereas lysine is a basic amino acid that can
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be modified by (de)methylase, (de)acetylase and hydrolase enzymes. Such a change 
could therefore cause an alteration in the folding or processing of the CLOCK protein 
and thus its function.
Three potential sequence variants were identified during database screening for which 
no IMAGE clones were available and hence these changes could not be confirmed. 
One of these identified potential changes in the 3’UTR of Clock and another 
identified a single nucleotide polymorphism in exon 14 altering the amino acid 
residue. This potential polymorphism is a C to T substitution leading to a proline 
residue being substituted by a serine. In addition, a 3-bp insertion in exon 20 was 
observed (AF260318). This would cause the insertion of an additional glutamine 
residue in the glutamine rich region of CLOCK. It is within this region where the 
mouse and human CLOCK proteins differ in glutamine residue number, and so this is 
potentially an exciting mutation. Both this polymorphism and the real polymorphism 
identified in exon 13 were chosen for further analysis in subject DNA material 
(described in Chapter 6).
The fact that the regions o f Clock that were assessed did not exhibit any non-silent 
sequence changes in the four -[-characterised subjects studied here suggests that 
selection pressure may have lead to the conservation of the sequence of these regions 
of the Clock gene.
A previous study in which the Clock gene was screened for polymorphisms in 22 
DSPS patients and 10 subjects with non-24-hour syndrome using single-strand 
conformation polymorphism (SSCP) analysis (Iwase et al., 2002) identified two
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polymorphisms - the silent polymorphism in exon 18 (observed in the i- 
characterised subjects described), and a mis-sense polymorphism in exon 17. Exon 17 
corresponds to the exon spliced out in the Clock mouse. During analysis of this mis- 
sense polymorphism in both control and patient populations (109 controls, 59 DSPS 
and 37 non-24 hour syndrome), another mis-sense polymorphism was identified in 
one heterozygous control subject by Iwase and colleagues. The original 
polymorphism in exon 17, however, was only observed in two heterozygous control 
subjects and two heterozygous DSPS subjects. Both of these polymorphisms therefore 
appear to be rare with no homozygotes in the population studied. Therefore, in the 
subjects studied by Iwase and colleagues (2002) Hardy-Weinberg equilibrium is not 
achieved. The Hardy-Weinberg equilibrium tests to see if the allele and genotype 
frequencies are in equilibrium- that is they should remain stable from generation to 
generation. This equilibrium assumes that there is no selection, no mutations, no 
migration and no random events resulting in certain individuals passing on more of 
their genes than others and that mating is random. The Hardy-Weinberg equilibrium 
assesses whether the population under study is random. Iwase and colleagues (2002) 
concluded from their study that the polymorphisms were not associated with DSPS. 
However, one of the polymorphisms was only observed in a control subject and the 
other was observed in both control and DSPS subjects. These two polymorphisms 
were not observed in the four i-characterised subjects studied in this investigation.
The silent polymorphism in exon 18 was not investigated further in the population 
groups studied by Iwase and colleagues (2002). However, this polymorphism was 
identified in the x characterised subjects investigated here, suggesting that this 
polymorphism is probably more prevalent in the population.
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6. SCREENING FOR THE EXON 13 AND EXON 20 
POLYMORPHISMS
6.1 Introduction
Exon 13 was investigated in three population groups (Chapter 2) that had been 
recruited in order to assess whether the polymorphism identified at position 1495 
during database screening and analysis (Chapter 5) was present in the normal 
population and whether it was associated with variation in x or with DSPS. The 
polymorphism, as previously described, was a G to A transition in exon 13 of Clock 
resulting in a change of amino acid from glutamate to lysine (Figure 6.1). No 
restriction site is present here and so each DNA sample requires compete sequencing 
for analysis. Exon 13 is not situated within any of the known functional domains of 
CLOCK.
The exon 20 polymorphism was also assessed in the three recruited population groups 
(Chapter 2) using a rapid screening technique that was developed to assess whether 
the three base pair insertion that was identified during database screens was present 
This technique was developed due to the ability to distinguish between different sized 
products during polyacrylamide gel electrophoresis. No IMAGE clone was available 
for the sequence deposited in the NCBI BLASTsearch database containing this 
insertion (Genbank accession number AF260318) and so it could not be confirmed in 
the same manner as the exon 13 polymorphism. However, due to its potential value it 
was decided that this would be an interesting site to investigate in subject DNA 
material. The observed variation would cause the insertion of an additional glutamine 
residue in the glutamine rich region of CLOCK. It is within this region that the mouse 
and human CLOCK proteins differ in the number of glutamine residues and so this is
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a potentially exciting polymorphism because the mouse CLOCK protein has 17 
glutamine repeats interrupted by a proline dimer, whereas the wild-type human 
CLOCK protein has 6 residues (Figure 6.2). In addition, glutamine repeats have been 
shown to be prevalent in cases of dynamic mutations, where the number of 
trinucleotide repeats in a particular gene varies between generations. A larger number 
of repeats usually above a set precise number for each gene generally leads to 
symptoms of a specific disorder such as Huntington’s disease. In this disorder, a CAG 
trinucleotide repeat expansion results in a protein with an extended polyglutamine 
tract. The mutant form of the protein appears to concentrate (having not been 
degraded properly) as nuclear inclusions in neural tissue (Thornton et al., 1997).
Figure 6.1: The exon 13 polymorphism in CLOCK
Position 1489 1495 1501 1507
Human 1 tat gca gaagtt agg get gaa aga
human 2 
amino
tat gca aaa gtt agg get gaa aga
acid (1) 
amino
TYR ALA GLU VAL ARG ALA LYSARG
acid (2) TYR ALA LYSVAL ARC ALA LYSARG
Position 1543 1549 1555 1561
Human 1 cct gag aca get get gac aaa
human 2 
amino
cet gag aca get get gac aaa
acid (1) 
amino
PRO GLU THR ALA ALA ASP LYS
acid (2) PRO GLU THRALA ALA ASP LYS
1513 1519 1525 1531 1537
cga cga gaa ctt ggcatt gaa gag tct ctt
cga cga gaactt ggc att gaa gag tct ctt
ARGARG LYS LEU GLY ILE LYS LYS SER LEU
ARGARG LYSLEU GLY ILE LYS LYS SER LEU
The exon 13 polymorphism (a G to A transition identified during database screening causes a 
glutamate (E) to lysme (K) amino acid substitution. The exon 13 genomic sequence is shown 
(human 1) with nucleotide (nt) numbers (according to Genbank accession number AF011568), in 
addition to the EST sequence (human 2).
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Figure 6.2: Alignment of human and mouse Clock sequence for exon 20
Position 4 10 16 22 28 34 40 46 52
Mouse attt tct caa ggtcag caa ctt gtg acc Aaa tta gtg act get cct gta get
Human 1 a ttt tct caa ggt caa caa ctt gtg acc Aaa tta gtg act get cct gta get
human 2 a ttt tct caa ggtcaa caa ctt gtg acc Aaa tta gtg act get cct gta get
amino 
acid (m) - PHE SER GLN GLY GLN GLN LEU VAL THR LYS LEU VAL THR ALA PRO VAL ALA
amino
acid (h) - PHE SER GLN GLY GLN GLN LEU VAL THR LYS LEU VAL THR ALA PRO VAL ALA
position 58 64 70 76 82 88 94 100 106
mouse tgt ggg gcc gtc atg gta cca agt acc atg ctt atg ggtcag gtg gtg act gcc
human 1 tgtggg gcagtc atg gta cct agt act atg ctt atg ggc cag gtg gtg act gca
human 2 tgt ggg gcagtc atg gta cct agt act atg ctt atg ggc cag gtg gtg act gca
amino 
acid (m) CYS GLY ALA VAL MET VAL PRO SER THRMET LEU MET GLYGLN VALVAL THRALA
amino
acid (h) CYS GLY ALA VAL MET VAL PRO SER THRMET LEU MET GLYGLN VALVAL THRALA
position 112 118 124 130 136 142 148 154 160
mouse tat cct acc ttc gcc aca — caa cag cag cag gca cag aca tta teg gta aca
human 1 tat cct act ttt get aca — caa cag caa cag tea cag aca ttg tea gta acg
human 2 tat cct act ttt get aca caa caa cag caa cag tea cag aca ttg tea gta acg
amino 
acid (m) TYR PRO THR PHE ALA TYR - GLN GLN GLN GLNALA GLN THR LEU SER VAL THR
amino 
acid (h) TYR PRO THR PHE ALA TYR IKUMIGLN GLN GLN GLNSER GLN THR LEU SER VAL THR
position 166 172 178 184 190 196 202 208 214
mouse caa cag cag cag cag cag cag cag cag cca cca cag caa cag caa caa caa cag
human 1 —  — ~  cag cag cag cag cag cag — —  — —  — —  — —  —
human 2 —  — —  cag cag cag cag cag cag — —  — —  — —  — —  —
amino 
acid (m) GLNGLN GLNGLN GLN GLN GLN GLN GLN PRO PRO GLN GLNGLN GLNGLN GLNGLN
amino
acid (h) - GLN GLNGLN GLNGLN GLN -
position 220 226 232 238 244 250 256 262 268
mouse cag agt tcc cag gaa cag cag ctt cct tea gtt cag cag cca get cag gcc cag
human 1 — age tcc cag gag cag cag etc act tea gtt cag caa cca tct cag get cag
human 2 —  age tcc cag gag cag cag etc act tea gtt cag caa cca tct cag get cag
amino 
acid (m) GLN SER SER GLN GLU GLN GLNLEU PROSER VALGLN GLNPRO ALA GLN ALAGLN
amino
acid (h) -  SER SER GLN GLU GLN GLNLEU THRSER VALGLN GLNPRO SER GLN ALAGLN
position 274 280 286 292 298
mouse ctg ggc cag cca cca cag cag ttc tta cag
human 1 ctg acc cag cca ccg caa caa ttt tta cag
human 2 ctg acc cag cca ccg caa caa ttt tta cag
amino
acid (m) LEU THR GLNPRO PRO GLN GLN PHE LEU GLN
amino
acid (h) LEU THR GLNPRO PRO GLN GLN PHE LEU GLN
Mouse exon 20 ( AF14631) is shown aligned with human cDNA sequence for exon 20 (human 1) adapted 
from sequence AF011568 (genomic sequence). Sequence AF260318 (EST sequence) is also aligned (human 2) 
- this sequence displays an addition glutamine residue compared to human 1 (green box).
84
6.2 Materials and Methods
6.2.1 Subjects
Subject details are shown in Chapter 2. The control population group consisted of
thirty volunteers recruited at the University of Surrey (8 males, 22 females, aged 32 ±
13 years, mean ± SD). In addition, all twenty-six free-running blind subjects (21
males, 5 females aged 46 ± 12 years, mean ± SD) and sixteen DSPS subjects were
assessed (8 males, 8 females, aged 27 ± 16 years, mean ± SD) (Chapter 2). All
subjects donated a blood sample from which genomic DNA was extracted for further 
analysis.
6.2.2 Exon 13 analysis
Genomic DNA was extracted from a blood sample provided by each subject (Chapter 
3.2) that was then amplified using the optimised PCR conditions and primers 
described in Chapter 5.3.2. PCR product was purified (Chapter 3.5) and finally 
sequencing was conducted as described in Chapter 3.7.
6.2.3 Development of exon 20 rapid screening technique
A rapid screening technique was developed using the fragment length analysis tool on 
the Open Gene Long Read Tower System (Visible Genetics) to screen for the 
potential 3-bp insertion in exon 20 in the subject groups described. Each DNA sample 
was amplified in the manner described in Chapter 5.3. However, the nested PCR used 
a Cy5.5 dye labelled custom primer (DLR 86- Cy5.5). In addition, a control sample 
for which the sequence was known was amplified in this manner using a Cy5 labelled
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nested primer (DLR 86- Cy5). Equal amounts of the test and control samples were 
mixed together before being mixed with an equal volume of formamide loading gel. 
After dénaturation for 2 minutes at 72°C, 2 pi of each sample was loaded onto a pre­
prepared long read gel poured using Surefill LR Sequencing Gel (Visible Genetics). 
The electrophoresis run was completed in 1 x TBE for 180 minutes at 60°C with a gel 
voltage of 1500V and laser power set to 50%. Data was collected and then analysed 
using the OpenGene Software (Visible Genetics).
As a control to ensure that this technique was appropriate for distinguishing fragments 
with only a 3-bp difference in size a control fragment was prepared using the control 
DNA sample that had been previously sequenced and was known not to contain the 
insert. This sample was processed in an identical manner to the test samples except 
that in the place of primer DLR 84, a primer was used with an additional 3-bp 
attached to the 5’ end (DLR 84a, Table 6.1) resulting in a product 3-bp larger in size 
than the original control fragment.
Table 6.1 : Primer used to develop control test sample
Primer Sequence (S’-3’)
DLR 48a ATTCTTTTT GÂÂT GTG GATÂTCC AAÂG ACGT
6.3 Results
The exon 13 polymorphism was not observed in any of the subject DNA samples 
assessed. The exon 20 screening technique was successfully developed. The control 
DNA fragment labelled with Gy5.5 containing an additional 3-bp migrated slower
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through the polyacrylamide gel than the control fragment labelled with Cy5 and 
resulted in an electropherogram with two separate peaks (Figure 6.3). The control 
DNA fragment labelled with Cy5.5 migrated at the same rate through the 
polyacrylamide gel as the control fragment labelled with Cy5 (Figure 6.4).
Figure 6.3: Electropherogram produced with control test (containing an additional 3- 
bp) and control fragments
685 bp 688 bp
I  I
Control sample labelled with CyS is shown in black. Control fragment containing an 
additional 3-bp labelled with Cy5.5 is shown in pink. This fragment has migrated 
through the polyacrylamide gel at a slower rate than the CyS control and thus two 
distinct peaks are observed.
Figure 6.4: Electropherogram produced with test and control fragments of equal size
685 bp
Control sample labelled with CyS (black) and control test labelled with CyS.S (pink). 
Samples of equal size migrated through the gel at the same time and appear as 
overlapping peaks on the electropherogram.
All the test subjects’ DNA fragments labelled with Cy5.5 migrated through the gel at 
the same rate as the control fragment labelled with Cy5.
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6.4 Discussion
Although the exon 13 polymorphism observed during database screening was found 
to be present during sequencing of the IMAGE clones obtained, it was not identified 
in any of the studied subjects. Therefore, it does not appear to be prevalent in the 
normal population, nor is it likely to be associated with t  or with DSPS. Since, to 
date, the polymorphism has only been confirmed in an IMAGE clone, it is 
theoretically a cloning artefact. However, due to the fact that it was present in a 
number of the identified IMAGE clones, this is unlikely. The four clones in which the 
polymorphism was identified were from the same subject (source- 
NCI_CGAP_Bm23 Homo sapiens cDNA) and so it seems likely that this is a rare 
mutation. Alternatively, the polymorphism may be associated with a phenotype, 
circadian or otherwise that was not investigated in this study such as ASPS. Due to 
the nature of the polymorphism, although it is not situated within any of the known 
functional domains of the Clock gene, it could alter the way the CLOCK protein is 
folded or is modified/processed and so could result in altered function of CLOCK. 
This polymorphism was also not identified during the SSCP screen conducted by 
Iwase and colleagues (2002) in 22 DSPS patients and 10 non-24 hour syndrome 
patients.
The polyacrylamide gel procedure described here for the analysis of exon 20 is able to 
distinguish between fragments that are only 1-bp different in size during sequencing 
when a large number of dye-labelled fragments are present. The results obtained with 
the control fragments in this study demonstrated that the technique developed was 
able to differentiate between two fragments that were only 3-bp different in size.
The peaks of all the subjects’ DNA samples were observed at the same time as the 
control fragment used in each lane suggesting than none of the subject test samples 
contained the insertion. Electrophoresis of the control sample in the same lane of the 
gel as the test sample overcomes any problems regarding different migration rates in 
different parts of the gel or on different gels.
Another laboratory has analysed exon 20 in 190 individuals, comprising 111 normal 
individuals, 50 bipolar disorder patients and 29 schizophrenics (Saleem et al., 2001). 
However, no differences in the number of glutamine repeat residues were observed in 
these individuals. Saleem and colleagues (2001) also investigated the number of 
glutamine repeat residues in exon 20 in different non-human primates and other 
animals including Drosophila and zebrafish. The number of glutamine repeats was 
found to vary, especially in Drosophila where the number of repeats varied from 25 to 
33 depending on the species and strain. In addition, in the rhesus monkey two allelic 
variants consisting of 7 and 9 repeats, respectively, were observed suggesting that this 
site can be polymorphic. In other genes, unstable trinucleotide repeat regions have 
been associated with certain disorders e.g. myotonic dystrophy (Thornton et al., 
1997). These mutations are know as dynamic mutations since the number of repeats 
can change from parent to child- repeat lengths below a certain length are stable in 
meiosis and mitosis but become unstable above a critical length. Stable variation in 
repeat length could be responsible for variation in phenotype. For example, the 
presence of additional repeats within a gene would result in additional amino acid 
residues being present in the resulting protein- this could perhaps alter protein folding 
or stability.
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The study described here supports the results of Saleem and colleagues (2001) who 
suggested that this site is not polymorphic in normal human subjects. In addition, it 
was not found to be polymorphic in subjects with DSPS or in subjects with 
characterised t values in the present study, suggesting that this site is not likely to be 
associated with inter-individual variation in t or with DSPS.
Although these two polymorphisms were not present in the subjects studied here it is 
possible that the mutations present in the IMAGE clone sequences were actual 
variations in Clock. These changes may be rare and as a result not seen frequently in 
the population. Alternatively, they could be associated with a phenotype not 
investigated here. As previously noted, sequence variation initially observed in 
MAGE clones is usually due to error since many of these sequences are generated 
rapidly from a single read. However, the exon ^polymorphism was actually 
confirmed as being present in the IMAGE clone but was not seen in subject DNA.
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7. ASSESSMENT OF THE 3111 CLOCK POLYMORPHISM IN 
SUBJECTS WITH DEFINED CIRCADIAN PHENOTYPE
7.1 Introduction
In the study conducted by Katzenberg and colleagues (Katzenberg et al., 1998), it was 
reported that a 3-point difference in HO score was observed between the 3111C 
positive (n=191) and 3111C negative (n=219) subject groups. The authors concluded 
that this corresponded to a 10-44 minute delay in the preferred timing of activities for 
the 3111C positive group compared to the 3111C negative group. The present study 
aimed to establish whether an even greater association could be observed between the 
3111C allele and eveningness in control subjects by assessing the 3111 Clock locus in 
the control subjects who had been selected for either morning, intermediate or 
evening preference groups (Chapter 4). In addition, since it was previously observed 
that diurnal preference could be correlated with t (Duffy et al., 2001), the 3111 locus 
was also assessed in the t-  characterised blind subjects to see if any association of 
3111C with t  could be observed. The locus was also investigated in the DSPS subject 
group to assess whether the frequency of the 3111C allele was different in this 
population group compared to the control group.
In order to rapidly screen this locus in the large number of subjects studied an 
amplification refractory mutation system (ARMS) was developed and optimised as 
part of this study.
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7.2 Materials and methods
7.2.1 Subjects
Subject details are shown in section 2.4. A characterised normal population group was 
characterised as part of this study and subjects were selected for genetic analysis 
according to HO score as described in Chapter 4. This characterised control 
population consisted of morning, intermediate and evening preference subgroups. In 
addition, all twenty-six free running blind subjects (21 males, 5 females aged 46 ± 12 
years, mean ± SD) and sixteen DSPS subjects were assessed (8 males, 8 females, aged 
27 ± 16 years (mean ± SD)) (Chapter 2). All the free-running and DSPS subjects 
donated a blood sample from which genomic DNA was extracted for further analysis.
7.2.2 Analysis of 3111 Clock
An amplification refractory mutation system was developed to rapidly assess the 3111 
genotype. For each DNA sample two PCRs were conducted using allele specific 
primers with the same reverse primer. The primers used are shown in Table 7.1. 
Initially, the system was optimised using samples from individuals whose 3111 
genotype had been determined by sequencing - a C/C, T/T and C/T sample were used 
to ensure specificity for each of the alleles.
Table 7.1: Primers used for ARMS amplification reactions
Primer name Sequence (5’-3’)
C specific AGGTGATCATAGGGGCAC
T specific AGGTGATCATAGGGGCAT
Reverse GAGGTC ATTT CAT AGCT G AGC
Amplification was conducted using Taq DNA Polymerase (Promega) and the
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following cycling parameters: 94°C for 3 minutes followed by 35 cycles of 94°C for 
45 seconds, 62°C (blood extract)/60°C (buccal extract) for 45 seconds, and 72°C for 
60 seconds. The primers were added after the PCR mix had been heated at 94°C for 2 
minutes. Following PCR, agarose gel electrophoresis was conducted as described in 
Chapter 3.4 to identify whether one (either homozygous for T or homozygous for C) 
or both (heterozygous) of the primer pairs had amplified successfully. Figure 7.1 
illustrates the ARMS procedure. Confirmatory sequencing was conducted on a 
proportion (20%) of subject samples.
Figure 7.1: The ARMS procedure used to investigate the 3111 Clock locus
3111
31113111
(a)
>—q  — ► T
(b)
▼ ▼
Product produced in PCR 
reaction with C specific 
primer (Y/N)
Product produced in PCR 
reaction with T specific 
primer (Y/N)
Genotype
Y N C/C
Y Y C/T
N Y T/T
a) A sample with unknown genotype is amplified in two reactions. Each reaction contains 
the same reverse primer with either a C specific or T specific primer, (b) Following 
amplification, agarose gel electrophoresis is conducted to identify which of the PCR 
reactions were successful for each product. The genotype is determined as shown in the 
Table.
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7.3 Results
7.3.1 Amplification refractory mutation system
Figure 7.2 shows the results of the ARMS technique for the samples for which 
optimisation was completed. PCR product was produced in the 3111C allele specific 
reaction for the 3111 C/C and the 3111 C/T samples, the 311 IT allele specific 
reaction generated product for the 3111 T/T and the 3111 C/T samples.
Figure 7.2: Agarose gel electrophoresis of ARMS reactions
Lane 1 -100 bp ladder
Lane 2 + 4 -  T/T individual (C specific primer) 
Lane 3 + 5 -  T/T individual (T specific primer) 
Lane 6 -  C/T individual (C specific primer) 
Lane 7 -  C/T individual (T specific primer) 
Lane 8 -  C/C individual (C specific primer) 
Lane 9 -  C/C individual (T specific primer)
1 2 3 4 5 6 7 8 9
7.3.2 Control subjects with defined diurnal preference
The frequencies of the 3111 C/C, C/T and T/T genotypes in the total control study 
population (n=T05) were 16/105, 44/105 and 45/105, respectively, and those of the 
alleles 0.36 (3111C) and 0.64 (311 IT). These values satisfied the Hardy-Weinberg 
equilibrium (P=0.71, appendix 6). The frequencies of the 3111C allele in the morning, 
intermediate and evening groups were 0.37, 0.37 and 0.34, respectively (Figure 7.3). 
These values were not significantly different from each other.
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Figure 7.3: Frequency of each 3111 genotype and allele in the control population
(a)
(b)
No. of subjects 
20
15
10 -j
5
0
Frequency 
0.70 1
0.60 4
0.50  
0.40  
0.30 -1 
0.20 
0.10 
0.00
M
M
A
I l  I L
(a) Number of subjects with each 3111 Clock genotype (black=C/C, grey=C/T, 
white=T/T) and (b) frequency of each allele (black=C, white=T) for the morning (M), 
intermediate (I) and evening (E) subgroups.
7.3.3 Free-running blind subjects with characterised % values
Only one of the 26 blind subjects was homozygous for the 3111C allele. This subject 
also exhibited the longest t value (24.95 h). The t value (mean ± SD) was 24.59 ± 
0.22 h for heterozygous subjects (3111 C/T, n=9) and 24.47 ± 0.24 h for homozygous 
subjects with the 3111 T/T genotype (Figure 7.4). This difference was not 
significantly different.
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(a)
(b)
Figure 7.4: Genotype distribution for the x-characterised subjects studied 
r (h )
25.00
24.80 
24.60 
24.40 
24.20
24.00
23.80 -t-*-1----------  !
C/C
--- ■ - | !
C/T T/T
Genotype
3111 Clock genotype t value (mean ± SD)
(hours)
C/C 24.95
C/T 24.59 ±0.22
T/T 24.47 ± 0.24
(a) The range of t  values observed for each genotype is shown, (b) The average 
(mean ± SD) t  value for each genotype
7.3.3 DSPS subjects
In the DSPS (n=16) patients studied the observed frequencies for each 3111 genotype 
were 4/16 (C/C), 2/16 (C/T) and 10/16 (T/T). For each allele the frequencies were 
0.31 (3111C) and 0.69 (311 IT) (Figure 7.5). These values did not differ significantly 
from those observed in our control study population.
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Figure 7.5: The frequency of the 3111 C and 3111 T alleles in the control and DSPS 
populations studied
Frequency
1.00 i 
0.80 - 
0.60 - 
0.40 - 
0.20 -  
0.00 -
Normal DSPS
The frequency of the 3111C (black) and the 3111T (white) alleles in the control (n=105) 
and DSPS (n=16) populations studied.
7.4 Discussion
By contrast to the finding of Katzenberg and colleagues (Katzenberg et a l, 1998), no 
association was found between the 3111C allele and eveningness in the control study 
population. There was also no association between 3111C and t as measured in free- 
running blind subjects. The frequency of this allele was not significantly different 
between the control population and the DSPS patients studied.
In the previous study, it was reported that a 3-point difference in the HO score was 
observed between the 3111C positive (n = 191) and 3111C negative (n — 219) subject 
groups. The present study aimed to establish whether an even greater association 
could be observed between 3111C and eveningness in normal subjects by selecting 
individuals with extreme diurnal preference according to HO score. The calculated 
mean HO score of the evening group was substantially lower than that of the morning 
and intermediate groups by 37 and 20 points, respectively. An allele which was 
associated with increased eveningness (Katzenberg et a l, 1998) would be at a higher
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frequency in the selected evening group compared to the intermediate and morning 
groups. However, this was found not to be the case.
The Clock 3111 locus was also assessed in free-running blind subjects with 
characterised t  values since diurnal preference has been previously found to be 
associated with x (Duffy et al., 2001). An allele associated with eveningness should 
thus be associated with longer x values. Of the 26 subjects studied, only one subject 
was homozygous for the 3111C allele. This subject also had the longest x. In the study 
conducted by Katzenberg and colleagues (Katzenberg et al., 1998), it was observed 
that individuals who were 3111C homozygotes (C/C) did not exhibit a greater evening 
tendency than those with just one 3111C allele. Hence, it was argued, possession of 
only one 3111C allele was sufficient to produce the reported phenotype. In fact, the 
subjects who possessed the C/T genotype (n = 163) in Katzenberg’s study appeared to 
have a greater evening tendency than the smaller number of subjects (n = 28) whose 
genotype was C/C. Comparison of the x values measured in the 3111 C/T with the 
T/T genotypes showed that there was no significant difference between the two 
groups thus supporting the results observed in our control population.
Additionally, the Clock 3111 locus was investigated in a population of subjects with 
DSPS. Since DSPS is characterised by a larger phase delay of the sleep-wake cycle 
than observed in the normal population (Weitzman et al., 1981) an allele associated 
with eveningness should be more prevalent in these subjects. However, no significant 
difference was observed in the frequency of the 3111C allele in the DSPS population 
compared to the control population studied here. This finding agrees with a similar 
observation reported for a group of Japanese DSPS patients (Iwase et al., 2002).
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At present, very little is known about the mechanism(s) of DSPS. However, it is 
thought that genetic components do play a role (Ebisawa et al., 2001, Ancoli-Israeli et 
al., 2001, Archer et al., 2003). The underlying genetic factors may not be the same in 
all DSPS subjects and in certain cases, since this is a fairly extreme phenotype found 
in less than 0.5% of the population (Ohta et al., 1995, Schrader et al., 1993, Yazaki et 
al., 1999), any genetic component responsible may not be observed in a normal 
population.
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8. FUNCTIONALITY TEST FOR THE 3111 CLOCK GENE LOCUS
8.1 Introduction
According to Katzenberg and colleagues (1998), the 3111 Clock gene locus was 
associated with diurnal preference. However, this finding was not observed in the 
subjects recruited in the present study (Chapter 8). The 3111 polymorphism is situated 
within the 3’UTR of Clock and so does not alter the amino acid sequence of the 
resulting CLOCK protein. The main function of this region is to regulate mRNA 
stability/translatability (Mignone et al., 2002). In order to assess the possibility of 
Clock 3111 having a functional role in mRNA regulation, an in vitro assay was 
developed using COS-1 cells into which luciferase reporter gene constructs containing 
the two different forms of Clock 3111 in their 3’UTR were transfected.
8.2 Materials and methods
8.2.1 Construction of 3’UTR fragment luciferase reporter gene constructs
A 718 bp fragment of the 3’UTR from two subjects (one homozygous for C, one 
homozygous for T at position 3111) was amplified from genomic DNA samples 
(prepared as described in Chapter 3.2). Nested PCR was conducted using the 
conditions specified in Chapter 3.4 and annealing temperatures of 56°C. The initial 
PCR was conducted using primer pair 245-246 (Figure 8.1), and the nested PCR was 
conducted using primer pair 247-246 (Figure 8.1). Primer 246 was designed so as to 
include the Xba I  site at position 3465 (Genbank accession number AF011568) within 
the amplified region, and primer 247 was designed so that an additional Xba I  was
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introduced at the opposite end of the product (Figure 8.1). Agarose gel electrophoresis 
was conducted (Chapter 3.2) to verify the success of amplification.
Figure 8.1: Primers used to amplify 3’ UTR section containing polymorphism at 3111
(i)
Primer
number
Primer sequence (5’-3’) 3’ base 
location
Upstream (U) / 
Downstream 
(D) Primer
245 GTCTCAGCAACAGCAGCAACTC 2845 D
246 GTAAACAAAAGGAAAAACAGGATGG 3576 U
247 GCTCTAGAGCGTTCAACCACAGTAGCAC
ACG
2915 D
Xba i  2 4 7  246
=►' ►245'
I CfocfccDNA
Stop Xba I
718bp
Each primer sequence is shown in (i) along with the position of the next base in the cDNA sequence foi 
Clock. The upstream primer has sequence complementary to that of Clock cDNA and is extended in c 
direction towards the 5’ end of the cDNA sequence, downstream primers are extended in a direction towards 
the 3’ end of Clock cDNA. The sequence shown in red is the Xba I site. The cDNA (Genbank accessior 
number AF011568) does not include sequence information after 3490 bp, therefore for 246 the 3’ base 
location has been inferred for this sequence using cDNA (Genbank accession number AB002332). Figure 8.1
(ii) is a schematic diagram of the primer arrangements. The portion of Clock cDNA shown as a bo> 
represents the 3’ region- the stop codon is depicted at position 2896.
A restriction digest (Chapter 3.8) of each PCR product was conducted using Xba I  
resulting in a 578 bp fragment. Digestion with Xba I  was also conducted for the vector 
pGL3-promoter (Promega). Completion of the digest reaction was confirmed by 
comparing digested and undigested product using agarose gel electrophoresis 
(Chapter 3.4), and either the 100 bp or 200 bp ladder and a supercoiled ladder 
(Promega) as size markers. Low melting point 1.2% agarose gel electrophoresis and
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gel purification was conducted for each digested PCR product using Wizard PCR 
Preps DNA Purification System (Promega), as described in Chapter 3.5. Purification 
of digested pGL3-promoter was conducted in the same manner.
Ligation of each of the 578 bp fragments with the pGL3-promoter vector was 
conducted using T4 DNA Ligase (Promega) as described in Chapter 3.9. The success 
of the ligation reaction was monitored using agarose gel electrophoresis (Chapter 3.4) 
to compare the completed ligation reaction product and a control reaction (containing 
no ligase). The successfully ligated DNA was transformed into Epicurian Coli XL1- 
Blue competent cells (Stratagene) using the manufacturer’s rapid transformation 
protocol (Chapter 3.11). Single colonies from each of the transformations were 
selected and grown as overnight cultures in LB broth containing 0.05 mg/ml 
ampicillin. Purification of the inserted vector for each of the overnight cultures was 
conducted using Wizard Purefect Purification Kit (Promega) as described in Chapter 
3.10.
Using agarose gel electrophoresis (Chapter 3.4) and a supercoiled ladder (Promega) as 
a size marker, the vectors containing one insert were selected and two restriction 
digest reactions were completed for each using Xba I  and Acc I  (Chapter 3.8). 
Agarose gel electrophoresis (Chapter 3.4) was conducted for the completed digests 
and the size of the fragment produced was determined by comparison with the 100 bp 
ladder that was electrophoresed on the same agarose gel. A 578-bp fragment produced 
by the Xba I  digest was indicative that a fragment of the correct size had been 
inserted. Digestion with Acc I  was used to determine the orientation of the insert. A 
403-bp fragment was indicative of the insert being in the sense orientation, and a
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fragment of 719 bp was indicative of the insert being in the anti-sense orientation 
(Figure 8.2).
Figure 8.2: Method used to determine the insert orientation and size
Xba I digest
/ ™ \
5010 bp 578 bp
Acc I digest:
s e n s e  o r ie n ta t io n
Acc I site 
2201
5185 bp 403 bp
a n t i s e n s e  o r ie n ta t io n
Acc I site- 
2201
4869  bp
S .
719  bp
Xba I was used to confirm the insert size, Acc I was used to determine the orientation 
of the fragment in the vector (this was determined from the size of the fragment 
produced using this digest reaction).
Two purified vectors were selected for each 3’UTR variant - one containing the insert 
in the sense orientation and one containing the insert in the antisense orientation. 
Custom sequencing was conducted (MWG Biotech, Ebersberg, Germany) using 
custom primers to confirm the sequence and orientation of the inserts in each vector. 
Once the orientation and sequence of the 4 selected vector constructs had been 
confirmed (Appendix 4), the concentration of each sample was determined using the 
fluorescent DNA quantitation kit (Bio-Rad) as described in Chapter 3.11.
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8.2.2 Transfection and luciferase reporter gene assay
Cos-1 cells were maintained as described in Chapter 3.12. The cells were transiently 
infected using Transfast Transfection Reagent (Promega) as described in Chapter 
3.13. Cells were co-transfected with 150 ng experimental vector and 15 ng control 
vector - pRL-SV40 (Promega) which had been transformed into XL 1-Blue competent 
cells and purified in an identical way to the experimental vector as described in 
Chapter 3.10. In addition, a number of control transfections were conducted (Table 
8.1). All transfections were completed in quadruplicate as described in Chapter 3.13.
Table 8.1: Transfection experiments and controls conducted
Experiment name Experimental vector 
(150 ng)
Control vector 
(15 ng)
pGL3-promoter/ sense  
3111T
PGL3-promoter with correct insertion of 
3’UTR fragment-3111 T
pRL-SV40
pGL3-promoter/ 
antisense 3111T
PGL3-promoter with reversed insertion of 
3’UTR fragment- 3111 T
pRL-SV40
pGL3-promoter/ sense  
3111C
PGL3-promoter with correct insertion of 
3’UTR fragment- 3111C
pRL-SV40
pGL3-promoter/ 
antisense 3111C
PGL3-promoter with reversed insertion of 
3’UTR fragment-3111 C
pRL-SV40
pGL3-promoter-no insert PGL3-promoter with no insert pRL-SV40
pGL3-promoter control PGL3-promoter with no insert -
pRL-SV40 - pRL-SV40
Transfection mix minus 
DNA -
-
Serum containing 
medium not removed- 
not transfected
- —
Serum free medium only - -
Each experiment was conducted in quadruplicate. PRL-SV40 was used to measure 
transfection efficiency in the experimental transfections. Controls were conducted in 
order to a ssess  background illuminescence
Luciferase activity was measured using the Dual-Luciferase Reporter Assay System 
(Promega) and a Lumicount (without injector) luminometer (Packard Instrument
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Company) as described in Chapter 3.14. The luciferase activity for each experimental 
vector was normalised for transfection efficiency and expressed as a percentage of the 
activity produced by the pGL3- promoter-no insert (also normalised for transfection 
efficiency).
8.3 Results
The initial amplification of the 3’ UTR as described in Chapter 8.2.1 resulted in a 
718-bp fragment which when digested with Xba I resulted in the formation of a 578- 
bp fragment (Figure 8.3). Successful linearisation of the pGL3-promoter vector is also 
shown (Figure 8.3).
Figure 8.3: Successful amplification and digestion using Xba / of a 3’UTR fragment 
from subject DNA
1 2 3 4 5 6 7
1000 bp 200 bp, brighter band at 1000 bp)
200 bp
Lanes 1 and 3: Each 3’UTR section 
digested with Xba I (578-bp 
fragment)
Lanes 2 and 4: Uncut 3’UTR 
sections (718-bp)
Lane 5: pGL3-promoter vector 
digested with Xba I 
Lane 6: Uncut pGL3-promoter vector 
Lane 7: 200 bp ladder (bands every
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750 bp 
500 bp 
250 bp
The ligation reaction was then conducted for each 3’UTR fragment with the vector 
and the completed ligation is shown in Figure 8.4. In the control reactions it can be 
seen by the presence of two bands that the 3’ UTR fragment and the vector fragment 
are not ligated together. In the completed reaction it is difficult to see product bands, 
however, the two separate bands are no longer present and a band of a larger size is 
seen in lane 2.
Figure 8.4: Completion of ligation of the 3’UTR fragments with pGL3-promoter vector
6 Lane 1: 1 kb ladder (bands of 250, 500, 750 and
1000 bp, then at intervals of 1 kb)
Lane 2 and 4: Aliquot of completed ligation 
' ruction
Lane 3 and 5: Control reaction mixes (no ligase 
enzyme added)
Lane 6: Supercoiled ladder
The ligated DNA was used for the transformation experiments described in Chapter
3.1.1 from which isolated colonies containing single vectors were selected. The 
purified vector products were then analysed using gel electrophoresis to determine the 
number of inserts (Figure 8.5).
106
Figure 8.5: Analysis of insert number using agarose gel electrophoresis
Lanes 1 - 8: Purified vectors 
Lane 9: Supercoiled ladder
6000 bp
5000 bp 
4000 bp
3000 bp 
2000 bp
Vectors containing only one insert were required for the transfection experiments. It can be seen that 
lane 3 does not have vector present. Lanes 1, 2, 4 and 8 contain vectors that appear to be of the 
desired size (5588 bp). Lanes 5, 6 and 7 contain vectors that are of the size of the pGL3-promoter 
vector alone and so do not contain insert.
Figure 8.6 shows the results of Xba I and Acc I digests for those vectors thought to 
contain one insert. Xba I  was used to verify the size of the insert (578-bp) and Acc /  
was used to determine the orientation - a 403-bp fragment indicated sense orientation 
and a 719-bp fragment indicated anti sense orientation.
Figure 8.6: Determination of insert size and orientation using agarose gel 
electrophoresis
700 bp
600 bp 
500 bp
400 bp
Lane 1: 100 bp ladder
Lane 3 and 4: Xba I digested 3'UTR- 
vector constructs
Lane 5 and 6: Acc I digested vector 
constructs
-
Lanes 3 and 4 show the inserts to be of the correct size (578-bp). Lane 5 shows that the 
insert is in the sense orientation (403-bp) and lane 6 shows the result for a vector that 
has an antisense insert (719-bp).
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A sense and antisense variant of each 3’UTR-vector construct was sequenced to 
confirm the polymorphism and the orientation (Appendix 4) and following 
quantification these variants were used in the transfection experiment that was 
repeated twice. The overall result of these experiments is shown in Figure 9.7. The 
luciferase activity produced by the pGL3 promoter/sense 311 IT vector construct 
expressed as a percentage of the pGL3-promoter vector containing no insert was 50.9 
± 8.0% (mean ± SD), that of the pGL3-promoter/ sense 3111C vector construct was 
48.8 ± 18.0 %. These values were not significantly different from each other 
(Appendix 6).
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9.4 Discussion
Because the 3111 polymorphism is situated in the 35 UTR of Clock it does not alter 
the amino acid sequence of the CLOCK protein. Thus, any phenotypic variability 
found to be associated with this polymorphism would be caused either by an as yet 
undiscovered co-segregating polymorphism within or near the Clock locus or by the 
disruption of a functional role of this part of the 3’UTR in mRNA translatability. 
Sequences present in the 3’UTRs of other genes have been shown to be involved in 
the regulation of mRNA levels either by providing binding sites for proteins which 
alter mRNA stability, or by forming hairpin loop structures which stabilise and thus 
slow down mRNA degradation (Mignone et al., 2002). An alteration in Clock mRNA 
affecting the translatability of CLOCK protein would be likely to ultimately change 
the output of the circadian clock, since more protein could enhance the positive 
regulation of Per and less protein could slow this process down. However, no 
significant differences were observed in the functionality test between the vector 
construct containing the 3’UTR section with 3111C and that containing 311 IT. 
Inevitably, negative results obtained with this type of experiment cannot be 
completely conclusive. In this study, COS-1 cells were used which are derived from 
Cynomolgus monkey kidney cells. It cannot be excluded that a SCN cell-specific or 
human-specific factor is required for any difference to be observed. Additionally, 
since in vitro studies concentrate on one cell line isolated from an organism rather that 
in vivo where intercellular interactions will occur different results may be observed. In 
studies conducted both in vitro and in vivo investigating the distribution and 
interaction mechanisms of clock proteins conflicting results were obtained. Studies in 
vitro suggested that CRY proteins were responsible for translocation to the nucleus of
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CRY:PER dimmers (Kume et al., 1999). However, in vivo, it was observed that in fact 
the PER protein is responsible for this mechanism (Lee et al., 2001).
It is also possible that any effect of the polymorphism would require interaction with 
other regions in the long Clock 3' UTR (almost 3 kb, Steeves et al., 1999). Alignment 
of the mouse and human Clock mRNA sequences revealed that the first 1.3 kb of the 
3’UTR share the highest similarity (80%) with two regions within this section being 
completely conserved (Steeves et a l, 1999). These two regions are therefore likely to 
be of more universal functional importance. In addition, Steeves and colleagues 
(1999) identified the presence of four ATTT A motifs within the first 0.8 kb of the 
3’UTR. These motifs have previously been found in the 3’UTRs of other genes and 
are involved in mRNA degradation. The Clock 3111 locus is not situated within either 
of the regions with 100% similarity or the ATTT A motifs. Analysis of the 3’UTR 
sequence containing position 3111 using the UTRscan software (Pesole et al., 1999) 
did not identify any RNA protein binding sites at this locus. Matlnspector (Quandt et 
al., 1995), which identifies DNA regulatory sites, indicated that 3111C is part of a 
potential glucocorticoid response element (GRE) (Chandler et al., 1983) that is 
disrupted by the transition to 311 IT. This element, however, is a transcriptional 
regulator that only appears to be functional when located in the 5' UTR of genes. 
Furthermore, the SCN does not contain receptors for glucocorticoids (Balsalobre et 
al., 2000). Nonetheless, even considering the intrinsic limitations of negative results, 
the absence of any observed differences in this analysis agrees entirely with the fact 
that no difference was observed in the various circadian phenotypes that were 
assessed (Chapter 7).
I l l
9. GENERAL DISCUSSION
9.1 Introduction
The aim of the work presented in this thesis was to screen for polymorphisms in the 
human Clock gene and to assess their prevalence in human subjects with defined 
circadian phenotypes. Previous investigations in humans and other organisms have 
shown that mutations in the core clock genes can be linked to variation in circadian 
phenotype. The first identified link between genotype and circadian phenotype was 
reported by Konopka and Benzer (1971). Forward genetic screening using 
mutagenesis conducted in Drosophila associated per with circadian rhythmicity in 
this study. The mutant flies generated had either abnormally long or short rhythms in 
eclosion and locomotor activity and some were arrhythmic- alterations in the same 
gene- per were found to be responsible for these altered phenotypes. A second 
Drosophila clock gene was identified in a similar way using mutagenesis screening- 
the mutant flies were arrhythmic with alterations in the gene timeless being 
responsible (Sehgal et a l, 1994). In mammals no homolog of this gene has been 
identified- a gene assigned as mammalian timeless is in fact more closely related to 
Drosophila timeout (Shearman et a l, 2000). In Drosophila PER and TIM form 
dimmers whereas in mammals PER appears to associate with CRY proteins (Shirasu 
et al., 2003). Mutagenesis screens in another model organism- Neurospora identified 
the genes frq  (Feldman and Hoyle, 1973) and wcl and wc2 (Lind et al., 1997) as core 
components of the Neurospora clock- the protein products of these genes cycle in a 
similar way to PER and TIM in Drosophila with a feedback loop mechanism 
operating in this organism too.
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In the 1990s, mutagenesis screening in the mouse generated a mutant with an 
abnormally long circadian period- the Clock gene was found to be involved in 
circadian rhythmicity (Vitatema et al., 1994) and Email was identified as a binding 
partner for CLOCK (Gekakis et al, 1998). Additionally, mutation of Sm all was 
shown to cause arrhythmicity in locomotor activity in mice (Takahata et al., 1998). 
Homologs of Clock (Allada et al., 1998) and Sm all (Darlington et al., 2998) were 
identified in Drosophila and have a similar role. Other components of the mammalian 
clock were identified through homology screens using Drosophila clock genes. 
Mutant mice have now been generated to see if the genes identified in this manner are 
involved in circadian rhythm generation in mammals. Deletion of Cryl was shown to 
shorten circadian period and alteration of Cry2 lengthens circadian period. Mice with 
deletions in both of these genes appear arrhythmic (van der Horst et al., 1999). 
Mutations in Per2 result in a shorter circadian period (Zheng et al., 1999) and in Per3 
a slight shortening of circadian period (Shearman et al., 2000). One gene that was 
identified using a reverse genetic approach was casein kinase I epsilon in the tau 
hamster (shortened circadian period (Lowry et al., 2000).
In humans, reverse genetics approaches have been conducted with a number of links 
being made between genotype and circadian phenotype. ASPS was found to be 
caused by a mutation in Per2 in one family (Toh et al., 2001) and DSPS was linked to 
a haplotype of Per3 (Ebisawa et al., 2001). This study was extended further by 
conducting an investigation into the prevalence of one of the polymorphisms 
identified in the previous study (the length polymorphism in exon 18) using the 
databases developed as part of this thesis containing subjects with extreme diurnal 
preferences and individuals diagnosed with DSPS (Appendix 5 and 7). The region
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containing the length polymorphism was shown to be composed of a repeat region 
that contained either 4 or 5 units containing predicted potential phosphorylation 
motifs. The study by Archer and colleagues (2003) showed that the frequency of the 
5-repeat allele was significantly higher in subjects with an extreme morning 
preference compared to those with an extreme evening preference. In addition the 
frequency of the 4-repeat allele was shown to be significantly higher in the 
individuals with DSPS compared to the total control population (Archer et al., 2003). 
The difference in the number of repeats present could affect phosphorylation of the 
PER3 protein leading to an alteration in phosphorylation dependent effects and thus 
the phenotypic differences in day time preferences observed (Archer et al., 2003). 
This was the first investigation to show a link between a polymorphism in the coding 
region of a gene and diurnal preference and emphasises the importance of recruiting 
and characterising subjects using validated methods. Additionally, it highlights the 
fact that posttranslational mechanisms are an extremely important part of circadian 
rhythm generation and that changes in genes that ultimately affect the way in which a 
protein is modified/ regulated can have an impact on circadian output.
The main focus of this thesis was the Clock gene. This was selected as a suitable 
candidate gene since it was associated with altered circadian phenotype in mice and 
humans. Screening for polymorphisms was conducted using two approaches: (i) 
screening genetic databases and then sequencing of cDNA clones identified as 
containing potential polymorphisms, (ii) direct sequencing of DNA from human 
subjects.
9.2 Subjects with defined circadian phenotypes
Subjects were successfully recruited for three major databases as part of this thesis in 
which the prevalence of polymorphisms could be assessed:
(i) Blind subjects with free-running circadian rhythms and characterised t 
values
A total of 26 free running blind subjects with previously characterised x values 
ranging from 23.92 h to 24.95 h were recruited (Lockley et al., 1997, Robilliard et al., 
2003). Linear regression analysis for these subjects showed no association between 
age and x. Interestingly, however, there was a difference between x in the males and 
females studied- the females had a significantly shorter x than males. In this study, 
only five of the twenty-six subjects recruited were female and so it would be of 
interest to see if this trend is observed in a larger population group.
(ii) Subjects clinically diagnosed with delayed sleep phase syndrome
Sixteen unrelated subjects clinically diagnosed as DSPS sufferers were recruited for 
this study having been previously diagnosed as sufferers of DSPS.
(iii) control subjects with characterised diurnal preference as assessed by the 
Home-Ostberg questionnaire
Initially, thirty subjects were recruited. These subjects were used initially to assess 
whether a polymorphism was present in the normal population.
A larger population group was recruited and their diurnal preference was 
characterised as part of this study using the HO questionnaire. The HO questionnaire
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was successfully used to select control subjects with specific diurnal preferences- 
moming-preference, intermediate, and evening-preference subgroups. The mean HO 
score of the evening group was substantially lower than that of the morning and 
intermediate groups by 37 and 20 points respectively. Their selection was validated 
by the data obtained from the one-night sleep diaries. The actual timing of their sleep- 
wake cycle agreed extremely well with the data obtained from the HO questionnaire 
supporting the fact that this is a good predictor of actual diurnal preference. HO score 
appears to give a good indication of circadian phenotype. It was validated further in 
this study by assessing typical sleep habits- a good agreement was observed between 
the two tools. Other investigations have conducted studies to assess how well the HO 
questionnaire can predict circadian phenotype. Initially, during its development, the 
score generated form the questionnaire was linked to circadian phase of oral 
temperature (Home and Ostberg, 1976). More recently, HO score has been linked to t  
with lower scores on the questionnaire indicating longer x values and higher scores on 
the questionnaire indicating shorter x values (Duffy et al., 2001). This suggests that 
the HO questionnaire could be used as a screening tool to select subjects with extreme 
circadian phenotypes in diurnal preference and thus variation in x. Using the 
questionnaire to identify potential subjects in this way would not be as time 
consuming or labour intensive as measuring x either in the field or in controlled 
conditions in the lab. Indeed, the estimation of circadian period using aMT6s depends 
on how frequently measurements are taken. In the study protocol used to measure x in 
the subjects studied as part of this thesis, an overnight collection was used with 4 
hourly samples taken during the day.
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The development of characterised subject DNA collections as part of this study has 
made it possible to screen for the presence and possible association with circadian 
phenotype of the identified Clock gene polymorphisms as described. This resource, 
however, will be of great benefit to future studies since the prevalence of 
polymorphisms in other genes that may cause an alteration in circadian phenotype can 
be assessed in the same subject samples. The resulting phenotypes produced by a 
combination of different polymorphisms can thus be investigated. It is extremely 
important for this kind of assessment to be conducted since, in general, variations in 
circadian phenotype are likely to be the result of interactions between environmental 
factors and a range of polymorphisms in a number of genes. Although in this study no 
polymorphisms were identified in the Clock gene, work conducted simultaneously 
using the same subjects identified that the Per3 polymorphism was indeed associated 
with DSPS and diurnal preference.
9.3 Screening for Clock gene polymorphisms using sequence alignment and the 
NCBÏ BLASTsearch database
9.3.1 Exon 13 polymorphism
Of the fifteen clones identified during NCBI BLASTsearch, only one contained a 
polymorphism that could be confirmed. This clone showed a G to A transversion in 
exon 13 of Clock resulting in a change of amino acid from glutamate to lysine. 
Glutamate is an acidic residue and can be potentially modified by y-carboxylase 
whereas lysine is a basic amino acid that can be modified by (de)methylase, 
(de)acetylase and hydrolase enzymes. Such a change therefore could cause an 
alteration in the folding or processing of the CLOCK protein and thus its function. 
Although the polymorphism observed during database screening was found to be real
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during sequencing of the IMAGE clones obtained, it was not identified in any of the 
subjects recruited. Therefore, it does not appear to be prevalent in our control 
population, nor was it found to be associated with t or with DSPS. Because, to date, 
the polymorphism has only been confirmed in an IMAGE clone, it is theoretically a 
cloning artefact. However, due to the fact that it was present in a number of the 
identified IMAGE clones, this is unlikely. The four clones in which the polymorphism 
was identified were from the same subject and so it seems quite likely that this is a 
rare mutation. Alternatively, the polymorphism may be associated with a phenotype, 
circadian or otherwise, that was not investigated in this study such as ASPS. Due to 
the nature of the polymorphism, although it is not situated within any of the known 
functional domains of the Clock gene it could alter the way the CLOCK protein is 
folded or is modified/processed and so could result in altered function of CLOCK. 
This polymorphism was not identified during the SSCP screen conducted by Iwase 
and colleagues in 22 DSPS patients and 10 non-24 hour syndrome patients. It would 
be interesting to investigate whether this polymorphism is associated with a particular 
ethnic group or possibly with a particular phenotype (circadian or otherwise) that was 
not studied as part of this thesis. Additionally, functionality studies could be 
developed to assess the potential outcome of such a polymorphism.
9.3.2 Polymorphisms identified during NCBI BLASTsearch database screening
(unconfirmed)
Three potential sequence variants were identified during database screening for which 
no IMAGE clones were available. One of these identified potential changes in the 3’ 
UTR of Clock and another identified a single nucleotide polymorphism in exon 14 
altering the amino acid residue. This potential polymorphism is a C to T substitution
leading to a proline residue being substituted by a serine. Due to time limitations they 
were not investigated further. However, it would be interesting to investigate these 
regions in a small number of subjects from each database to investigate their 
prevalence.
The remaining clone in which a sequence variation was observed identified a 3-bp 
insertion in exon 20 and is described below.
9.3.2.1 Exon 20 3-bp insertion
The 3-bp insertion in exon 20 observed in clone AF260318 would cause the insertion 
of an additional glutamine residue in the glutamine rich region of CLOCK. It is within 
this region where the mouse and human CLOCK proteins differ in glutamine residue 
number, and so this is potentially an exiting mutation. A rapid screening technique 
was developed as part of this study using the fragment length analysis tool on the 
Open Gene Long Read Tower System to screen for the potential 3-bp insertion in 
exon 20 in the subject groups described. None of the subject samples studied 
contained the insertion.
The study described here supports the results of Saleem and colleagues (2001), who 
suggest that this site is not polymorphic in normal human subjects. In addition, it was 
not found to be polymorphic in subjects with DSPS or in subjects with characterised t  
values in the present study suggesting that this site is not associated with variation in t  
value or DSPS. However, now that a rapid screening technique has been developed it 
would be possible to rapidly screen other subjects, for example, those with other 
circadian phenotypes such as ASPS for this polymorphism. As shown by the Per 3
investigation additional repeat in a gene can be responsible for variation in circadian 
phenotype.
9.4 Direct sequencing of hClock in subject DNA
Four subjects with characterised x values (the two shortest and two longest values 
exhibited in the Surrey group) were selected for analysis. PCR conditions were 
optimised as part of this study for exons 2, 4, 6, 8-9, 10-11, 13, 17, 18, 19 and 20 as 
part of this study and could now be used to screen these regions in other subjects.
The regions that were amplified and contained functional regions of the CLOCK 
protein, i.e. exon 4 (bHLH), exon 6 (PAS A) and exons 10-11 (PAS B) did not exhibit 
any sequence variation between the four x-characterised subjects. In addition no 
sequence variations were observed in exons 2 (containing the translational start site), 
8,9, 13, 17 (exon corresponding to that missing in the Clock mouse), 18, 19 or 20 
(both containing sections of the unidentified repeat regions). A silent mutation, a C to 
T transition positioned at 2121 (numbered according to Genbank accession no. 
AFO11568) was observed in exon 18. The subject with the longest x (24.95 h) value 
was homozygous for C and that with the shortest x was heterozygous. The subjects 
with the x values of 24.13 and 24.81h were homozygous for T at this site. The fact 
that the regions of Clock that were assessed did not exhibit any non-silent sequence 
changes in the four x-characterised subjects suggests that these regions are exposed to 
selective pressure in order to conserve the sequence of this important gene.
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A previous study in which the Clock gene was screened for polymorphisms in 22 
DSPS patients and 10 subjects with non-24-hour syndrome using single-strand 
conformation polymorphism (SSCP) analysis (Iwase et al., 2002) identified two 
polymorphisms- the silent polymorphism in exon 18 that was observed in the t  
characterised subjects described here, and a mis-sense polymorphism in exon 17. The 
silent polymorphism in exon 18 was not investigated further in the population groups 
studied by Iwase and colleagues. However, this polymorphism was identified in the t  
characterised subjects investigated here, suggesting that this polymorphism is 
probably more prevalent in the population. It would be of interest to investigate the 
prevalence of this polymorphism in different ethnic populations.
Due to time limitations and the complicated intronZ exon structure, the remaining 
exons in Clock were not screened for polymorphisms. Initially, the regions of the 
Clock gene containing known functional domains were targeted followed by other 
regions of interest such as the exon missing in the Clock mouse. As part of future 
studies, it would be of interest to screen the other regions of Clock in these subjects 
and possibly extend the screening to subjects with other circadian phenotypes. From 
the initial results of this study and the results of Iwase and colleagues’ investigation 
(2002) it appears that this is an extremely conserved gene reflecting the importance of 
its function. However, as shown by the Clock mouse, it is possible for mutations to 
occur in this gene which can lead to altered circadian phenotype (Vitatema et al., 
1994).
121
9.5 Assessment of the 3111 Clock locus
The 3111 Clock locus which was previously associated with diurnal preference 
(Katzenberg et al., 1998) was assessed in the three subject groups described here 
using a rapid screening technique (ARMS) that was developed as part of this study.
In contrast to the finding of Katzenberg and colleagues (1998), no association was 
found between the 3111C allele and eveningness in the control study population. 
There was also no association between 3111C and x as measured in free-running blind 
subjects and the frequency of this allele was not significantly different between the 
control population and the DSPS patients studied (Appendix 5).
The work conducted here has enabled a thorough investigation into the association 
between extreme diurnal preference and the 3111 locus to be conducted, and has 
challenged the results of the previous study (Katzenberg et al., 1998). The conclusions 
drawn form this study are supported by the functionality test results that show no 
significant differences in translatability between the vector construct containing the 
3’UTR section with 3111C and that containing 311 IT. In this study subjects who had 
extreme diurnal preferences were selected based on their HO score and these results 
were validated using the data generated from the sleep diary. The study conducted by 
Katzenberg and colleagues did not include independent validation of the results from 
the HO questionnaire. Additionally, Katzenberg did not investigate the frequency of 
the 3111 alleles and genotypes in relation to phenotype. The methodology used 
appears to have led Katzenberg and colleagues to the wrong conclusion.
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9.6 Summary and future work
This thesis describes the development of three repositories containing DNA samples 
from subjects whose circadian phenotypes have been characterised. These samples 
can be used to assess the prevalence of polymorphisms that could be associated with 
variation in phenotype (extreme diurnal preference, t, DSPS). In addition, the 
resulting phenotypes generated by different combinations of polymorphisms can be 
assessed in these subjects. As part of the future work for this study, additional subjects 
should be recruited for the DSPS and i-characterised databases (whether the t- values 
of females are shorter than males could be investigated), in addition to recruiting 
subjects with other defined circadian phenotypes e.g. ASPS so that investigations into 
the polymorphisms responsible for circadian variation can be extended. It would also 
be of interest to recruit sets of identical twins so that the effects of the environment on 
circadian phenotype can be investigated.
BLASTsearch identified one actual polymorphism and a further three potential 
polymorphisms that could be associated with a circadian phenotype. Two of the 
unconfirmed polymorphisms (a coding polymorphism in exon 14 and changes in the 
3’UTR) were not investigated further due to time limitations. However, it would be 
interesting to assess the regions containing these polymorphisms in a small selected 
number of subjects from each database.
The results of the investigation described here suggest that the exon 13 polymorphism 
and the exon 20 polymorphism are not associated with extreme diurnal preferences, t  
or with DSPS. These polymorphisms could be investigated in subjects with other 
defined circadian phenotypes such as ASPS or in subjects of different ethnic
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backgrounds to assess their prevalence. The development of a rapid screening tool for 
the exon 20 polymorphism as part of this study enables relatively easy screening of 
subject samples without the need for sequencing.
Due to the fact that different seasonal and daily light-dark schedules exist at different 
latitudes, certain polymorphisms may become more prevalent in individuals in 
particular regions. DNA samples could be collected to create collections of samples 
from different populations that could be rapidly screened. It would be possible to pool 
DNA samples from individuals within the same population and to screen for 
polymorphisms in such a sample- this would rapidly screen large numbers of samples 
at once. Certain polymorphisms could even be advantageous in particular conditions. 
If these polymorphisms were identified in the population, any phenotypic association 
could be investigated and functionality assays could be developed to assess how the 
function of CLOCK is altered by these changes.
Direct sequencing of exons 2, 4, 6, 8-9, 10-11, 13, 17, 18, 19 and 20 of Clock in the 
four t-  characterised subjects showed the gene to be highly conserved in these regions 
with only one silent mutation observed in exon 18. Due to time limitations, the 
remaining exons were not investigated. However, these should be investigated to 
assess whether sequence variation in this gene could be responsible for the variation 
in t  observed in these subjects. In addition, other genes that could be responsible for 
circadian variation could be investigated in these subjects to extend the data available 
concerning clock gene polymorphisms and variations in t. Indeed, it would be 
interesting to assess the Per2 and Per3 polymorphisms in these individuals and 
investigate the resulting impact of different combinations of genotypes.
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The fact that no novel polymorphisms were identified in the subjects studied during 
this investigation does not rule out the possibility that polymorphisms in Clock could 
be responsible for variation in circadian phenotype in humans. As observed in the 
Clock mouse, a single nucleotide polymorphism in Clock was responsible for a longer 
circadian period. Since the other components of the circadian system exhibit circadian 
variation in mRNA and proteins levels, a alteration in these genes that alters the 
oscillating rhythm of the mRNA or protein will ultimately have an effect on circadian 
output. Clock mRNA levels do not show circadian variation and indeed, it appears 
that CLOCK protein remains bound to the DNA through out the circadian cycle. 
Hence, it is more difficult to envisage a mechanism through which variation in 
circadian output could occur due to mutations in Clock. However, changes which alter 
the sequence of CLOCK (as in the Clock mouse) could alter the way in which 
CLOCK is processed or its ability to bind to the other core components which appear 
to associate with CLOCK. Alternatively, changes that alter the amount of Clock 
mRNA or protein levels could have an impact on the output generated.
The work conducted on the 3111 locus showed that this site was in fact not linked to 
diurnal preference as previously suggested (Katzenberg et al., 1998). In addition, it 
was not found to be associated with variation in t or with DSPS. The functionality 
assay provided further evidence to support this finding. During analysis of the 3111 
Clock locus, a rapid screening technique was developed to investigate this site in large 
numbers of subject’s samples- this could be adapted by designing suitable primers to 
assess other single nucleotide polymorphisms in the subject databases described in 
future studies.
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The work presented here focussed on identifying novel polymorphisms using 2 
techniques- direct sequencing of subject DNA in characterised individuals and the 
screening of genetic databases Indeed now that these subjects have been 
characterised, they provide an excellent resource for screening for polymorphisms in 
other circadian genes and assessing whether there is any link between these and 
phenotype. Of course, there are other techniques that could have been implemented to 
enhance the search for polymorphisms in the core circadian genes in the subjects 
recruited such as restriction fragment length polymorphism analysis of single genes. 
However, the results of this would depend upon the presence of suitable restriction 
sites or the presence of a length polymorphism that could be detected using such a 
techniques. Another approach that could be used to identify potential polymorphisms 
associated with circadian phenotype would be to recruit family members of 
individuals who also exhibit an extreme circadian phenotype such as DSPS and non­
suffering family members as controls. Markers such as microsatellites could be used 
to positionally clone the genes responsible (Chakravarti, 1998). However, sequencing 
can only truly confirm the presence or absence of polymorphisms.
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Appendix 1: Horne Ostberg Questionnaire (scoring shown for each 
question- omitted during study)
Instructions:
1) Please read each question very carefully before answering.
2) Answer all questions.
3) Answer questions in numerical order.
4) Each question should be answered independently of others. Do not go 
back and check your answers.
5) All questions have a selection of answers. For each question place a 
cross alongside ONE answer only.
6) Please answer each question as honestly as possible. Both your 
answers and the results will be kept in strict confidence.
7) Please feel free to make any comments in the section provided below 
each question.
Question 1) Considering only your own ‘feeling best’ rhythm, at what 
time would you get up if you were entirely free to plan your day?
AM 5 0
X X
1
X
12
Question 2) Considering only your own ‘feeling best’, at what time would 
you go to bed if you were entirely free to plan your day?
1 | | I | | | | | | | | | ,
8 < 10 ]11 12AJV 2 3PM 
x x X X
Question 3) If there is a specific time you have to get up in the 
morning, to what extent are you dependent on being woken up by an 
alarm clock?
a) Not at all dependent [ ]
b) Slightly dependent [ ]
c) Fairly dependent [ ]
d) Very dependent [ ]
Question 4) Assuming adequate environmental conditions, how easy 
do you find getting up in the mornings?
a) Not at all easy [ ]
b) Not very easy [ ]
c) Fairly easy [ ]
d) Very easy [ ]
1
2
3
4
Question 5) How alert do you feel during the first half hour after having 
woken in the mornings?
a) Not at all alert [ ]
b) Slightly alert [ ]
c) Fairly alert [ ]
d) Very alert [ ]
1
2
3
4
Question 6) How is your appetite during the first half hour after having 
woken in the morning?
a) Very poor [ ] 1
b) Fairly poor [ ] 2
c) Fairly good [ ] 3
d) Very good [ ] 4
Question 7) During the first half hour after having woken in the 
morning, how tired do you feel?
a) Very tired [ ] 1
b) Fairly tired [ ] 2
c) Fairly refreshed [ ] 3
d) Very refreshed [ ] 4
Question 8) When you have no commitments the next day, at what time 
do you go to bed compared to your usual bedtime?
a) Seldom or never later [ ] 4
b) Less than one hour later [ ] 3
c) 1-2 hours later [ ] 2
d) More than 2 hours later [ ] 1
Question 9) You have decided to engage in some physical exercise. A 
friend suggests that you do this one hour twice a week and the best time 
for him is between 0700 and 0800h. Bearing in mind nothing else but 
your own ‘feeling best’ rhythm, how do you think you would perform?
a) Would be on good form [ ] 4
b) Would be on reasonable form [ ] 3
c) Would find it difficult [ ] 2
d) Would find it very difficult [ ] 1
Question 10) At what time in the evening do you feel tired and as a result 
in need of sleep?
PM
Question 11) You wish to be at your peak for a test which you know is 
going to be mentally exhausting and lasting for 2 hours. You are entirely 
free to plan your day and considering only your own ‘feeling best’ 
rhythm which ONE of the four testing times would you chose?
a) 0800-1000 [ ] 6
b) 1100-1300 [ ] 4
c) 1500-1700 [ ] 2
d) 1900-2100 [ ] 0
Question 12) If you went to bed at 2300, at what level of tiredness 
would you be?
a) Not at all tired [ ] 0
b) A little tired [ ] 2
c) Fairly tired [ ] 3
d) Very tired [ ] 5
Question 13) For some reason you have gone to bed several hours later 
than usual, but there in no need to get up at any particular time the next 
morning. Which ONE of the following events are you most likely to 
experience?
a) Wake up at the usual time and not go back to sleep [ ] 4
b) Wake up at the usual time and doze [ ] 3
c) Wake up at the usual time and go back to bed [ ] 2
d) Wake up later than usual [ ] 1
IQuestion 14) One night you have to remain awake between 0400 and 
0600h in order to carry out a night watch. You have no commitments the 
next day. Which ONE of the following alternatives will suit you best?
a) Not to go to bed until 0600h [ ] 1
b) Nap between 0400h and sleep after 0600h [ ] 2
c) Sleep before 0400b and nap after 0600h [ ] 3
d) Sleep before 0400h and remain awake after 0600h [ ] 4
Question 15) You have to do two hours of hard physical work. You are 
entirely free to plan your day and considering your own ‘feeling best’ 
rhythm which one of the following times would you chose?
a) 0800-1000 [ ] 4
b) 1100-1300 [ ] 3
c) 1500-1700 [ ] 2
d) 1900-2100 [ ] 1
Question 16) You have decided to engage in hard physical exercise. A 
friend suggests that you do this for one hour twice a week and the best 
time for him is between 2200 and 2300 hrs twice each week. Bearing in 
mind nothing else but your own ‘feeling best’ rhythm how well do you 
think you would perform?
a) Would be on good form [ ] 1
b) Would be on reasonable form [ ] 2
c) Would find it difficult [ ] 3
d) Would find it very difficult [ ] 4
Question 17) Suppose that you can choose your own work hours, but had 
to work five hours in the day (including breaks) and that your job was 
interesting and paid by results. Which FIVE consecutive hours would you 
choose?
12 1 2 3 4 5 6 7 8 9 10 11 12 1 2 3 4 5 6 7 8 9  10 11 12
Midnight Midnigh4oon
4
Question 18) At what time of day do you think that you reach your 
‘feeling best’ peak?
12 1 2 3 4
Midnight
X
10 11 12 1 
Noon
X X - X
10 11 12
Midnight
1
Question 19) One hears of "morning" and "evening" types of people. 
Which ONE of these do you consider yourself to be?
a) Morning type [ ] 6
b) More morning than evening [ ] 4
c) More evening than morning [ ] 2
d) Evening [ ] 0
Appendix 2: One-night sleep diary
SLEEP DIARY
CUihiont nnidiRV .......................  Daté! ....................... ...........
What time do you usually go to bed?
What time do you usually try starting to sleep 
at? !
How long does it take you to fall asleep? (mins)
How many times do you usually wake up?
What time do you usually wake up?
1
What time do you usually get up?
How would you rate your usual quality of sleep (please circle one number)?
1 2 3 4 5 6 7 8 9  
B e st s le e p  ever  W orst s le e p  ever
Is the time you typically wake up/ sleep  determ ined by any com m itm ents you may have, 
for exam ple the time you start w ork/college (please give details)?
Subjects were asked to complete the sleep diary for a typical nights sleep. They were asked to complete the 
questionnaire for the night before the study if that was deemed to be the usual routine.
Appendix 3: Alignment of intronic clones with exon 13 and introns 12 and 13
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I5338-SEQ(;>441) - »
I9452-SEQ(1>451)
>1447-SEQ ( 1> 453) —> 
?3466-SEQ(1> 465) —> 
19176-SEQ(1>342) —>
agacottataggtatat1 taggtttgtg 
agacattataggtatattttaggtttgtg 
agacattataggtatat1taggtttgtg 
agacattataggtatattttaggtttgtg 
agacattataggtatat tttaggtttgtg 
agacattataggtatat1 taggtttgtg
tagcacatagcaaatagtctac 
tagcacatagcaaatagtctac 
tagcacatagcaaatagtctac 
tagcacatagcaaatagtctac 
tagcacatagcaaatagtctac 
t age ac a t age o a a t a qtctac
900 910 920L.1.1 l.i-l.t.li I I 1 I 1 I I I I I I I l t 1 t i ; , 940I I I I I t . I 1 1 l-t-L-L -l 1
CAG ATG AGACACGTAACAACACTGAATA GTTACAGGTGTGCACTATTTTA;
i 12 and 13d>977)  
I5338-SE0(1>441)  
l9452-SEQd>451  
)1447-SEQ(1>453) - »
:3466-SEQ(1> 465) — >
9176-SEQ =42)
cagatgagacacgtaacaacactgaatagttacagc 
cagatgagacacgtaacaacactgaatagtacagc 
c aga t gagacacgtac aacact gaatagttac age 
c aga tgagacac gt ac ac ac t ga tagttac age 
c agatgagacaca t ac acac t ga tagttacage 
c aga t gaacac a t ac ac ac taa t a a t tac a a c
tgtgcactattttac 
tgtgcactattttac 
tgtgcactattttac 
tgtgcactattttac 
t g t g c a c t a t t t t a c  
tatacactattttac
960 970 960 990 1000
I i I I > i 1 1 1 I I t 1 I t » I 1 I ■ I I L -l.I-l.-L-i 1 1 I t i l l  I 1 ...i .—l—J—.1.1 ..i > 1 1
T G A C C A G A C A C T A A A A T T T G A T T A T T T T T T C - C A - T - T T G T A - G T i A i G C A
; 12 a n d  1 3 ( 1  > 9 7 7 ) —> 
53 3 8 - SE 0 (1>441) 
i9452-SE0(1>451)  
)1447-SEQ(i>453)  
>3466-SEQ(1>465) 
I9176-SE0(1>342) 
I6674-SEQ(1>303)  
iD13d>76)
t g a c c a g a c o c t a a a a t t t g a t t a t t  t t t t c - c a - 1 - 1 t g t a - g t t a t g c a
t qacaqacact aa 1 1 1 ga  11  a 11 1 1 1 1 c- c  a  * t - 1 g  t  a - g  1 a  t  gc  a  
tgaccagocactaaaatttgattattttttc-ca-t-ttgta-gttatgca 
tgaccaqacactaaaatttgattattttttc-ca-t-ttgta-gt tatgca 
tgaccagacoctaaaatttgattattttttc-ca-t-ttgta-gttatgca 
taaccagacactaaaat t tgat tat ttt ttc - - a-t-t-.gta-gt tatgca
111111111 g t ac t c ac a 1 g t ag t aag 11 o t gc a
t t a t a c c
1010 1020 1030 1040 1050 1C
i 1 i i i i i < t I I i I 1 1 l i I l i » I t » I I 1 I t l. l I > I i i I t I « I 1 l -I—I 1 1 I—1—1—L.
Tagggctgaaagacgacgagaacttggcattgaa- gagtctcttcctgaga
1 12 and 13 { 1 ’ 97 / ) 
15338-SEOi1>441! 
19452-SEQ 0  >451}
51447-SEQ i 1>453! 
53466-SEC(1>4655 
19176-SEQ(1>342)  
16674-SEC(1>303)  
0)13(1 >76!
t a g g g c t g a a o g a c g a c g a g a a c t t g g c a t t g a a - g a g t c t c t t c c t g a g c  
t agg gc tgaaagacgacgagaac t  t ggcat  t gaa-gag t c ‘".c t t c c t  gage  
t agg gc t gaaagac gacgagaac  11g g c a t t g a a - g a g t c t c t t c c t g a g c  
t agggc tgaaaga cg acg ag aac 11 g g c a t t g a a - g a g t e t c t  t c c tg a g e
t. agggc t gaaagac gacgagaac 11 ggcat  t gaa -gag  t c t c 11 ce  t gage 
t a g g g c t g a a a g a c g a c g a g a a c t t g g c a t t g a a a g a g t c t c t t  c tgagc  
t agggc tgoaagacgacgagaac t  t ggca t  t g a a - g a g t c t e t t c c t ga g c  
t ga aac ta aa q aa cQ ac a aa a ac t t Q a ca t t aa o -Q aa tc t c t t cc t a aq c
1 0 7 0  1 0 8 0  1 0 8 0  1 1 0 0  1 1 1 0I > i < t ! i i i i I i i i i 1 i i t i L t i i i i i i i i 1 t i t i I i » < » I » i i i 1 j-i—i—t—L 
G C T G A C A A A -G T - A T G T T T C T T A T A A T T A A A A A A A A T T A T T T T T A - A T T T C
, 12 and 13(1>977)
5338-SEQ(1>441)
9452-SE0(1>451)
447-S EQ(1>453) — >
23466-SEQ(1>465)  
19176-SEQ(1>342)  
16674-SEQ(1>303)  
nD13(1 >76)
a t g t  t t c t t a t a a t t a a a a a a a a t  t a t  t t t t a - a t t t c  
a t g t t t c t t a t a a t t a a a a a a a a t t a t 1 1 1 t a - a t t t c  
a t g t t  t c t t a t a a t t a a a a a a a a t t a t t t  t t a - a t  t t c  
a t g t  t  t c t  t a t a a t t a a a a a a a a t  t a t  1 1 1  t a - a t  1 1 <: 
a t q t  t  t e t t a t a a t t a a a a a a a a t t a t t 1 1  t a - a t t t c
g c t g a c o a a - g t -
g o  t g a c  a a a - g  t -  
g c t g a c a a a - g t - 
q c t g a c a a a - g t -  
g c t g a c a a a - g t -  
g c t g a c a a - - g
gc t ga ca aaa g : c a a g  ;t  t c t  g a g - - t c a g a t a a t e g t a t a a a c a  : a g t  
g e t  g a c  a a a _____________________________________________________________ __
1130 1140 1150 1160 11/
, 1 I 1 I I : I I I ' ' ' ' I I t ' I 1 I I I ' I I ' I I I I ] ! I I 1 I 1. I I 1 1 1 1  ^ j
AATAAA-AGAT-GAAACTCAÀTAATTAATAGGAAAACTAII i i iCAAAAA
n 12 and 13 (1 >9/  /) —> 
15338-SEQ(1>441) - »
19452-SEQ(1>451) - »
61447-SEQ(1>453)  
23466-SEQ(1>465)  
16674-SEQ(1>303)
aat a a a - a g a t - g a a a c t c a a t a a t t a a t a g g a a a a c t a t t t t t c a a a a a
aa t aaa - a g a t - g a a a c t c a a t a a t t a a t a g g a a a a c t  a
aa t a a a - a g a t - g a a a c t c a a t a a t  t aa taggaaaac  t a t t  111caaaaa
a a t a a a - a g a t - g a a a c t c a a t a a t t a a t a g g a a a a c t a t t  t t t c a a a a a  
a a t a a a - a g a t - g a a a c t c a a t a a t t a a t a g g a a a a c t a t t  t t t c a a a a a
aa aaaa -  a c  at t aaaaaaat  t  t aa t  c. ac - age c c aac c  c c 11 c tacr. tc -
1180 1190 1200 1210 1220
t i i t i » i i i » i i i i i i i » i » i » i i i i i » i i i » » i » i i i i » i i i i i t
- A T T T C C T C A - - - - C T T A T A A C A G G G A T G T 6 T C A G A C C C T T C C i C A A C A C
n 12 and 13(1>977)  
19452-SEQ(1>451)  
61447-SEQ(1>453)  
23466-SEQ(1>465) 
16674-SEO(1>303)
- a t t  t e e t e a ------c t t a t a a c a g g g a t g t g
-at
- a t  t tee  t e e ------e t  t
-at11" c t c o ------ct t a t a a c  agggat g
■:;aot t e a  cicqqacitcatc  t c a c a c q q c c a t c  t c a a a c c c t  t e e  t c a a c a c
i)n 12 and 13; sequence adapted from AC069200 for nitron 12.exon 13 and intron 13. 
cm 1)13: exon 13 sequence adapted from AFO 11568
Appendix 4: Alignment of sequence data for sense and antisense 3'UTR vector 
constructs
■I191v;l . s c f  {1 > 3 5 6 )
)4 w l. s c f  ( i> 5 8 0 )
1 1 9 1 A 2 r. s c f  {1 > 5 4 0 )  <—
> 1 3 ~ Jr . s c f  (1 > 6 5 0 )
[5 A 2 r. s c f  (1 > 6 0 0 )
: io c k  3 '  UTR c o n s t r u c t  i n s e r t ( i > 5 8 6 ) 
,13w i . s c f  ( 1 > 6 5 0 )  <—
s c f (1>5C0) v~
100a > » » - I t
gCCGt-crtA-'It:
110 120 130
- C C G  AC
-COG AC
FCTAGAGCGTTCAACCACAGTAGCACACGiGCTT
GCCGi GTAAT TCTAGs 3CGTTCAACCACAGTÀGCACACGTGCTT 
GCCGTGTA.A1 CCTAGA GCGTTCAACCACAGTAGCACACGTGCTT:
FCTAGA 3CG7TC.AACCACAGTAGCACA.CGTGCTTi 
î  3CGTTCAACCACAGTAGCACACG rGCTT; 
3CGTTCAACCACAGTAGCACACGTGCTT<
t t c a a c c a c a g t a g c a c a c g t g c t b
iCTTGaCATCAAGGGAGGAAGGGGATGGrrr AT'Ta r c ri y iw i . s e t (1>356)
4 w l . s c f ( 1 > 5 8 0 )  
1 5 1 A 2 r . s c f ( 1 > 5 4 G }  
1 3 A 2 r . s c f ( l > 6 5 0 )  
S A 2 r . s c f ( l > 5 0 0 )
lo c k  3 s UTR c o n s t r u c t  
L 3v :l. s c f  ( I > 6 5 0 )  
: A 2 r . s c f ( l > 6 0 0 )
^—
_>58'
C i CTTG^CATCAAGGGAGGAAGGGGATGGCCCATTAAGAGTTAC] 
CTC a a <3aCATCaAGGGA.GGAAGGGGATGGCCCATTAAGAGTTAC3 
^ 0 k 5 v ^ V TC‘aAC^ 3AGG-LAC^ ' GATGGCCC3-TTAA.GAGTTAC'] 
^j^^^^^GGAGGAAGGGGATGGCCCATTAAGAGTTACl
u T g  1 AG.HCrt a u.^.GGGaGG.haGGGGATOGCCCATTAAGAGTTAC'I 
Sir  ^ 1 -iQ-~.~nTCAAGGGkGGAAGGG3ATGGCCCATTAkGRGTTR.Cr
GATGACCTGAGGAAA zÇAAAGTTCCAGCAG'TTTCATGAGATi v . - l . s c : ( l > 3 5 6 )
:w i .s c f ( l> 5 8 0 )
. 9 l A 2 r . s c f ( 1 > 6 4 0 )
.3A 2r . s c f  {1 > 6 5 0 )
A 2 r . s c f ( 1 > 5 0 0 )
o c k  3 '  UTR c o n s t r u c t
3 v ; l . s c f  ( 1 > 6 5 0 )
A 2 r . s c f ( 1 > 6 0 0 )  
v ; l , s c f  ( 1 > 6 0 0 )
i n s e r t ( 1 > 5 8 6
f—
< - 
“ç —
4—
5v^5ACr l3AQ3AAJ^ 3GAGG3A“AG,I^ CAGCAGTTTCATG.AGAT 
u  a  x v7ACGTGAGGA.AAGG/iGGGA.AAGTTCCAGCAGTTTCATGAGAT 
3 ; ' ^ a c c gg a g g -"-Zl“-g g a g g -g a - A a g t t c c a g c a g t t t c a t g a g a t  
G.nioüCu'j.GAGGAAAGG.AGGGAAAGTTCCA.GCAGTTTCATGAGA.T 
-.hTGAvCTGAGGAAAGGAGQGAAAGTTCCAGCAGTTTCATG.AGAT 
3^T3A3G3GAGGAAAGGAGGGAA^G7TCCAGCAGTTTCATGAGATG^-L 1 GAOO'UO 5 CCü rit'l A ■*. _________ __
-■.■ATGA^C<fGAUrGAAAGGAGGAAAAGiTCCA.GCAGTTTCATGj S.GAT
3 1 A 2 r . s c f ( 1 > 6 4 0 )
^ A 2 r . s c f ( l > 6 5 0 )
X 2 r . s c f ( 1 > 6 0 0 }
>ck 3 '  UTR c o n s t r u c t  i n s e r t ( 1 > 5 8 6 )  : 
>wl . s c f {1 > 6 5 0 )  <—
i l r . s c f  ( 1> 6 0 0 ) <—
s c f  ( 1 ^ 0 0 )  """ e -
r ^ ? 33G; GTGTTCTAGT’iCCTC^ ^ATTAG7TX3GCAGAG.AAAATG( 
iUxGiWi'ie'iAGTlUCTGGAAffÂ6TTCÙCÀüAGAAAAT(X
jUÜ,.i i .1 .1. i ; i -i .i i t i i ! i
ACAGATGTACATTAAATAC
s c f
I 9 Y"
156
?A2r
.ock
.3wl
;  ^O >'
>WI.!
(1>580) 
s c f {i > 6 4 0 )
;cf(1>65G)
:f (1>600)
UTR c o n s t r u e  
: f(1>650) 
rf(1>600) 
:(1>600)
4 -
t  i n s e r t (1>586)
<—
<—
<—
1 i 1 1 ' I i 1 J J 1 1—1 1—
XCAGCAGGAGGTG. 
GCCTAGTGCTACAGATGTACATTAAATACCAGCCAGCAGGAGGTG. 
GCCTAGTGCTACAGATGTACATTAAATACCAGCCAGCAGGAGGTG 
GCCTAGTGCTACAGATGTG.CATTAAATAGCAGCCAGCAGGAGGTG 
GCCTAGTGCTACAGATGTACATTGAATACCAGGCAGCAGGAGGTG 
GCCTAGTGCTACAGATGTACATTAAATACCAGCCAGCAGGAGGTG 
GCCTAGTGCTACAGATGTACATTAAATACCAGCCAGCAGGAGGTG 
GCCTAGTGCTACAGATGTACATTAAATACCAGCCAGCAGGAGGTG
GCCTAG'TGCTACAGATGTACATTAAATACCAGGCAGCAGGAGGTG
i l ,
i .
t/T ^ou j /ü
. I. ,1.„ l—l—L..
CATAGGGGCAYAGCCAGTTCTGACAGTGTTTTAGGTGC .A
I S l w l . s c f ( 1 > 3 5 6 )  
i ^ l . s c i ( l > 5 S 0 )
1 9 1 A 2 r . s c f ( 1 > 6 4 0 )
1 3 A 3 r . s c f ( I > 6 5 0 )
5 A 2 r . s c f ( l > 6 0 0 )
l o c k  3 1 UT'ri. c o n s t r u c t ,  i n s e r t  ( 1 > 5 8 6 )  
13.vl.scf (1>65G)
4 A 2 r . s c f ( 1 > 6 0 0 )
5 v : l . s c f  ( 1 >6 0 0 )
e -
<—
<—
CATAGGGGCATAGCCAGTTCTGA-CAGTGTTTï’
CATAGGGGCACAGCCAGTTCTGACAGTGTTTTA
CATAGGGGCATAGCCAGTTCTGACAGTGTTTTA
CATAGGGGCACAGCCAGTTCTGACAGTGTTTTA
CATAGGGGCATAGCCAGTTCTGACAGTGTTTTA
CATAGOGGCACAGCCAGTTCTGACAGTGTTTTA
CATAGGGGCACAGCCAGTTCTGACAGTGTTTTA
CATAG=GGGCACAGCCAGTTCTGACAGTGTTTTA
CATAGGGGCATAGCCAGTTCTGACAGTGTTTTA
i GGa TA
G C'A! A
—v'iG'.
- iü “Ci.;
TTITGATGGAAAAAGAATATATTGCCAAATATTAAGAAGCTCAGC
4 v :l . s c f  ( 1 >5 S 0 )
151A 2r .sc f (1>640)
13ÀT2i'.scf (1>650)
£ A 2 r . s c f ( 1 > 5 0 0 )
l o c k  3 * UTR c o n s t r u c t  i n s e r t ( 1 > 5 8 6  
1 3 v ; l . s c f  {i > 6 5 0  )
4 A 2 r . s c f {1 > 6 0 G )
5 v : l . s c f  ( 1>6Û0}
<—
Ç— 
■C— 
•(—
TTTTGATGGAAAAAGAATATATTGCCAAATATTAAGAAGCTCAGC
TTITGATGGAAAAAGAATATATTGCCAAATATTAAGAAGCTCAGC
7TTTGATGGAAAAAGAATATATTGCCAAATA7TAAGAAGCTCAGC
TTTTGATGGAAAAAGAATATATTGCCAAATATTAAGAAGCTCAGG
JITTIX3ATGGAAAAAGAATAmTTGCCAAATATTAAGAAGCTCAGC
TTTTGATGGAAAAAGAATATATTGCCAAATATTAAGAAGCTCAGC
TTTTGATGGAAAAAGAATATATTGCCAAATATTAAGAAGCTCAGC
TTTTGATGGAAAAAGAATATATTGCCAAATATTAAGAAGCTCAGC
430 440 450 460
i 1 ' -1 l 1 I I _1. I 1 I I I ! i i i i } i i i i t i i i > I ; l 1 t I l l ! l ! L.J—L
TGAAATGACCTCCAGGGAATCAGAAAGGCACTAATGA.TGTTAGTG
4 w l . s c f ( 1 >5S0) TGAAATGACCTCCAGGGAATCAGAAAGGCACTAATGA.TGTTAGT^
1 9 1 A 2 r . s c f ( l > 6 4 0 ) —^ TGAAATGACCTCCAGGGAATCAGAAAGGCACTAATGATGTTAGT^
1 3 A 2 r . s c f ( l > 6 5 0 ) TGAAATGACCTCCAGGGAATGAGAAAGGCACTAATGATGTTAGT2
5 A 2 r . s c f ( 1 > 6 0 0 ) TGAAATGACCTCCAGGGAATCAGAAAGGCACTAATGATGTTAGT^
l o c k  3 ' UTR c o n s t r u c t i n s e r t ( 1 > 5 8 6) TGAAATGACCTCCAGGGAATCAGAAAGGCACTAATGATGTTAGTP
13v.-l. s c f ( 1 > 6 5 0 ) 4— TGAAATGACCTCCAGGGAATCAGAAAGGCACTAATGATGTTAGT?
4 A 2 r . s c f ( 1 > 6 0 0 ) (— TGAAATGACCTCCAGGGAATCAGAAAGGCACTAATGATGTTAGT^
S w l . s c f f 1 > 6 0 0 ) 4— TGAAA.TGACCTCCAGGGAATCAGAAAGGCA.CTAATGATGTTAGTr
480 490 500 510
' '  I - 1..1 1 I i t t l J...1 t  i .  l_ » l t ; i i l 1 i .1 i l 1 .» l t l 1 l l l l L.l .1 l—1—1
TTTTAGTGGTTCTGTGCCTCTTATCAAGTGTTACAGAGGACATAC
4vvT. s c f  ( 1 > 5 8 0  ) TTTTAGTGGTTCTGTGCCTCTTATCAAGTGTTACAGAGGACATAC
1 9 1 A 2 r . s c f ( 1 > 6 4 0 ) (--- TTTTAGTGGTTCTGTGCCTCTTATCAAGTGTTACAGAGGACATAC
1 3 . ^ r . s c f  ( 1 > 6 5 0 ) TTTTAGTGGTTCTGTGCCTCTTATCAAGTGTTACAGAGGACATAC
5 A 2 r . s c f ( 1 > 6 0 0 ) TTTTAGTGGTTCTGTGCCTCTTATCAAGTGTTACAGAGGACATAC
Lock 3 ’ UTR c o n s t r u c t  i n s e r t {1 > 5 8 6 ) TTrTAGTGGTTCTGTGCCTCTTATCAAGTGTTACAGAGGACATAC
L S v . T . s c f  ( 1 > 6 5 0 ) <— TTITAGTGGTTCTGTGCCTCTTATCAAGTGTTACAGAGGACATAC
4 A 2 r . s c f ( 1 > 6 0 0 ) (— TTTTAGTGGTTCTGTGCCTCTTATCAAGTGTTACAGAGGACATAC
5 ' , \ T . s c f ( l > 6 0 0 ) <— TTÎTAGTGGTIGTGTGCCTCTTATCAAGTGTTACAGAGGACATAC
520 530 540 550 560
.2 I i I J, I ■ I ■ 1—i—* ' 2 I I I , . ! , , , Ï ! ; » : , | * Ï , , 1 i | I j C 1 I ,
CTGCCATGTCAGGGGTTTGCTTACAGTGATGCCATGAAGACAGT'
j 4 w l . scf{1>5S0)
•!19IA2r. scf (I>640) 
j!3A2r.scf(1>650) 
"l6A2r. scf (1>600) 
flock 3 ‘ UTR construct 
D13wl.scf(1>650;
34A2r.scf(1>60Q5 
■'iSv/l. scf (1>600)
insert(1>586) " 
<—  
v— 
<—
CTGCCATC-TCAGGGGTTTGC'TTACAGTGATGCCATGAAGACAGT’
CTGCCATGTCAGGGGTT'TGCTTACAGTGATGCCATGAJ-.GACAGG
CTGCCATGTCAGGGGTTTGCTTACAGTGATGCCATG^AGAGAG?
CTGCCATGTCAGGGGTTTGCTTACAGTGATGCCATGAAGACAGT*
CTGCCATGTCAGGGGTTTGCTTACAGTGATGCCATGAAGACAGTi
CTGCCATGTCAGGGGTTTGCTTACA.GTGATGCCATGAAGACAGTi
CTGCCATGTCAGGGGTT'IGCTTACAGTGATGCCATGGA.GACAGTî
CTGCCATGïCÀGGGGTTTGCTTACAGTGAÏGCCATGAAGACAGTi
J—L.
570 1 580 590 60Ci , . . , i .
GTAGACTIGG-TAGCGACCCCCTCCCCCAAGCCCTCTGCCTGTI'
D4wl.scf(1>5S0)
1191A2r.scf(1>640)
D13A2r.scf(1>65Q)
-l6A2r. scf (1>600)
flock 3; UTR construct insert(1>586)
fl3v;l. scf (1>650) <—
14A2r.scf(1>600)
-iSu-l.scf (1>600J <— GTAGACTTGG
GTAGACTTGGGTAGCGACCCCCTCCCC
GTAGACTTGG-TAGCGACCCCCTCCCCCAACCCCTCTCCCTTTTi 
GTAGACTTGG-TAGCGACCCCCTCCCCCAACCCCTCTGCCTTTT' 
GTAGACTTGG - TAGCGACCCCCTCCCCCAACCCCTCTCCCTTTT
l-TAGCGACCCCCTCCCCCAACCCCTCTCCCTTTTi 
GCGACCCCCTCCCCCAACCCCTCTCCGTTTT
X c30 ILjg; i ! ! » i t
ATAATGATGGAACA-GTAATTAC - TTTCAGAATGT
)13A2r.scf(1>650)
16A2r.scf(l>600)
"lock 3 1 UTR construct i n s e r t  ( 1>586 ) - 
313a1.scf(1>650) <—
D4A2r,scf(1>600) <—
•I6a1 . scf {1>500) <—
ATAATGATGGAACA-GTAA'TTAC-
ATAATGATGGAACA-GTAATTAC-
ATAATGATGGAACAAGTA^.TTACT
ATAATGATGGAACA-GTAATTAC- 
ATAATGATGGAACA-GTAATTAC- 
ATAATGATGGAACA-GTAATTAC - 
ATAATGATGGAACA-GTAATTAC-
TTTCAGAATGTTGTGTGGGT
TTTCAGAATGTTGTGTGC-GT
TTTCAGAATGTTGTGTGGGT
TTTCAGAATGTTGTGTGGGT
TTTCAGAATGTTGTGTGGGT
TTTCAGAATGTTGTGTGGGT
L3A2r.scz(1>650)
>A2r.scf{1>600)
Lock 3 1 UTR constru 
.3wl.scf(I>650) 
IA2r.scf(1>600)
A T .scf(I>600)
AAAa ATATGTATATC iCTAG
■ t insert(1>585)
i— 
<—
AATTTCtCTATGTACAGATGAIGT 
AATT-CTCTATGTACAGATGATGT
aatt-ctctatgtacagatgatgt.
AATT - CTCTATGTACAGATGATGT. 
AATT-CTCTATGTACAGATGATGT 
AATT-CTCTATGTACAGATGATGT
AAAAATATGTATATC
'AAAAATATGTATATC
AAAATATGTATAT
AAA_eT“.TGTATA.T
AAAAATATGTATATC
AAAATATGTATAT^
CTAG
M6: 3111 T antisense construct 
M l91: 3111 T sense construct 
D4. 3111 C sense construct 
D13: 3111 (: antisense construct
w l: sequencing in fonvartl direction 
A2r: sequencing in reverse direction 
XI)a I sites are shown in boxes.
Position 340 shows polymorphism (3111).
Other sites shown with arrows represent sites of poor sequencing w hich are not 
supported by sequencing in the opposite direction- these are not real differences.
Appendix 6
linear regression age vs tau
R 0.005722 
R squared 3.27e-5 
F 0.000622 
P 0.980362
Mann Whitney U test gender vs tau 
U 87
Z 2.24457 
P 0.0247958
Multiple regression age, gender vs HO score
Multiple R squared 0.1245 
F 34.19
X1 (gender) P 0.13 
X2 (age) P < 0.001
Hardy-Weinberg equilibrium chi squared test
Chi squared 0.35270092226614
Multiple regression analysis
Bedtime, sleep time, wake time rise time vs HO score
Multiple R squared 0.6517 
F 39.36 
X1 bedtime 
X2 sleep time 
X3 wake time 
X4 rise time
P0.0001
One-way Analysis o f Variance (ANOVA) HO score
The P value is < 0.0001, considered extremely significant.
Variation among column means is significantly greater than expected 
by chance.
Student-Newman-Keuls Multiple Comparisons Test 
Mean
Comparison Difference q P value
evening HO vs morning -36.786 44.966 *** P<0.001
evening HO vs intermed -19.714 24.098 *** P<0.001
intermed vs morning -17.071 20.868 *** P<0.001
With Student-Newman-Keuls test, it is impossible to calculate confidence 
intervals.
Assumption test: Are the standard deviations of the groups equal?
ANOVA assumes that the data are sampled from populations with identical 
SDs. This assumption is tested using the method of Bartlett.
Bartlett statistic (corrected) = 4.063 
The P value is 0.1312.
Bartlett's test suggests that the differences among the SDs is 
not significant.
Assumption test: Are the data sampled from G rian distributions?
ANOVA assumes that the data are sampled from populations that follow 
Gaussian distributions. This assumption is tested using the method 
Kolmogorov and Smirnov:
Group KS P Value Passed normality test?
evening HO 0.1940 >0.10 Yes 
intermed 0.1270 >0.10 Yes
morning 0.1205 >0.10 Yes
Intermediate calculations. ANOVA table
Source of Degrees of Sum of Mean
variation freedom squares square
Treatments (between columns) 2 23722 11861
Residuals (within columns) 102 2389.2 23.424
Total 104 26111
F = 506.36 =(MStreatment/MSresidual)
Summary of Data
Number
of
Standard 
Standard Error of
Group Points Mean Deviation Mean Median
evening HO 35 32.329 5.585 0.9440 31.000
intermed 35 52.043 3.930 0.6643 52.000
morning 35 69.114 4.861 0.8217 69.500
95% Confidence Interval
Group Minimum Maximum From To
evening HO 25.000 44.000 30.409 34.248
intermed 45.000 61.000 50.692 53.394
morning 60.000 80.000 67.443 70.785
*  *  *
One-way Analysis of Variance (ANOVA) -  ql
The P value is < 0.0001, considered extremely significant.
Variation among column means is significantly greater than expected 
by chance.
Student-Newman-Keuls Multiple Comparisons Test
morning vs evening q 1 -2.532 14.619 *** P<0.001
morning vs intermediate -1.242 7.172 *** P<0.001
intermediate vs evening ql -1.290 7.447 *** P<0.001
With Student-Newman-Keuls test, it is impossible to calculate confidence 
intervals.
Assumption test: Are the standard deviations of the groups equal?
ANOVA assumes that the data are sampled from populations with identical 
SDs. This assumption is tested using the method of Bartlett.
Bartlett statistic (corrected) = 2.187 
The P value is 0.3351.
Bartlett's test suggests that the differences among the SDs is 
not significant.
Assumption test: Are the data sampled from Gaussian distributions?
ANOVA assumes that the data are sampled from populations that follow 
Gaussian distributions. This assumption is tested using the method 
Kolmogorov and Smirnov:
Group KS P Value Passed normality test?
Mean
Comparison Difference q P value
evening ql 0.1200 >0.10 Yes 
intermediate 0.1430 >0.10 Yes
morning 0.1459 >0.10 Yes
Intermediate calculations. ANOVA table
Source of Degrees of Sum of Mean
variation freedom squares square
Treatments (between columns) 2 112.18 56.090
Residuals (within columns) 102 107.07 1.050
Total 104 219.25
F = 53.436 =(MStreatment/MSresidual)
Summary of Data
Number Standard
of Standard Error of
Group Points Mean Deviation Mean Median
evening ql 35 10.071 1.153 0.1949 10.000
intermediate 35 8.781 1.011 0.1709 8.750
morning 35 7.539 0.8928 0.1509 7.700
95% Confidence Interval 
Group Minimum Maximum From To
evening ql 7.500 12.000 9.675 10.467
intermediate 6.800 10.500 8.434 9.129
morning 6.000 9.520 7.232 7.846
*  *  *
One-way Analysis of Variance (ANOVA)
The P value is < 0.0001, considered extremely significant.
Variation among column means is significantly greater than expected 
by chance.
Student-Newman-Keuls Multiple Comparisons Test 
Mean
Comparison Difference q P value
mom vs evening q2 -3.109 17.205 *** P<0.001 
mom vs inter -1.287 7.124 *** P<0.001
inter vs evening q2 -1.821 10.081 *** P<0.001
With Student-Newman-Keuls test, it is impossible to calculate confidence 
intervals.
Assum ption test: Are the standard deviations o f  the groups equal?
ANOVA assumes that the data are sampled from populations with identical 
SDs. This assumption is tested using the method of Bartlett.
Bartlett statistic (corrected) = 0.1476 
The P value is 0.9289.
Bartlett's test suggests that the differences among the SDs is 
not significant.
Assumption test: Are the data sampled from Gaussian distributions?
ANOVA assumes that the data are sampled from populations that follow 
Gaussian distributions. This assumption is tested using the method 
Kolmogorov and Smirnov:
Group KS P Value Passed normality test?
evening q2 0.1435 >0.10 Yes 
inter 0.2106 0.0897 Yes 
mom 0.2239 0.0598 Yes
Intermediate calculations. ANOVA table
Source of Degrees of Sum of Mean
variation freedom squares square
Treatments (between columns) 2 170.77 85.386
Residuals (within columns) 102 116.54 1.143
Total 104 287.31
F = 74.733 =(MStreatment/MSresidual)
Summary of Data
Number Standard
of Standard Error of
Group Points Mean Deviation Mean Median
evening q2 35 25.531 1.105 0.1867 25.620
inter 35 23.710 1.034 0.1747 23.500
mom 35 22.423 1.067 0.1804 22.120
95% Confidence Interval 
Group Minimum Maximum From To
evening q2 23.000 27.000 25.151 25.911
inter ,21.500 27.000 23.354 24.065
mom 21.000 25.750 22.056 22.789
*  *  *
One-way Analysis of Variance (ANOVA) — reciprocal qlO
The P value is < 0.0001, considered extremely significant.
Variation among column means is significantly greater than expected 
by chance.
Student-Newman-Keuls Multiple Comparisons Test 
Mean
Comparison Difference q P value
Column A vs Column C -0.005349 13.960 *** PO.OOl
Column A vs Column B -0.003288 8.581 *** PO.OO 1
Column B vs Column C -0.002061 5.378 *** PO.OOl
With Student-Newman-Keuls test, it is impossible to calculate confidence 
intervals.
Assumption test: Are the standard deviations of the groups equal?
ANOVA assumes that the data are sampled from populations with identical 
SDs. This assumption is tested using the method of Bartlett.
Bartlett statistic (corrected) = 3.294 
The P value is 0.1926.
Bartlett's test suggests that the differences among the SDs is 
not significant.
Assumption test: Are the data sampled from Gaussian distributions?
ANOVA assumes that the data are sampled from populations that follow 
Gaussian distributions. This assumption is tested using the method 
Kolmogorov and Smirnov:
Group KS P Value Passed normality test?
Column A 0.08477 >0.10 Yes 
Column B 0.1796 >0.10 Yes 
Column C 0.1337 >0.10 Yes
Intermediate calculations. ANOVA table
Source of Degrees of Sum of Mean
variation freedom squares square
Treatments (between columns) 2 0.0005095 0.0002548 
Residuals (within columns) 102 0.0005242 5 .139E-06
Total 104 0.001034
F = 49.574 =(MStreatment/MSresidual)
Summary of Data
Number Standard
of Standard Error of
Group Points Mean Deviation Mean Median
Column A 35 0.04022 0.002496 0.0004218 0.04000
Column B 35 0.04351 0.002400 0.0004056 0.04348 
Column C 35 0.04557 0.001852 0.0003131 0.04545
95% Confidence Interval 
Group Minimum Maximum From To
Column A 0.03704 0.04968 0.03936 0.04107
Column B 0.03704 0.04968 0.04268 0.04433
Column C 0.04167 0.05000 0.04493 0.04620
Kruskal-Wallis Test (Nonparametric ANOVA) -q l7  non gaussian distribution for intermediate and 
morning groups
The P value is < 0.0001, considered extremely significant.
Variation among column medians is significantly greater than expected 
by chance.
The P value is approximate (from chi-square distribution) because 
at least one column has two or more identical values.
Calculation detail
Number Sum Mean 
of of of
Group Points Ranks Ranks
Column A 35 2976.5 85.043
Column B 35 1812.0 51.771
Column C 35 776.50 22.186
Kruskal-Wallis Statistic KW = 75.537 (corrected for ties)
Dunn's Multiple Comparisons Test
Mean Rank 
Comparison Difference P value
Column A vs. Column B 33.271 *** PO.OOl
Column A vs. Column C 62.857 *** PO.OOl
Column B vs. Column C 29.586 *** PO.OOl
Summary of Data
Number
of
Group Points Median Minimum Maximum
Column A 35 13.000 10.000
Column B 35 9.500 7.500
Column C 35 8.000 6.000
* * *
intermediate group non-gaussian
24.000
21.500
10.000
Kruskal-Wallis Test (Nonparametric ANOVA) -q l8
The P value is < 0.0001, considered extremely significant.
Variation among column medians is significantly greater than expected 
by chance.
The P value is approximate (from chi-square distribution) because 
at least one column has two or more identical values.
Calculation detail
Number Sum Mean 
of of of 
Group Points Ranks Ranks
Column A . 35 2683.0 76.657
Column B 35 1749.5 49.986
Column C 35 1132.5 32.357 .
Kruskal-Wallis Statistic KW = 37.716 (corrected for ties)
Dunn's Multiple Comparisons Test
Mean Rank 
Comparison Difference P value
Column A vs. Column B 26.671 *** PO.OOl
Column A vs. Column C 44.300 *** PO.OOl
Column B vs. Column C 17.629 * PO.05
Summary of Data
Number
of
Group Points Median Minimum Maximum
Column A 35 17.000 1.000 24.000
Column B 35 11.000 7.000 22.000
Column C 35 9.500 7.000 15.500
One-way Analysis of Variance (ANOVA) reciprocal bed time
The P value is < 0.0001, considered extremely significant.
Variation among column means is significantly greater than expected 
by chance.
Student-Newman-Keuls Multiple Comparisons Test 
Mean
Comparison Difference q P value
eve bedtime vs mom -0.003985 13.884 *** P<0.001 
eve bedtime vs inter -0.001853 6.504 *** P<0.001 
inter vs mom -0.002132 7.675 *** P<0.001
With Student-Newman-Keuls test, it is impossible to calculate confidence 
intervals.
Assumption test: Are the standard deviations of the groups equal?
ANOVA assumes that the data are sampled from populations with identical 
SDs. This assumption is tested using the method of Bartlett.
Bartlett statistic (corrected) = 3.657 
The P value is 0.1607.
Bartlett's test suggests that the differences among the SDs is 
not significant.
Assumption test: Are the data sampled from Gaussian distributions?
ANOVA assumes that the data are sampled from populations that follow 
Gaussian distributions. This assumption is tested using the method 
Kolmogorov and Smirnov:
Group KS P Value Passed normality test?
eve bedtime 0.1512 >0.10 Yes 
inter 0.2243 0.0722 Yes 
mom 0.1342 >0.10 Yes
Intermediate calculations. ANOVA table
Source of Degrees of Sum of Mean
variation freedom squares square
Treatments (between columns) 2 0.0002429 0.0001214 
Residuals (within columns) 91 0.0002282 2.507E-06
Total 93 0.0004710
F = 48.432 =(MStreatment/MSresidual)
Summary of Data
Number Standard
of Standard Error of
Group Points Mean Deviation Mean Median
eve bedtime 29 0.04092 0.001851 0.0003438 0.04082
inter 33 0.04277 0.001300 0.0002264 0.04348
mom 32 0.04490 0.001587 0.0002805 0.04444
95% Confidence Interval 
Group Minimum Maximum From To
eve bedtime 0.03704 0.04444 0.04021 0.04162
inter 0.04000 0.04444 0.04231 0.04323
mom 0.04167 0.04762 0.04433 0.04548
*  *  *
One-way Analysis of Variance (ANOVA) -time to fall asleep twice square rooted
The P value is 0.0194, considered significant.
Variation among column means is significantly greater than expected 
by chance.
Student-Newman-Keuls Multiple Comparisons Test 
Mean
Comparison Difference q P value
Column C vs time to fall as -0.4087 3.706 * P<0.05 
Column C vs Column B -0.04054 0.3798 ns P>0.05 
Column B vs time to fall as -0.3682 3.362 * P<0.05
With Student-Newman-Keuls test, it is impossible to calculate confidence 
intervals.
Assumption test: Are the standard deviations of the groups equal?
ANOVA assumes that the data are sampled from populations with identical 
SDs. This assumption is tested using the method of Bartlett.
Bartlett statistic (corrected) = 0.5852 
The P value is 0.7463.
Bartlett's test suggests that the differences among the SDs is 
not significant.
Assumption test: Are the data sampled from Gaussian distributions?
ANOVA assumes that the data are sampled from populations that follow 
Gaussian distributions. This assumption is tested using the method 
Kolmogorov and Smirnov:
Group KS P Value Passed normality test?
time to fall as 0.2206 >0.10 Yes 
Column B 0.2497 0.0326 No 
Column C 0.2046 >0.10 Yes
At least one column failed the normality test with P<0.05. 
Consider using a nonparametric test or transforming the data 
(i.e. converting to logarithms or reciprocals).
Intermediate calculations. ANOVA table
Source of Degrees of Sum of Mean
variation freedom squares square
Treatments (between columns) 2 3.047 1.524
Residuals (within columns) 91 33.678 0.3701
Total 93 36.725
F = 4.117 =(MStreatment/MSresidual)
Summary of Data
Number Standard
of Standard Error of
Group Points Mean Deviation Mean Median
time to fall as 29 2.034 0.6544 0.1215 1.968
Column B 33 1.666 0.6042 0.1052 1.778
Column C 32 1.625 0.5681 0.1004 1.655
95% Confidence Interval 
Group Minimum Maximum From To
time to fall as 0.000 3.080 1.785 2.283
Column B 0.000 2.783 1.452 1.880
Column C 0.000 2.590 1.420 1.830
*  *  *
Kruskal-Wallis Test (Nonparametric ANOVA) -time to fall asleep as above but non-para since 
inter non-gaussian
The P value is 0.0095, considered very significant.
Variation among column medians is significantly greater than expected 
by chance.
The P value is approximate (from chi-square distribution) because 
at least one column has two or more identical values.
Calculation detail
Number Sum Mean 
of of of 
Group Points Ranks Ranks
time to fall as 29 1747.0 60.241 
Column B 33 1409.5 42.712
Column C 32 1308.5 40.891
Kruskal-Wallis Statistic KW -  9.311 (corrected for ties)
Dunn's Multiple Comparisons Test
Mean Rank 
Comparison Difference P value
time to fall as vs. Column B 17.529 * P<0.05
time to fall as vs. Column C 19.351 * P<0.05
Column B vs. Column C 1.821 ns P>0.05
Summary of Data
Number
of
Group Points Median Minimum Maximum
time to fall as 29 1.968 0.000 3.080
Column B 33 1.778 0.000 2.783
Column C 32 1.655 0.000 2.590
One-way Analysis of Variance (ANOVA)
The P value is < 0.0001, considered extremely significant.
Variation among column means is significantly greater than expected 
by chance.
Student-Newman-Keuls Multiple Comparisons Test 
Mean
Comparison Difference q P value
Column C vs eve sleep onset -0.02079 16.751 *** P<0.001 
Column C vs Column B -0.009586 7.981 *** PO.OOl 
Column B vs eve sleep onset -0.01121 9.094 *** PO.OOl
With Student-Newman-Keuls test, it is impossible to calculate confidence 
intervals.
Assumption test: Are the standard deviations of the groups equal?
ANOVA assumes that the data are sampled from populations with identical 
SDs. This assumption is tested using the method of Bartlett.
Bartlett statistic (corrected) = 4.602 
The P value is 0.1002.
Bartlett's test suggests that the differences among the SDs is 
not significant.
Assumption test: Are the data sampled from Gaussian distributions?
ANOVA assumes that the data are sampled from populations that follow 
Gaussian distributions. This assumption is tested using the method 
Kolmogorov and Smirnov:
Group KS P Value Passed normality test?
eve sleep onset 0.09769 >0.10 Yes 
Column B 0.1305 >0.10 Yes 
Column C 0.08591 >0.10 Yes
Intermediate calculations. ANOVA table
Source of Degrees of Sum of Mean
variation freedom squares square
Treatments (between columns) 2 0.006578 0.003289 
Residuals (within columns) 91 0.004265 4.687E-05
Total
F = 70.170 =(M Streatm ent/M Sresidual)
Summary of Data
Number Standard
of Standard Error of
Group Points Mean Deviation Mean Median^
Column C 1.464 1.488 1.474 1.479
Column C 32 1.477 0.006201 0.001096 1.477
95% Confidence Interval 
Group Minimum Maximum From To
One-way Analysis of Variance (ANOVA) 
by chance.
Student-Newman-Keuls Multiple Comparisons Test 
Mean
Comparison Difference q p value
Column C vs no awaken eve -0.1825 1.414 nf j / ^ 0-05
Column C vs Column B -0.08117 — ns •
Column B vs no awaken eve -0.1013 — ns P>0.05
W i t h  S t u d e n t - N e w m a n - K e u l s  t e s t ,  i t  i s  i m p o s s i b l e  t o  c a l c u l a t e  c o n f i d e n c e  
in t e r v a l s .
Assumption test: Are the standard deviations of the groups equal?
ANOVA assumes that the data are sampled from populations with identical 
SDs. This assumption is tested using the method of Bart ett.
Bartlett statistic (corrected) = 1.490
The P value is 0.4747. c n c .
Bartlett's test suggests that the differences among the SDs is
not significant.
Assumption test: Are the data sampled from Gaussian distributions? 
ANOVA assumes that the data are sampled from populations that follow
Gaussian distributions. This assumption is tested using the method 
Kolmogorov and Smirnov:
Group KS P Value Passed normality test?____________
no awaken eve 0.1674 >0.10 Yes 
Column B 0.1696 >0.10 Yes 
Column C 0.1811 >0.10 Yes
Intermediate calculations. ANOVA table
Source of Degrees of Sum of Mean
variation freedom squares square
Treatments (between columns) 2 0.4833 0.2417
Residuals (within columns) 88 42.470 0.4826
Total 90 42.953
F = 0.5007 =(MStreatment/MSresidual)
Summary of Data
Number Standard
of Standard Error of
Group Points Mean Deviation Mean Median
Column C 30 0.7886 0.6254 0.1142 1.000
95% Confidence Interval 
Group Minimum Maximum From To______
no awaken eve 0.000 2.345 0.6671 1.275
Column B 0.000 2.236 0.6307 1.109
Column C 0.000 1.871 0.5551 1.022
Kruskal-Wallis Test (Nonparametric ANOVA) -wake time- SD not equal
The P value is <0.0001, considered extremely significant.
Variation among column medians is significantly greater than expected
by chance.
The P value is approximate (from chi-square distribution) because 
at least one column has two or more identical values.
Calculation detail
Number Sum Mean 
of of of
Group Points Ranks Ranks
Column A 28 843.00 30.107
Column B 29 1164.5 40.155
Column C 27 1562.5 57.870
Kruskal-Wallis Statistic KW = 18.424 (corrected for ties)
Dunn's Multiple Comparisons Test
Mean Rank 
Comparison Difference P value
Column A vs. Column B -10.048 ns P>0.05
Column A vs. Column C -27.763 *** P<0.001
Column B vs. Column C -17.715 * P<0.05
Summary of Data
Number
of
Group Points Median Minimum Maximum
Column A 28 12.162 9.667 19.887
Column B 29 13.420 10.688 17.226
Column C 27 14.316 12.162 36.525
* * *
One-way Analysis o f Variance (ANOVA) for wake time as above but SDs not equal
The P value is 0.0100, considered significant.
Variation among column means is significantly greater than expected 
by chance.
Student-Newman-Keuls Multiple Comparisons Test 
Mean
Comparison Difference q P value
Column A vs Column C -2.448 4.044 * P<0.05
Column A vs Column B -0.2895 0.4867 ns P>0.05
Column B vs Column C -2.159 3.596 * P<0.05
With Student-Newman-Keuls test, it is impossible to calculate confidence 
intervals.
Assumption test: Are the standard deviations of the groups equal?
ANOVA assumes that the data are sampled from populations with identical 
SDs. This assumption is tested using the method of Bartlett.
Bartlett statistic (corrected) = 30.222 
The P value is < 0.0001.
Bartlett's test suggests that the differences among the SDs is 
extremely significant.
Since ANOVA assumes populations with equal SDs, you should consider 
transforming your data (reciprocal or log) or selecting a 
nonparametric test.
Assumption test: Are the data sampled from Gaussian distributions?
ANOVA assumes that the data are sampled from populations that follow 
Gaussian distributions. This assumption is tested using the method 
Kolmogorov and Smirnov:
Group KS P Value Passed normality test?
Column A 0.09595 >0.10 Yes 
Column B 0.2249 >0.10 Yes 
Column C 0.1096 >0.10 Yes
Intermediate calculations. ANOVA table
Source of Degrees of Sum of Mean
variation freedom squares square
Treatments (between columns) 2 98.193 49.096 
Residuals (within columns) 81 816.25 10.077
Total 83 914.44
F = 4.872 =(MStreatment/MSresidual)
Summary of Data
Number Standard
of Standard Error of
Group Points Mean Deviation Mean Median
Column A 28 12.976 2.851 0.5388 12.162
Column B 29 13.265 1.458 0.2707 13.420
Column C 27 15.424 4.546 0.8749 14.316
95% Confidence Interval 
Group Minimum Maximum From To
Column A 9.667 19.887 11.870 14.082
Column B 10.688 17.226 12.731 13.820
Column C 12.162 36.525 13.625 17.223
*  *  *
One-way Analysis of Variance (ANOVA) total sleep squared
The P value is 0.0161, considered significant.
Variation among column means is significantly greater than expected 
by chance.
Student-Newman-Keuls Multiple Comparisons Test 
Mean
Comparison Difference q P value
total sleep eve vs Column C -13.947 3.947 * P<0.05
total sleep eve vs Column B -10.898 3.140 * P<0.05
Column B vs Column C -3.049 0.8703 ns P>0.05
With Student-Newman-Keuls test, it is impossible to calculate confidence 
intervals.
Assumption test: Are the standard deviations of the groups equal?
ANOVA assumes that the data are sampled from populations with identical 
SDs. This assumption is tested using the method of Bartlett.
Bartlett statistic (corrected) = 3.046 
The P value is 0.2180.
Bartlett's test suggests that the differences among the SDs is 
not significant.
Assumption test: Are the data sampled from Gaussian distributions?
ANOVA assumes that the data are sampled from populations that follow 
Gaussian distributions. This assumption is tested using the method 
Kolmogorov and Smirnov:
Group KS P Value Passed normality test?
total sleep eve 0.1326 >0.10 Yes
Column B 0.1539 >0.10 Yes
Column C 0.1477 >0.10 Yes
Intermediate calculations. ANOVA table
Source of Degrees of Sum of Mean
variation freedom squares square
Treatments (between columns) 2 2985.3 1492.7
Residuals (within columns) 81 27799 343.19
Total 83 30784
F = 4.349 =(MStreatment/MSresidual)
Summary of Data
Number Standard
of Standard Error of
Group Points Mean Deviation Mean Median
total sleep eve 28 47.305 21.641 4.090 42.250
Column B 29 58.203 17.925 3.329 56.250
Column C 27 61.251 15.390 2.962 60.063
95% Confidence Interval 
Group Minimum Maximum From To
total sleep eve 9.000 100.00 38.913 55.697
Column B 16.000 110.25 51.386 65.019
Column C 22.563 95.063 55.162 67.341
*  *  *
Kruskal-Wallis Test (Nonparametric ANOVA) -get up time
The P value is < 0.0001, considered extremely significant.
Variation among column medians is significantly greater than expected 
by chance.
The P value is approximate (from chi-square distribution) because 
at least one column has two or more identical values.
Calculation detail
Number Sum Mean 
of of of 
Group Points Ranks Ranks
Column A 29 1817.5 62.672
Column B 32 1582.5 49.453
Column C 30 786.00 26.200
Kruskal-Wallis Statistic KW = 29.070 (corrected for ties)
Dunn's Multiple Comparisons Test
Mean Rank 
Comparison Difference P value
Column A vs. Column B 13.219 ns P>0.05
Column A vs. Column C 36.472 *** PO.OOl
Column B vs. Column C 23.253 ** PO.01
Summary of Data
Number
of
Group Points Median Minimum Maximum
Column A 29 3.767 3.758 3.771
Column B 32 3.764 3.761 3.769
Column C 30 3.762 3.761 3.766
* * *
One-way Analysis of Variance (ANOVA) total time in bed
The P value is 0.5139, considered not significant.
Variation among column means is not significantly greater than expected 
by chance.
Student-Newman-Keuls Multiple Comparisons Test 
Mean
Comparison Difference q P value
total time in b vs Column C -0.3249 1.507 ns P>0.05
total time in b vs Column B -0.2819 — ns P>0.05
Column B vs Column C -0.04298 — ns P>0.05
With Student-Newman-Keuls test, it is impossible to calculate confidence 
intervals.
Assumption test: Are the standard deviations of the groups equal?
ANOVA assumes that the data are sampled from populations with identical 
SDs. This assumption is tested using the method of Bartlett.
Bartlett statistic (corrected) = 5.913 
The P value is 0.0520.
Bartlett's test suggests that the differences among the SDs is 
not quite significant.
Assumption test: Are the data sampled from Gaussian distributions?
ANOVA assumes that the data are sampled from populations that follow 
Gaussian distributions. This assumption is tested using the method 
Kolmogorov and Smirnov:
Group KS P Value Passed normality test?
total time in b 0.1275 >0.10 Yes 
Column B 0.09198 >0.10 Yes 
Column C 0.1229 >0.10 Yes
Intermediate calculations. ANOVA table
Source of Degrees of Sum of Mean
variation freedom squares square
Treatments (between columns) 2 1.839 0.9196
Residuals (within columns) 88 120.64 1.371
Total 90 122.48
F = 0.6708 =(MStreatment/MSresidual)
Summary of Data
Number Standard
of Standard Error of
Group Points Mean Deviation Mean Median
total time in b 29 8.153 1.291 0.2397 8.250
Column B 32 8.435 1.304 0.2305 8.500
Column C 30 8.478 0.8563 0.1563 8.415
95% Confidence Interval 
Group Minimum Maximum From To
total time in b 5.250 10.000 7.662 8.644
Column B 5.000 11.000 7.964 8.905
Column C 6:500 10.500 8.158 8.797
One-way Analysis of Variance (ANOVA)
The P value is 0.0020, considered very significant.
Variation among column means is significantly greater than expected 
by chance.
Student-Newman-Keuls Multiple Comparisons Test 
Mean
Comparison Difference q P value
Vt anti vs c/c anti -0.003872 5.724 ** PO.Ol
t/t anti vs t/t sense -0.0009586 1.417 ns P>0.05
t/t anti vs c/c sense -0.0007087 — ns P>0.05
c/c sense vs c/c anti -0.003163 4.676 ** P<0.01
c/c sense vs t/t sense -0.0002499 — ns P>0.05
t/t sense vs c/c anti -0.002913 4.306 ** P<0.01
With Student-Newman-Keuls test, it is impossible to calculate confidence 
intervals.
Assumption test: Are the standard deviations of the groups equal?
ANOVA assumes that the data are sampled from populations with identical 
SDs. This assumption is tested using the method of Bartlett.
Bartlett statistic (corrected) = 4.709 
The P value is 0.1944.
Bartlett's test suggests that the differences among the SDs is 
not significant.
Assumption test: Are the data sampled from Gaussian distributions?
ANOVA assumes that the data are sampled from populations that follow 
Gaussian distributions. This assumption is tested using the method 
Kolmogorov and Smirnov:
Group KS P Value Passed normality test?
t/t sense 0.1275 >0.10 Yes
c/c sense 0.2627 >0.10 Yes 
t/t anti 0.2148 >0.10 Yes 
c/c anti 0.1993 >0.10 Yes
Intermediate calculations. ANOVA table
Source of Degrees of Sum of Mean
variation freedom squares square
Treatments (between columns) 3 6.992E-05 2.331E-05 
Residuals (within columns) 28 0.0001025 3.660E-06
Total 31 0.0001724
F = 6.368 =(MStreatment/MSresidual)
Summary of Data
Number Standard
of Standard Error of
Group Points Mean Deviation Mean Median
t/t sense 8 0.006081 0.0009596 0.0003393 0.005992 
c/c sense 8 0.005831 0.002154 0.0007615 0.004855 
t/t anti 8 0.005123 0.002158 0.0007628 0.004783 
c/c anti 8 0.008994 0.002104 0.0007439 0.008308
95% Confidence Interval 
Group Minimum Maximum From To
t/t sense 0.004396 0.007800 0.005279 0.006884 
c/c sense 0.003584 0.009467 0.004031 0.007632 
t/t anti 0.002539 0.008400 0.003319 0.006927 
c/c anti 0.005968 0.01173 0.007235 0.01075
Appendix 7
Work conducted towards the Per3 investigation (appendix 5)
- recruited the 484 volunteers at the Science Museum collecting HO 
questionnaire, sleep diary and buccal swabs with the assistance of the 
individuals listed in the acknowledgements
- phenotypically characterised the subjects by analysis HO scores and sleep 
diary data
- extracted DNA from blood samples of DSPS subjects
- extracted DNA from buccal swabs of control population with Dr Simon 
Archer
- helped with statistical analysis
Appendix 8
Primers and annealing temperatures used for amplification of regions of hClock
Region of 
hClock
Primers (S’-S1) Annealing
temperature
(°C)
Product
size
(bp)
Exon 2 DLR 54 (GGGGAAAAGAAGCCTCAAAT)
DLR 55 (TTAGGCATAAAATTCCTTCTATCA) 49 374
Exon 4 DLR 58 (CAGTTTTTCTTATTGGCATTTTCA) 
DLR 59 (ACCCTGCATCATGAGGATTTAG) 51 604
Exon 6 DLR 62 (GCTTTGGAGACATTAGCATCTTC) 
DLR63 (CCTACCCCTTTAACGACTGTTG) 51 541
Exon 8/9 DLR 66 (CTGTTGGGGAAAATAATGGTTGT) 
DLR 67 (GTTTCAGGCAGCTCTCAGCATA) 52 551
Exon 10/11 DLR 68 (CCACTGCACCTGGCCATGACTTA) 
DLR 69 (GCTCACGTGCTTCAGAACAAGGTG) 53 749
Exon 13 i) DLR 43 (AATGATAGC1 I IS GGTT)
DLR 44 (II 1TCCTATTAATTATTGAGTTTC)
then
43
ii)MVS 142 (GGATTTGGCTTCAGACTCATTATT) 
DLR 44 (as above) 52 789
Exon 17 DLR 78 (AAAGCAGAGCAAAGATGGGTGGAT 
DLR 79 (CAAAATGTGAATGGGATGCT) 52 362
Exon 18 DLR 80 (CATACTTTGTAGCTTGATTTTGCC) 
DLR 81 (ACCACTGATCACTCCATAGCCCGC) 56 344
Exon 19 DLR 82 (ATTCTCAGTTACCACGAGTC)
DLR 83 (GGTTGTTTTTCCAGAGCAGTCCAC) 49 994
Exon 20 i) DLR 84 (CTTTTGAATGTGGATATCCAAAGACGT) 
DLR 85(TATTATGACCTCCACTTTACACGTGACG)
then
50
ii) DLR 84 (as above)
DLR 86 (CGTCGTAAAGTCTTCCSSCGACTG) 56 685
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